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SUMMARY 
 
 
Regulation of transcription is crucial for the appropriate development and function of 
eukaryotic cells. In eukaryotes, DNA is organized into a dynamic, complex, nucleoprotein 
structure called chromatin. Chromatin structure provides markedly restricted access of 
transcription factors to regulatory sites. Several mechanisms have evolved to modulate 
chromatin dynamics in order to regulate proper gene expression. One of the most intriguing 
mechanisms that modulate chromatin structure is the exchange of canonical histones with 
histone variants by chromatin remodeling complexes. 
 
Among the histone variants, H2A.Z is an essential regulator of gene transcription. H2A.Z is 
enriched at regulatory regions but significant levels of the histone variant can also be found 
within gene bodies. However, the role of H2A.Z within the gene bodies is still not well 
understood. Recent evidence suggests that active recruitment of H2A.Z within gene bodies is 
required to induce gene repression. In contrast to this view, we show that global inhibition of 
transcription results in H2A.Z accumulation at gene transcription start sites, as well as within 
gene bodies. Our results indicate that accumulation of H2A.Z within repressed genes can also 
be a consequence of the absence of gene transcription rather than an active mechanism required 
to establish repression. 
 
The second part of my Ph.D. project was to investigate the potential role of BRD8 - a subunit 
of the p400/Tip60 complex - in p53-mediated signaling. We find that knockdown of BRD8 
leads to p21 induction and concomitant cell cycle arrest in G1/S. We further demonstrate that 
the p53 transcriptional pathway is activated in BRD8-depleted cells, and this accounts for 
upregulation of not only p21 but also proapoptotic genes, an event that leads to consequent 
apoptosis. Importantly, the DNA damage response is induced upon depletion of BRD8 and 
DNA damage foci are detectable in BRD8-depleted cells under normal growth conditions, as 
indicated by immunostaining for γ-H2AX. Notably, H4K16 acetylation is reduced in BRD8-
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depleted cells suggesting that BRD8 may have a role in recruiting and/or stabilizing the 
p400/Tip60 complex within chromatin, thus facilitating DNA repair. Consistent with the 
activated DNA damage response, we find that in BRD8-depleted cells, CHK2 is activated but, 
surprisingly, CHK1 protein levels are severely reduced. Taken together, our results suggest 
that BRD8 is involved not only in mediating p53-dependant gene suppression, but also in 
mediating the DNA damage response.  
 
In the last part of my Ph.D. project, I investigated the possible mechanisms involved in 
recruitment of the p400 chromatin remodeler complex to chromatin. I showed that histone 
variant H2A.Z is essential for efficient recruitment of p53 and p400 to the distal p53 binding 
element of the p21 promoter. Furthermore, using double knockout (DKO) MEFs for p300/CBP 
I showed that the depletion of p300/CBP lead to a severe decrease in the recruitment of p400 
at p21 promoter. Further studies are necessary to fully understand the role of p300/CBP in 
targeting p400 to chromatin. 
 
In conclusion, my studies provide insights into the molecular mechanisms involved in 
chromatin regulation by histone variant H2A.Z and chromatin remodeler complex p400. 
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SOMMAIRE 
 
 
La régulation de la transcription est un mécanisme crucial pour le bon développement et 
fonctionnement des cellules eucaryotes. Chez les eucaryotes, l'ADN est organisé dans une 
structure dynamique de nucléoprotéines appelée chromatine. La structure de la chromatine 
forme une barrière qui contrôle l'accès des facteurs de transcription à leurs sites de fixation sur 
l’ADN. Plusieurs mécanismes ont été acquis au cours de l'évolution pour moduler la 
dynamique de la chromatine afin de réguler de manière adéquate l'expression des gènes. Un 
des mécanismes les plus intriguant qui module la structure de la chromatine est le 
remplacement des histones canoniques par des variants d'histones. Il est effectué par des 
complex de remodelage de la chromatine.  
 
Parmi les variants d'histones, H2A.Z est un régulateur essentiel de la transcription des gènes. 
H2A.Z est enrichi aux régions régulatrices des gènes, mais des niveaux significatifs de ce 
variant d'histone peuvent aussi être observés au cœur des gènes. Le rôle de H2A.Z localisé a 
lèintérieur gènes n'est, pour l'instant, pas bien compris. Des résultats récents suggèrent que le 
recrutement actif de H2A.Z dans les gènes est requis pour induire leur répression. En 
opposition à ces résultats, nous montrons que l'inhibition globale de la transcription conduit à 
l'accumulation de H2A.Z aux sites d'initiation de la transcription, mais aussi au cœur des gènes. 
Nos résultats indiquent que l'accumulation de H2A.Z dans les gènes réprimés serait une 
conséquence de l'absence de transcription plutôt qu'un mécanisme actif requit pour établir la 
répression. 
 
La seconde partie de mon doctorat a été dédiée à l'étude du rôle de BRD8 (une sous-unité du 
complexe p400/Tip60) dans la signalisation contrôlée par p53. Nous avons trouvé que la 
déplétion de BRD8 conduit à l'induction de p21 et à l'arrêt concomitant du cycle cellulaire en 
phase G1/S. Nous montrons aussi que le circuit transcriptionnel de p53 est activé dans les 
cellules déplétées en BRD8. Cela résulte en l'induction de p21, mais aussi de gènes 
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proapoptotiques, ce qui conduit la cellule en apoptose. De manière marquante, la voie de 
réponse aux dommages de l'ADN est induite suite à la déplétion de BRD8, ce qui est observée 
par l'apparition de foci de dommages à l'ADN révélés par immunocoloration de γ-H2AX. De 
plus, l'acétylation de H4K16 est réduite dans les cellules déplétées en BRD8, suggérant que 
BRD8 pourrait avoir un rôle dans le recrutement et/ou la stabilisation du complexe p400/Tip60 
dans la chromatine, et pourrait donc faciliter la réparation de l'ADN. En accord avec le fait que 
la réponse aux dommages de l'ADN soit activée, nous trouvons que dans les cellules déplétées 
en BRD8, CHK2 est activé mais étonnamment le niveau de la protéine CHK1 était fortement 
diminué. Ensemble, nos résultats suggèrent que BRD8 est impliqué non seulement dans la 
répression des gènes régulés par p53, mais aussi dans la réponse aux dommages de l'ADN.  
 
Finalement, dans la dernière partie de mon doctorat j'ai étudié le mécanisme qui pouvait être 
responsable du recrutement du complexe p400 au niveau de la chromatine. Nous avons montré 
que le variant d'histone H2A.Z est essentiel pour le recrutement de p53 et de p400 au site distal 
de fixation de p53 sur le promoteur de p21. De plus, en utilisant des cellules MEF DKO pour 
p300/CBP, nous avons montré que la déplétion de p300/CBP conduit à une diminution sévère 
du recrutement de p400 au promoteur de p21.  
 
En conclusion, mes études permettent de mieux comprendre les mécanismes moléculaires 
impliqués dans la régulation de la chromatine par l'histone H2A.Z et le complexe de 
remodelage de la chromatine p400. 
 
 
Mots-clés : H2A.Z; p400; Initiation de la transcription; BRD8; dommages de l'ADN 
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CHAPTER 1 
 
 
 
GENERAL INTRODUCTION 
 
 
The present thesis introduction provides a review on the basics of chromatin structure and 
important regulatory mechanisms involved in chromatin dynamics affecting gene regulation. 
In addition, different aspects of the histone variant H2A.Z and the chromatin remodeler 
p400/Tip60 are also reviewed, as they relate to the project and the results presented in chapters 
2, 3 and 4. 
 
 
Chromatin Structure and Regulation of Transcription 
 
 
It is estimated that the human genome encodes approximately 25,000 genes. All the somatic 
cells in one organism have the same genome, the same genotype, but at the same time, cells 
from different tissues drastically differ in appearances, properties and biological 
functions. Proper regulation of gene expression guarantees the proper phenotype and is crucial 
during differentiation and development of an organism. In eukaryotes, transcriptional 
regulation necessitates a balance between repressive packaging of the genome into 
nucleosomes and enabling access to RNA polymerase II (RNA pol II) and regulatory proteins. 
In this process, epigenetic mechanisms play a crucial role to regulate the states of chromatin 
compaction, conformation, modifications and content (Venkatesh and Workman, 2015). 
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1.1 Chromatin Structure  
 
 
In eukaryotes, the size of DNA is far larger than the size of the compartment in which it is 
contained. Indeed, the total length of a human being's DNA is approximately two meters, while 
the average diameter of the nucleus, where the DNA is stored, is approximately six 
micrometers (Alberts et al., 2014). In order to be able to fit into the nucleus, DNA has to be 
condensed in some manner. To do so, DNA molecules form millions of ordered nucleoprotein 
particles, referred to as nucleosomes, which are just the first level of DNA packing. Next, 
higher ordered structures help to further compact the DNA within the nucleus, which results 
in an organized and dynamic structure known as the chromatin (Woodcock and Ghosh, 2010). 
Although these levels of compaction are necessary to help contain DNA in the nucleus, they 
represent an important accessibility barrier for many cellular processes. Hence, several 
mechanisms have evolved to overcome this barrier and to regulate proper gene expression, an 
aspect that is crucial for the appropriate development and function of eukaryotic cells (Clapier 
and Cairns, 2009).  
 
 
1.1.1 Nucleosomes 
 
 
In eukaryotic cells, DNA is associated with about an equal mass of histone proteins in a highly 
condensed nucleoprotein complex called chromatin. The building block of chromatin is the 
nucleosome. The nucleosome consists of an octamer of core histone proteins, 2 copies each of 
canonical histone H2A, H2B, H3, and H4, that is wrapped 1.65 times per 146 base pairs (bp) 
of DNA (Fig. 1.1). Histones’ N- and C-terminal tails protrude from the nucleosome and can 
be the harbor sites for various post-translational modifications and make contact with adjacent 
nucleosomes. Of note, all eukaryotes also contain lower abundance histone variant proteins 
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that can be incorporated into nucleosomes for regulatory purposes (Talbert and Henikoff, 
2010) (see also section 4.1). 
 
 
 
Figure 1.1 Nucleosome structure in front (left) and side view (right), showing that (H3/H4)2 
is at the center of the DNA wrap, with two dimers of H2A/H2B docked at the edges, near the 
DNA entry and exit locations. The different histone proteins (depicted in cartoon 
representation) are drawn in yellow: H2A, red: H2B and blue: H3, green: H4. The backbone 
of DNA is in gray (Weber and Henikoff, 2014).  
 
 
Two adjacent nucleosomes in an array connect to each other by linker DNA. The length of 
linker DNA is variable between species and tissues and even within a single cellular genome. 
It ranges between 20 and 90 base pairs (Van Holde et al., 1974). In higher eukaryotes, a linker 
histone (commonly H1 or H5) associates with the linker DNA at the site of DNA's entry to/exit 
from the nucleosome and influences the orientation of linker DNA with respect to the 
nucleosome (Hamiche et al., 1996; Syed et al., 2010; Szerlong and Hansen, 2011).  
 
 
In low salt concentration and in the absence of divalent cations (e.g. Mg2+), nucleosomes that 
are connected by linker DNA have the appearance of “beads on a string” by electron 
microscopy. This structure is the 10 nm fiber (Olins and Olins, 1974) and has been seen in 
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endogenous and reconstituted chromatin. However under physiological conditions this 
conformation is not the most favored conformation of the chromatin (Szerlong and Hansen, 
2011; Thoma et al., 1979; Woodcock and Ghosh, 2010). 
 
 
1.1.2 Structure of the 30 nm Fiber 
 
 
Under physiological conditions, linear chromatin condenses to form chromatin superhelical 
secondary structure of 30 nm fibers in both interphase and metaphase chromosomes (Szerlong 
and Hansen, 2011; Woodcock and Ghosh, 2010) (Fig. 1.2). X-ray diffraction revealed 30 nm 
chromatin fibers in different cell types such as transcriptionally active chicken erythrocytes, 
HeLa metaphase chromatin and Balbiani ring genes in Chironomus tetans (Midge) (Andersson 
et al., 1982; Horowitz-Scherer and Woodcock, 2006; Langmore and Paulson, 1983; Langmore 
and Schutt, 1980; Paulson and Langmore, 1983). Several models have been proposed for the 
30 nm fiber:  
- Two start helical ribbon model (zigzag) (Dorigo et al., 2004; Schalch et al., 2005; Woodcock 
and Ghosh, 2010) 
- Two start cross-linker model (zigzag) (Szerlong and Hansen, 2011; Woodcock and Ghosh, 
2010) 
- One start solenoid model (Robinson and Rhodes, 2006; Widom and Klug, 1985) 
 
 
So far, our knowledge about the detailed structure of the 30 nm chromatin fiber remains 
controversial. The structure is mostly the result of intrinsic characteristics of native chromatin 
such as the variation of linker length, histone components, histone variants and their 
modifications, DNA sequence and architectural chromatin proteins (scaffold protein) (Li and 
Reinberg, 2011; Szerlong and Hansen, 2011; van Holde and Zlatanova, 2007).  
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Figure 1.2 Levels of chromatin compaction from double helix DNA toward metaphasic 
chromosome (Felsenfeld and Groudine, 2003). 
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1.1.3 Chromatin Structure beyond the 30 nm 
 
 
Chromatin tertiary structures, also referred to as fiber–fiber interactions, are formed from 
interactions between 30 nm chromatin fibers. Fibrous chromatin loops and other 
superstructures found in both metaphase chromosomes and specialized regions of interphase 
chromosomes, such as gene enhancers and insulators, are examples of chromatin tertiary 
structures. (Li and Reinberg, 2011; Szerlong and Hansen, 2011; Woodcock and Ghosh, 2010). 
The structural properties of chromatin structure beyond the 30 nm are largely unknown. In 
addition, chromatin fiber oligomerization is both cooperative and reversible and, like 
chromatin secondary structure, requires core histone amino-terminal “tail” domains.  
 
 
1.1.4 Chromatin Dynamics  
 
 
The mechanisms of gene expression rely on the structure and the composition of chromatin. 
The packaging of chromosomal DNA by nucleosomes condenses and organizes the genome 
but occludes many regulatory DNA elements and represents an accessibility barrier for many 
cellular metabolic processes such as gene transcription, DNA replication, DNA repair and 
DNA recombination (Clapier and Cairns, 2009). There are different mechanisms in the cell to 
overcome this barrier that provide a highly regulated system of DNA packaging and 
unpackaging, thus regulating the accessibility of DNA to DNA-binding factors. Indeed, 
chromatin structure exhibits a highly dynamic equilibrium between an open and permissive 
conformation of 10 nm beads on string, and the condensed, non-permissive 30 nm fiber.  
 
 
The accessibility of DNA in chromatin is modulated by the incorporation of histone variants 
and two classes of enzymes: histone modifying enzymes and ATP-dependent nucleosome 
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remodelers (Clapier and Cairns, 2009; Kouzarides, 2007). The introduction of each histone 
variant to the nucleosome conveys a unique structure in chromatin that can influence the 
accessibility of DNA (Talbert and Henikoff, 2010). Histone modifying enzymes post-
transcriptionally modify histones which alters the structure of chromatin and also provides 
binding sites for regulatory proteins; whereas, chromatin remodeling complexes use the energy 
of ATP to disrupt histone octamer-DNA contacts by translocating nucleosomes along DNA, 
removing histones by ejection or exchanging histones. Below, I describe these regulatory 
elements in more detail. 
 
 
1.2 Histone Modifications and Modifying Enzymes 
 
 
Histone modifying enzymes post-transcriptionally modify histones. There are ever-growing 
numbers of different histone post-translational modifications (PTMs), which introduce 
meaningful variation into chromatin and are referred to collectively as the “Histone Code”. 
The “histone code hypothesis,” initially proposed by Allis in 2000, states that “multiple histone 
modifications, acting in a combinatorial or sequential fashion on one or multiple histone tails, 
specify unique downstream functions” (Strahl and Allis, 2000). Further studies revealed a wide 
range of histone modifications and the enzymes responsible for their placement (referred to as 
writers) and removal (referred to as erasers), as well as the protein domains that can recognize 
these modifications (referred to as readers). Writers, erasers and readers are responsible for the 
establishment of homeostasis of combinatorial patterns of histone modifications in a given 
cellular context (Allis and Jenuwein, 2016). 
 
 
Most of the histone modifications occur in the N-terminal tails, but histone cores and C-termini 
can be modified as well. Modifications affect the properties of the histones and the chromatin 
containing them and, hence, the chromatin structure of the region. In addition to regulating the 
chromatin structure, they also recruit chromatin remodeling complexes. The recruitment of 
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proteins and complexes with specific enzymatic activity is how modifications mediate their 
function (Bannister and Kouzarides, 2011). In this way, modifications can influence all the 
DNA-involved processes such as transcription, replication, recombination and repair. Different 
classes of modifications and their functions are summarized in Table 1.1 and, in the following 
sections, the most studied modifications, namely acetylation and methylation, will be 
reviewed.  
 
Table 1.1 Different classes of modifications identified on histones and their functions 
(Adapted from (Sadri-Vakili and Cha, 2006). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
2.1 Histone Acetylation 
Chromatin Modifications Histone  Residues Modified Associated Function 
Acetylation H2A 
H2B 
H3 
 
 
H4 
K5 
K5, K12, K15, K20 
K4, K14, K18, K23, K27 
K9 
K5, K12 
K8, K16 
Transcription Activation 
Transcription Activation 
Transcription Activation 
Histone Deposition 
Histone Deposition 
Transcription Activation 
Methylation (K) H3 
 
 
 
H4 
K4, K79 
K9, K27 
R17 
K36 
R3 
K20 
Euchromatin 
Silencing 
Transcription Activation 
Transcription Elongation 
Transcription Activation 
Silencing 
Phosphorylation H2A 
H2AX 
 
 
H2B 
H3 
H4 
S1, T119 
S139 
Y142 
 
S14 
T3, S10, T11, S28 
S1 
Mitosis 
DNA Damage Repair 
Regulation of DNA 
Damage Foci Formation 
Apoptosis 
Mitosis 
Mitosis 
Ubiquitylation H2A 
H2B 
K119 
K120 
Silencing, Spermatogenesis 
Transcription Activation/ 
(elongation?) 
Sumoylation H2A 
H2B 
H3 
H4 
K126 
K6, K7, K16, K17 
K6, K7 
K12 
 
Transcription Repression 
ADP ribosylation H2A 
H2B 
H3 
H4 
K13 
E2, K30 
K27, K37 
K16 
 
Relaxed Chromatin and 
DNA Damage Response 
Deimination R > Cit Arginine Demethylation 
Transcription Repression 
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1.2.1 Histone Acetylation 
 
 
1.2.1.1 Histone Acetyl Transferases (HATs) 
 
 
The HATs utilize acetyl Co-A as a cofactor and catalyze the transfer of an acetyl group to the 
ε-amino group of lysine side chains and by doing this they neutralize the lysine’s positive 
charge and cause weaker interaction between histones and DNA. In addition, acetylated lysines 
of histones provide binding sites for protein domains such as bromodomains and PHD fingers, 
which are often found in HATs, and chromatin remodeling complexes. Their function may be 
to open up chromatin by neutralizing the positive charges of histones, and thereby weakening 
their interaction with DNA (Bannister 2011).  
 
 
There are two major classes of HATs: type–A and type-B. The type-A HATs are a diverse 
family. They are classified into three separate families depending on amino acid sequence 
homology and conformational structure: GNAT, MYST and CBP/p300 (Hodawadekar and 
Marmorstein, 2007). Each of these enzymes modifies multiple sites within the histone N-
terminal tails. This class of enzyme exhibits functions of numerous transcriptional coactivators. 
(Bannister and Kouzarides, 2011; Das et al., 2009). Like many other histone modifying 
enzymes, type-A HATs are often found associated in large multiprotein complexes. The 
components of these complexes have important roles in controlling enzyme recruitment, 
activity and substrate specificity (Bannister and Kouzarides, 2011). Type-B HATs are 
predominantly cytoplasmic and acetylate-free histones; they are not able to acetylate histones 
already incorporated into the chromatin. This class of HATs is highly conserved and has high 
sequence homology with scHat1. Type-B HATs acetylate newly synthesized histones H4 at 
K5, K12 and H3. This pattern of acetylation is important for histone deposition and is removed 
after their incorporation (Bannister and Kouzarides, 2011).  
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1.2.1.2 Histone Deacetylases (HDACs) 
 
 
HDAC enzymes oppose the effects of HATs, they reverse lysine acetylation and restore the 
positive charge of lysine residues. By doing this they stabilize the chromatin structure and act 
as transcriptional repressors. HDACs have relatively low substrate specificity; a single enzyme 
is capable of deacetylating multiple sites within histones (Bannister and Kouzarides, 2011). 
There are four classes of HDACs: Classes I and II contain enzymes that are most closely related 
to yeast scRpd3 and scHda respectively, class III (sirtuins) are homologous to yeast scSir2 and 
class IV has only one member, HDAC11. In contrast to other HDAC classes, class III requires 
NAD+ for its activity (Bannister and Kouzarides, 2011). 
 
 
1.2.2 Histone Methylation 
 
 
1.2.2.1 Histone Methyltransferases 
 
 
Histone methylation mainly occurs on side chains of lysine and arginine. This modification 
does not alter the charge of the histone. Furthermore, lysines may be mono-, di-, or tri-
methylated, whereas arginines may be mono- or di- (symmetrically or asymmetrically) 
methylated. Histone lysine methyltransferases (HKMT) mainly methylate lysines within N-
terminal tails of histones. All HKMTs catalyze the transfer of a methyl group from S-
adenosylmethionine (SAM) to the ε-amino group of a lysine residue. HKMTs are generally 
specific for residues and also for modification degrees (i.e., mono-, di- and/or tri-methyl state) 
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(Bannister and Kouzarides, 2011). There are two classes of arginine methyltransferases: type-
I and type-II. Type-I generates mono-methyl arginine (Rme1) and asymmetric di-methyl 
arginine (Rme2as), whereas type-II generates Rme1 and symmetric di-methyl arginine 
(Rme2s). Together, these two types of arginine methyltransferases, referred to as PRMT, have 
11 members.  
 
 
1.2.2.2 Histone Demethylases 
 
 
Histone demethylase enzymes were discovered more recently. In 2004, the first lysine 
demethylase was identified: lysine-specific demethylase 1 (LSD1) (Shi et al., 2004). Another 
class of lysine demethylase JHDM1 (JmjC domain-containing histone demethylase 1) was 
discovered in 2006 (Tsukada et al., 2006). Today, many additional histone lysine demethylases 
have been found and, with the exception of LSD1, they all contain a catalytic jumonji domain. 
Like methyltransferases, demethylases possess specificity for their targets and for the level of 
demethylation of their targets (Bannister and Kouzarides, 2011). The jumonji protein is also 
shown to be capable of demethylating arginine (i.e. JMJD6) (Chang et al., 2007). Moreover, 
there is another mechanism for the reversal of the methylation of arginine residues - the 
conversion of arginine to citrulline via deimination reaction (Bannister and Kouzarides, 2011; 
Goto et al., 2002; Sugiyama et al., 2002).  
 
 
1.3 Histone Variants  
 
 
A fraction of histones are non-allelic variants that are less abundant compared to canonical 
histones. The variants are usually present as single-copy genes. Histone variants have distinct 
biophysical characteristics and localize to specific regions of the genome where they are 
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thought to alter the properties of nucleosomes and nucleosome dynamics within those regions 
(Kamakaka and Biggins, 2005). These properties of histone variants are important to shape the 
chromatin landscape of cis-regulatory and coding regions in support of specific transcription 
programs (Weber and Henikoff, 2014). Unlike canonical histones, the expression of most 
histone variant genes is not restricted to S-phase but continues throughout the cell cycle 
(Kamakaka and Biggins, 2005). Their genes contain introns and their transcripts are often 
polyadenylated. The major histone variants and their general functions are summarized in 
Table 1.2.  
 
 
Since my PhD project was focused on the histone variant H2A.Z, I will present this variant in 
more detail in the following section. 
 
 
Table 1.2 The most studied histone variants and their functions. 
Family Variant Species Localization Function 
H3 H3.3 Ubiquitous Transcription region Active transcription triggers 
deposition/removal 
CenH3 Ubiquitous Centromere Kinetochore formation/function 
H2A H2A.Z Ubiquitous Promoter, heterochromatin 
boundary, gene body of 
repressed genes, DNA 
DSBs 
Transcription activation/ 
repression, chromatin segregation, 
DNA repair 
H2A.X Ubiquitous DNA damage site DNA repair, recombination, 
transcription repression 
H2A.BbD Vertebrates Active X chromosome / 
autosome 
Transcription activation 
Macro H2A Vertebrates Inactive X chromosome X chromosome inactivation 
H2A.Lap1  Mouse  Inactive X chromosome Transcription activation during 
spermatogenesis. 
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1.3.1 Histone Variant H2A.Z 
 
 
H2A.Z is highly conserved with Ң90% sequence identity among different organisms ranging 
from yeast to humans (Malik and Henikoff, 2003). It replaces H2A in approximately 5% of 
yeast and 10% of chicken and mammalian nucleosomes. H2A.Z is essential for viability in 
mice (Faast et al., 2001), Xenopus (Ridgway et al., 2004), Drosophila (van Daal and Elgin, 
1992) and Tetrahymena (Liu et al., 1996), while its deletion causes growth retardation in yeast 
(Redon et al., 2002). H2A.Z is involved in diverse biological functions in different species 
such as regulation of gene expression both positively and negatively (Adam et al. 2001; 
Larochelle and Gaudreau 2003, Barski 2007, Gevry 2007), chromosome segregation 
(Rangasamy 2004, Krogan et al. 2004), cell cycle progression (Dhillon et al. 2006), 
maintenance of heterochromatin-euchromatin boundaries (Meneghini et al. 2003), the 
establishment of constitutive heterochromatin (Fan et al. 2004, Sarcinella 2007) and DNA 
damage repair (Alatwi and Downs, 2015; Gonzalez-Perez et al., 2013; Xu et al., 2012). Despite 
the fact that H2A.Z has been studied in detail, the role of this variant in the regulation of 
transcription is as of yet not fully understood.  
 
 
1.3.1.1 H2A.Z Nucleosome Properties 
 
 
H2A.Z shares ~60% sequence identity with H2A (Fig. 1.3 A). The three-dimensional structure 
of an H2A.Z-containing nucleosome is overall similar to that of the H2A nucleosome (Suto et 
al., 2000) (Fig. 1.3 A). However, there are subtle differences in specific regions between the 
structures of the two nucleosomes (Suto et al., 2000) that might explain their functional 
differences. The main structural difference between H2A and H2A.Z resides within the C-
terminal “docking domain,” which is the surface interacting with the H3/H4 dimer (Fig. 1.3 A 
and B). The H2A.Z docking domain has less than 40% amino acid identity with H2A. 
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Structural studies have shown that altering H2A.Z's docking domain affects the interface 
between the H2A.Z/H2B dimer and the H3/H4 dimer (Malik and Henikoff, 2003; Suto et al., 
2000). Indeed, substitution of glutamine 104 (Q) in H2A with glycine (G) in H2A.Z (Fig. 1.3 
red arrow) results in the loss of three hydrogen bonds with H3, causing subtle destabilization 
of the interaction between the H2A.Z docking domain and H3 (Suto et al., 2000). This results 
in a ‘looser’ packaging of H2A.Z-containing nucleosomes and an open chromatin structure 
that improves the accessibility of the nucleosomal DNA to the transcriptional machinery. 
Furthermore, the docking domain of H2A.Z creates (presents) an interaction site for metal ion-
binding on the surface of the nucleosome that may create a very specific interaction interface 
for other factors, whereas the corresponding region in H2A is not able to perform this type of 
interaction (Suto et al., 2000). Another difference between H2A and H2A.Z is the extension of 
a patch of acidic residues in the αC helix of the docking domain. In H2A.Z, the acidic patch is 
composed of four acidic residues compared to three in H2A. Altogether, these differences 
result in an altered H2A.Z/H2B dimer surface and an uninterrupted acidic surface around the 
H2A.Z nucleosomes that are important to explain the distinct physiological role of the variant. 
 
 
Several studies have attempted to understand the importance of the altered C-terminus of 
H2A.Z. Research on Drosophila revealed that a region of H2A.Z, referred to as M6 and 
containing the acidic patch, is essential for embryonic development and viability (Clarkson et 
al., 1999) demonstrating the functional importance of the acidic patch. Furthermore, specific 
mutations in the acidic patch result in sensitivity to genotoxic stress (Jensen et al., 2011). In 
addition, the acidic patch and C-terminus contain some residues, such as a metal ion-binding 
site, that are important for H2A.Z deposition into chromatin and can also serve as a potential 
interaction platform on the surface of the nucleosome to recruit specific factors or modulators.
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Figure 1.3 Comparison between H2A.Z and H2A (A) Sequence alignment of Xenopus laevis 
H2A and mouse H2A.Z. Intervals of 10 amino acids for H2A (filled circle) and H2A.Z (open 
circle) are indicated. Differences between the two amino acid sequences are colored red. 
Regions that are essential for the function of H2A.Z are boxed. The docking domain is 
indicated with a dashed line, secondary structure elements of the histone fold (α1, α2 and α3) 
and extensions (αN and αC) are indicated. Red arrow shows glutamine 104 [Q] in H2A and 
glycine [G] in H2A.Z. (B) Superposition of canonical nucleosome and H2A.Z nucleosome, 
viewed down the superhelical axis. Only 73 bp of the DNA and associated proteins are shown. 
Regions of protein-DNA interaction are numbered starting from the nucleosomal dyad. H3 is 
colored blue, H4 green, H2B red, H2A yellow, H2A.Z gray, and DNA brown. (C) Side view 
of the superimposed nucleosomes in (A) (rotated by 90° around the y-axis) with parts of the 
DNA removed for clarity. (D) Superposition of H2A and H2A.Z, in a view similar to that in 
(A). The docking domain is boxed (Suto et al., 2000).
B C D 
A 
 16 
 
It has been shown that the C-terminal region of H2A.Z can interact with some components of 
the transcriptional apparatus such as pol II and TBP and the substitution of the H2A C-terminus 
with H2A.Z is sufficient to provide the H2A.Z’s unique function in positive regulation of gene 
transcription in yeast cells with a deletion of H2A.Z gene (Adam et al., 2001). The acidic patch 
of H2A.Z in yeast was shown to be critical for mediating its deposition in chromatin and 
represents a potential candidate for the interaction of H2A.Z with its deposition and/or 
targeting machinery (Jensen et al., 2011). Recently, it was shown that a short region of the 
docking domain of H2A.Z interacts with the histone chaperone ANP32E (Obri et al., 2014). 
This interaction is important in order to evict H2A.Z/H2B dimers from nucleosomes and to 
stabilize the dimers once released (Obri et al., 2014). Finally, the acidic patch is also required 
for H2A.Z to promote higher-order chromatin folding in higher eukaryotes (Fan et al., 2004). 
 
 
In addition to the docking domain, the loop 1 (L1) region is quite different between H2A and 
H2A.Z. Loop 1 is where the two H2A (or two H2A.Z) molecules come into contact with each 
other in the same nucleosome (Luger et al., 1997; Suto et al., 2000). Structural studies indicate 
that steric clashes preclude heterodimerization of H2A and H2A.Z in the same nucleosome 
(Suto et al., 2000). However, more recent studies confirm that both homotypic (with 2 
H2A.Z/H2B dimers), and heterotypic (with one H2A.Z/H2B dimer), nucleosomes exist (Luk 
et al., 2010; Weber et al., 2010). 
 
 
Based on the structural study, incorporation of H2A.Z confers unique structural features on the 
nucleosome compared to H2A (Suto et al., 2000). Surprisingly, there are contradictory reports 
indicating that H2A.Z both positively and negatively affects nucleosome stability in vitro 
(Abbott et al., 2001; Li et al., 2005; Park et al., 2005; Suto et al., 2000). In vitro studies showed 
that nucleosomes containing recombinant H2A.Z or native chicken erythrocyte H2A.Z are 
more stable than H2A-containing nucleosomes (Park et al., 2004; Thambirajah et al., 2006). 
Controversially, there are studies indicating that nucleosomes containing H3.3/H2A.Z have 
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decreased nucleosome stability (Jin and Felsenfeld, 2007; Jin et al., 2009), while another in 
vitro study reported no difference in stability between H3.3/H2A.Z and H3.3/H2A (Thakar et 
al., 2009). Overall, it seems that H2A.Z slightly stabilizes in vitro and destabilizes in vivo. This 
may be partly explained by the different methods used in these studies. Besides, acetylation of 
H2A.Z in active genes in vivo (Bruce et al., 2005; Valdes-Mora et al., 2012) or the fact that 
H2A.Z nucleosomes can be either heterotypic or homotypic might explain these discrepancies 
(Luk et al., 2010; Weber et al., 2010). However, the mechanism of transcription regulation by 
the incorporation of H2A.Z is as of yet not fully understood. 
 
 
1.3.1.2 H2A.Z in Transcriptional Regulation 
 
 
A role for H2A.Z in transcription was first proposed more than 30 years ago by Allis et al. In 
1980, they showed that H2A.Z is exclusively present in the transcriptionally active 
macronucleus in Tetrahymena but not in the inactive micronucleus (Allis et al., 1980). Further 
studies in yeast showed that H2A.Z regulates gene transcription (Adam et al., 2001; 
Santisteban et al., 2000). Later, studies on the role of H2A.Z in transcription were also 
conducted in yeast ,where genome-wide localization analysis demonstrated that H2A.Z-
containing nucleosomes occupy specific regions across the genome. It has been observed that 
H2A.Z marks the 5' ends of both active and inactive genes in euchromatin (Raisner et al., 
2005). Furthermore, one or two H2A.Z-containing nucleosomes observed at TSS flanking 
regions of nearly all euchromatic genes, both active and inactive, and at TATA-less promoters, 
are perhaps indicative of a role in the formation of nucleosome free regions (NFR) (Guillemette 
et al., 2005; Li et al., 2005; Raisner et al., 2005; Zhang et al., 2005a). Loss of H2A.Z in yeast 
leads to defects in transcriptional activation, while its presence at gene promoters seems to be 
inversely correlated with transcription levels (Guillemette et al., 2005; Li et al., 2005; Raisner 
et al., 2005; Zhang et al., 2005a). Following gene activation, H2A.Z is rapidly evicted (Adam 
et al., 2001; Auger et al., 2008; Larochelle and Gaudreau, 2003; Li et al., 2005; Santisteban et 
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al., 2000), suggesting a role for H2A.Z in the chromatin structure of inducible genes 
(Guillemette et al., 2005; Zhang et al., 2005a).  
 
 
Intriguingly, the repressive effect of H2A.Z on stress-inducible genes was also observed in 
yeast (Lindstrom et al., 2006). H2A.Z mutant yeast have been reported to de-repress silencing 
at the HMR locus (Dhillon and Kamakaka, 2000). H2A.Z found at genes near sub-telomeric 
regions antagonizes the spreading of heterochromatin onto euchromatin regions (Meneghini et 
al., 2003). Non-acetylated and ubiquitinated versions of H2A.Z co-localizes with facultative 
heterochromatin marks, such as H3K9me2, in heterochromatic, peri-centric and sub-telomeric 
regions (Fan et al., 2004; Hanai et al., 2008; Hardy et al., 2009; Sarcinella et al., 2007; 
Swaminathan et al., 2005). Furthermore, immunofluorescence experiments in Drosophila and 
mammalian cells confirmed that H2A.Z is mainly associated with heterochromatin such as 
peri-centric regions (Rangasamy et al., 2003; Sarcinella et al., 2007; Swaminathan et al., 2005). 
In 2008, the Zilberman and Henikoff research group’s genome-wide studies on Arabidopsis 
thaliana showed that DNA methylation could be antagonistic to the incorporation of H2A.Z 
and thereby regulate gene silencing by excluding H2A.Z (Zilberman et al., 2008).  
 
 
Beside the activation role of H2A.Z in transcription, it has been shown that H2A.Z has a role 
in promoting elongation via facilitating RNA pol II passage by affecting the correct assembly 
and modification status of pol II elongation complexes and by favoring efficient nucleosome 
remodeling over the gene (Santisteban et al., 2011). More recently, an anti-correlation between 
H2A.Z occupancy and stalled pol II has been observed (Weber et al., 2014). These 
observations suggest that H2A.Z/H2B dimers can be more easily removed from nucleosomes 
than H2A/H2B dimers hence aiding RNA pol II transcriptional elongation. In addition, it 
proposes that H2A.Z has a role in recruitment or stimulating the activity of the transcription 
elongation complex FACT (Weber and Henikoff, 2014). 
 19 
 
In higher eukaryotes, H2A.Z is highly enriched at promoter regions both at the upstream -1 
nucleosome and downstream +1 nucleosome of TSS, similar to its distribution in yeast 
(Raisner et al., 2005) (Fig. 1.4), and also at regulatory elements such as enhancers and 
insulators (Barski et al., 2007; Bruce et al., 2005). One difference between yeast and humans, 
as well as Drosophila is that the presence of H2A.Z at human genes promoters is positively 
correlated with the presence of RNA pol II and transcription (Barski et al., 2007; Hardy et al., 
2009; Mavrich et al., 2008).  
 
 
 
 
Figure 1.4 H2A.Z enrichment patterns and promoter architecture differences in different 
organisms. Green intensity represents H2A.Z enrichment (Weber and Henikoff, 2014). 
 
 
A negative role for H2A.Z in transcription has also been reported in mammals. It was shown 
by our laboratory that H2A.Z negatively regulates p53 target gene p21 (Gevry et al., 2007). 
Indeed, it was shown that p400 inhibits p21 expression by depositing H2A.Z into nucleosomes 
at p53 binding sites in the p21 promoter in unstressed condition (Gevry et al., 2007). In stressed 
conditions, p53 binds to its specific response elements (REs) at the p21 promoter and activates 
its transcription. Furthermore, the Espinosa laboratory identified a mechanism of repression 
involving the recruitment of the H2A.Z remodeling complex SRCAP and H2A.Z deposition at 
the promoters of ∆Np63α target genes (Gallant-Behm and Espinosa, 2013; Gallant-Behm et 
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al., 2012). As mentioned earlier, H2A.Z occupies the +1 nucleosome of the promoter of active 
genes; it was shown that the +1 nucleosome of active genes silenced during mitosis shifted 
upstream to occupy TSSs during mitosis thereby significantly reducing the length of the NFR. 
The mitotic shifting was specific to active genes that were silenced during mitosis and was not 
seen at promoters which are silenced by methylation or mitotically expressed genes (Kelly et 
al., 2010). 
 
 
How can H2A.Z produce both positive and negative effects in transcription? One explanation 
is that H2A.Z facilitates the recruitment of both activator and repressor complexes by acting 
as a ‘general facilitator’ that generates access for a variety of complexes both activating and 
repressive (Creyghton et al., 2008; Hu et al., 2013; Li et al., 2012). Studies in embryonic stem 
cell (ESC) self-renewal and differentiation provide evidence for this model. H2A.Z facilitates 
the binding of the PRC2 complex to repressed genes and of MLL complexes to active genes 
in self-renewing ESCs (Hu et al., 2013). During differentiation of ESCs, H2A.Z facilitates 
retinoic acid-induced RARα binding, activation of differentiation markers and the repression 
of pluripotency genes (Hu et al., 2013). H2A.Z and transcription factor Foxa2 both act to 
regulate nucleosome depletion and gene activation during ESCs differentiation (Li et al., 
2012). Interestingly, nucleosome depletion during ESC differentiation is dependent on the 
SWI/SNF and Ino80 chromatin remodeling complexes (Li et al., 2012), which suggests that 
the cycle of deposition and removal of H2A.Z modulates the accessibility of regulatory factors 
or complexes (Weber and Henikoff, 2014).  
 
 
Another explanation for the role of H2A.Z in both positive and negative regulation of 
transcription comes from our own laboratory studies in both human cells and yeast, where we 
showed that H2A.Z is required for the proper positioning of nucleosomes at promoters (Gevry 
et al., 2009; Guillemette et al., 2005; Marques et al., 2010; Millau and Gaudreau, 2011). As 
such, one can imagine that stable phasing of nucleosomes by H2A.Z may influence 
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transcription by either favoring the recruitment of transcription factors or the opposite; 
preventing the recruitment of such factors by masking their DNA binding sites (Marques et al., 
2010).  
 
 
Although genome-wide localization of H2A.Z is principally at gene regulatory regions, it can 
also be found within gene bodies in both yeast and metazoans (Hardy et al., 2009; Latorre et 
al., 2015). However, little is known about the role of H2A.Z within gene bodies. In a recent 
study, the recruitment of H2A.Z within gene bodies by the DREAM complex has been 
proposed to cause the repression of the targeted gene. They suggested that active recruitment 
of H2A.Z within gene bodies is required to establish gene transcriptional repression (Latorre 
et al., 2015). In contrast, Hardy and colleagues previously showed that active gene transcription 
would prevent H2A.Z from associating to gene bodies (Hardy et al., 2009). They showed that 
upon shut down of heat-shock genes in yeast, H2A.Z re-associates with gene bodies. Moreover, 
they found that yeast RNA Pol II-associated histone chaperones FACT and Spt6 prevent 
accumulation of H2A.Z within gene bodies during transcription by evicting H2A.Z from 
nucleosomes and exchanging it with H2A (Jeronimo et al., 2015). These experiments suggest 
that H2A.Z accumulation within gene bodies would be the consequence of gene repression. In 
chapter 2 we attempt to verify whether the recruitment of H2A.Z within the body of repressed 
genes is the cause, or the consequence of the gene repression. 
 
 
1.3.1.3 H2A.Z Deposition and Removal  
 
 
Deposition of yeast H2A.Z is accomplished by the Swr1 complex (Swr1.com) (Kobor et al., 
2004; Krogan et al., 2003; Mizuguchi et al., 2004). Histone chaperones Nap1 and Chz1 
preferentially bind to H2A.Z–H2B dimers and deliver them to Swr1.com for deposition into 
chromatin (Luk et al., 2007). Efficient Swr1.com deposition of H2A.Z at promoter regions is 
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further promoted by a specific pattern of histone H3 and H4 tail acetylation (Altaf et al., 2007; 
Li et al., 2005; Raisner et al., 2005; Zhang et al., 2005a). H4 Lys 16 is shown to be required 
for H2A.Z incorporation at telomeres by Swr1(Altaf et al., 2007; Shia et al., 2006). Higher 
eukaryotes contain two distinct ATP-dependent complexes depositing H2A.Z in vivo and in 
vitro: SRCAP and p400, (Gevry et al., 2007; Ruhl et al., 2006; Wong et al., 2007) both of 
which are homologous to yeast Swr1 (see also section 5).  
 
 
Mutagenesis of a typical promoter revealed that a 22 bp segment of DNA containing a binding 
site of the Myb-related protein Reb1 and an adjacent dT:dA tract is sufficient to program 
formation of a NFR flanked by two H2A.Z nucleosomes (Raisner et al., 2005; Ranjan et al., 
2013; Yen et al., 2013). NFRs are characterized by two well-positioned flanking nucleosomes 
principally located at the gene promoter. Whether NFR formation is required for H2A.Z 
deposition or vice versa is debated. Our laboratory suggested that H2A.Z deposition plays a 
role in nucleosome positioning, while others proposed that H2A.Z deposition has no role 
(Guillemette et al., 2005; Li et al., 2005). Later, it has been shown that H2A.Z pre-deposition 
is dispensable for NFR formation but NFR formation promotes H2A.Z deposition (Hartley and 
Madhani, 2009). Recruitment of H2A.Z to NFR may explain H2A.Z enrichment at 
nucleosomes flanking promoters but it cannot explain the lack of upstream H2A.Z 
nucleosomes in organisms such as Arabidopsis and Drosophila (Mavrich et al., 2008; 
Zilberman et al., 2008) (Fig. 1.4), and it also cannot explain the enrichment of H2A.Z in the 
gene bodies of all eukaryotes (see section 3.1.2).  
 
 
One of the mechanisms for removal of H2A.Z from the nucleosome is through the INO80 
complex. It was shown that the INO80 complex exchanges nucleosomal H2A.Z/H2B dimers 
with free H2A-H2B in vivo and in vitro (Papamichos-Chronakis 2011). Recently, another 
mechanism for the removal of H2A.Z was found. A new H2A.Z-specific chaperone ANP32E 
has been identified and characterized as a component of p400/Tip60 complex in 2014 (Mao et 
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al., 2014; Obri et al., 2014). ANP32E interacts with a short region of the C-terminal docking 
domain of H2A.Z in the H2A.Z/H2B dimer to evict the dimer from the nucleosome (Mao et 
al., 2014; Obri et al., 2014). Genome-wide chromatin immunoprecipitation followed by high-
throughput sequencing showed that ANP32E regulates H2A.Z deposition at TSS’s as well as 
enhancers and insulators (Mao et al., 2014; Obri et al., 2014). These results suggest that 
p400/Tip60 targeting by ANP32E regulates the H2A.Z genome-wide localization pattern. 
 
 
1.3.1.4 H2A.Z in DNA Damage Repair 
 
 
Cells regularly encounter with endogenous and exogenous stresses that can ultimately lead to 
DNA damage. To preserve genomic integrity, cells have numerous DNA damage sensors that 
detect different types of damage and initiate the appropriate repair pathway. DNA damage 
response pathways include cell cycle arrest, the transcriptional and post-transcriptional 
activation of a subset of genes including DNA repair factors (Jackson and Bartek, 2009). 
Amongst different forms of DNA lessions, DNA double strand breaks (DSBs) are particularly 
important, because they are difficult to repair and extremely toxic. Two principal mechanisms 
existe for DSBs repair: non-homologous end-joining (NHEJ) and homologous recombination 
(HR) (Khanna and Jackson, 2001). One of the major challenges in biology today is to 
understand how the chromatin state can affect the DNA repair and to investigate the role of 
histone variants and chromatin remodelers in these events. 
 
 
Previous studies showed that cells lacking either H2A.Z or components of p400/Tip60 
complex are hypersensitive to DNA damage and show defects in both NHEJ and HR DNA 
damage repair (Downs et al., 2004; Ikura et al., 2000; Murr et al., 2006; Xu et al., 2012; Xu et 
al., 2010). In yeast, H2A.Z is transiently incorporated at DNA damage sites where it regulates 
DNA end resection and hence homologous recombination repair (Billon and Cote, 2013). It 
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has been proposed that the p400/Tip60 remodeling complex decreases nucleosome stability at 
DNA damage sites which is required for the RNF8-dependent ubiquitination of chromatin and 
subsequent recruitment of the repair factors BRCA1 and 53BP1 to DSBs (Xu et al., 2010). 
Later, the same research group demonstrated that H2A.Z is transiently exchanged into 
nucleosomes at DSBs by the p400 remodeling complex and shifts the chromatin to an open 
conformation which is required for acetylation and ubiquitination of histones and for loading 
of the BRCA1 complex (Xu et al., 2012). They also showed the exchange of H2A.Z restricts 
single-stranded DNA production which is required for the loading of Ku70/80 proteins at 
damage sites (Xu et al., 2012). In contrast to the data generated by Price and colleagues, 
Canitrot, Trouche, and colleagues presented divergent results in 2014 (Taty-Taty et al., 2014). 
No H2A.Z incorporation was detected at DSBs by immunofluorescence or chromatin 
immunoprecipitation, thereby, they proposed that p400 function at the break is independent of 
H2A.Z incorporation and rather mostly through TIP60 and acetylation of chromatin . However, 
recent studies shed light on this discrepancy. Using micro-irradiation (“laser stripping”), it was 
shown that H2A.Z rapidly accumulates at DNA damage sites and that H2A.Z is retained for a 
few minutes before being rapidly removed (Alatwi and Downs, 2015; Gursoy-Yuzugullu et 
al., 2015a). The data from this study also suggest that H2A.Z is removed from damaged sites 
by the histone chaperone ANP32E and the INO80 chromatin remodeler. Removal of H2A.Z 
by ANP32E promotes acetylation of histone H4, (Taty-Taty et al., 2014) which remodels the 
chromatin and facilitates DNA repair through NHEJ by recruiting Ku70 (Gursoy-Yuzugullu 
et al., 2015a), while INO80 facilitates HR steps downstream of resection (Alatwi and Downs, 
2015).  
 
 
1.3.1.5 Post-transcriptional Modifications of H2A.Z 
 
 
Like other histones, H2A.Z undergoes post-translational modifications such as acetylation, 
ubiquitylation, and sumoylation (Babiarz et al., 2006; Keogh et al., 2006; Millar et al., 2006). 
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H2A.Z can be acetylated at up to four lysine residues on its N-terminal tail in yeast by NuA4 
and SAGA histone acetyltransferase complexes. It is acetylated only after its assembly into 
chromatin (Babiarz et al., 2006; Keogh et al., 2006) which may play a role in its rapid 
nucleosome exchange during gene activation or repression. It was shown that non-acetylated 
H2A.Z spreads across the entire promoter of inactive genes but only acetylated H2A.Z 
localizes at the TSS of active genes; furthermore, acetylated H2A.Z anti-correlates with 
promoter H3K27me3 and DNA methylation (Valdes-Mora et al., 2011). Deacetylation of 
H2A.Z led to its degradation via the ubiquitin–proteasome pathway (Chen et al., 2006) while 
mono-ubiquitilated H2A.Z is found on the X chromosome and is thought to be involved in the 
maintenance of heterochromatin (Sarcinella et al., 2007). In S. cerevisiae, sumoylation of 
H2A.Z is important for chromosome fixation to the nuclear periphery in response to persistent 
DNA double-stranded break (Kalocsay et al., 2009). 
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1.4 Chromatin Remodelers 
 
 
As discussed above, remodelers are needed for nucleosome dynamics to (Clapier and Cairns, 
2009): 
i. Deposit and correctly space nucleosomes following replication and also, in a 
replication-independent manner, fill the gaps where nucleosomes were ejected; 
ii. Prevent the impeding of advancing DNA/RNA polymerase by the nucleosomes during 
replication and transcription by ejecting or chaperoning the histone octamer around the 
advancing polymerase; 
iii. Position the cis-element in nucleosome free regions or in the DNA linker between 
nucleosomes or to expose the element transiently on the nucleosome surface; 
iv. Provide rapid access for DNA damage response factors to the sites of DNA damage by 
removing or sliding the nucleosomes and also reconstruct the nucleosomes afterward. 
Likewise in the case of DNA recombination (Clapier and Cairns, 2009). 
 
 
1.4.1 Chromatin Remodeling Complexes (CRCs) 
 
 
CRCs are DNA translocases which utilize the energy of ATP hydrolysis to alter histone–DNA 
contacts and, consequently, they all share a similar ATPase domain (Clapier and Cairns, 2009). 
The ATPase domain of the remodeling enzymes is composed of two tandem Rec-A like folds 
consisting of seven conserved helicase-related sequence motifs. The ATPase subunit of all 
CRCs classifies as part of the Superfamily 2 (SF2) group of helicase-like proteins (Eisen et al., 
1995; Flaus et al., 2006). CRCs have similarities in their DEAD/H-containing ATPase subunits 
and also have other divergent characteristics. Based on the structural similarities of their 
ATPase domains they are divided into four different families: SWI/SNF, ISWI, CHD and 
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INO80 (Fig. 1.6) (Clapier and Cairns, 2009; Langst and Manelyte, 2015). They all share five 
basic properties:
 
i. Affinity for nucleosomes, beyond DNA itself; 
ii. Domains that recognize covalent histone modifications except for the ISWI family; 
iii. A similar DNA-dependent ATPase domain, required for remodeling and serving as a 
DNA-translocating motor to break histone-DNA contacts; 
iv. Domains and/or proteins that regulate the ATPase domain; 
v. Domains and/or proteins for interaction with other chromatin or transcription factors. 
 
 
1.4.2 Nucleosome Recognition by Remodelers 
 
 
The presence of chromatin-interaction domains like bromo, chromo and SANT domains in 
different ATPase remodelers suggests that they can be selectively targeted to chromatin 
regions with distinct modification patterns to carry out specialized roles (Wang et al., 2007). 
These domains are also called epigenetic reader domains (Taverna et al., 2007). Additionally, 
they recognize different DNA structures/sequences and RNA signals that target them to 
specific genome loci (Langst and Manelyte, 2015). 
  
 
1.4.2.1 Chromatin Remodeler Domains 
 
 
The Bromodomain 
 
 
Bromodomains (BRD) are conserved structural modules in chromatin-associated proteins and  
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histone acetyltranferases and are the only protein domain known to recognize acetyl-lysine 
residues on proteins (Sanchez and Zhou, 2009). BRDs are found in diverse nuclear proteins 
such as HATs (GCN5, PCAF, p300/CBP), ATP-dependent chromatin-remodeling complexes 
(p400/Tip60, BAZ1B), helicases (SMARCA), methyltransferases (MLL, ASH1L), 
transcriptional coactivators (TRIM/TIF1, TAFs) transcriptional mediators (TAF1), nuclear-
scaffolding proteins (PB1), and the BET family (Filippakopoulos et al., 2012). SWI/SNF 
family remodelers have a bromodomain in the C-terminal region of the ATPase. Some of the 
SWI/SNF-related complexes like yRSC, dPBAP and hPBAF contain multiple bromodomains. 
The polybromo in a single subunit or several bromodomains among different subunits (e.g., 
yRsc1/2/4/10) of one remodeling complex can allow cooperative recognition of separate 
modifications (Clapier and Cairns, 2009). The bromo-adjacent homology (BAH) domain often 
resides near bromodomains. It was shown that the BAH domain is also a histone recognition 
domain (Onishi et al., 2007). 
 
 
The human genome encodes 61 BRDs that are present in 46 diverse BRD-containing proteins 
which cluster into eight families based on structure/sequence similarity (Filippakopoulos et al., 
2012). Dysfunction of BRD-containing proteins has been linked to disease processes, including 
cancer, inflammation and viral replication (Sanchez and Zhou, 2009). Despite that recent 
studies of BRD-containing proteins have highlighted the role of these domains in various 
biological processes and their association with disease, the function of many of the human 
BRD-containing proteins is not well characterized. 
 
 
The Chromodomain 
 
 
Chromodomain (chromatin organization modifier) is a protein structural domain of about 40-
50 amino acid residues that is found in the chromodomain family of remodeling complexes. 
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Chromodomains recognize methylated lysines in histones. Chromatin family remodelers 
contain two (2) tandem chromodomains in their N-terminal. hCHD1 tandem chromodomains 
bind H3K4me3, an active chromatin mark (Clapier and Cairns, 2009), whereas, it has been 
shown that chromodomains in Mi-2 recognize DNA itself rather than methylated histone tails 
(Clapier and Cairns, 2009; Flanagan et al., 2005).  
 
 
The Plant Homeodomain (PHD finger) 
 
 
PHD fingers are methyl-lysine interaction motifs. They can specifically interact with 
methylated H3K4. The BPTF subunit of NURF contains a PHD finger which directly interacts 
with H3K4me3 and stabilizes NURF/BPTF within active chromatin (Clapier and Cairns, 
2009). PHD fingers can also recognize acetylated lysines and these interactions can act 
antagonistically (Zeng et al., 2010). The structure of tandem PHD fingers was identified in the 
DPF3b component of BAF chromatin remodeling complex (Lange et al., 2008). This tandem 
PHD domain functions as one cooperative unit to interact with unmodified H3. Specifically, 
acetylation of K14 enhances H3 binding whereas methylation of H3 at K4 abolishes the 
interaction (Yap and Zhou, 2010). 
 
 
HAND-SANT-SLIDE 
 
 
SANT domains are the subunits of several chromatin-remodeling complexes: Drosophila 
ISWI (the catalytic subunit of the remodeling complex NURF, CHRAC and ACF), yeast 
ISWI1 and ISWI2 (catalytic subunits of ISWI1 and ISWI2 complexes, respectively) and 
human SNF2 and SNF2H (member of the RSF complex). The SANT domain is also present 
in: yeast Swi3, a component of the SWI/SNF complex; human and mouse MTA1 and MTA2, 
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which are part of the remodelling, deacetylating complexes NURD, RSC8p and BAF155/170 
(Boyer et al., 2004; de la Cruz et al., 2005). The SANT domain could contribute to the 
recruitment of chromatin modifying enzymes, or help the interaction between histones and the 
enzymes (Boyer et al., 2004). 
 
 
There is a combination of three domains, HAND-SANT-SLIDE, which is found in the C-
terminal of ISWI. In this example, the SANT domain binds unmodified histone tails and the 
juxtaposed SLIDE (SANT-like ISWI domain) domain contacts nucleosomal DNA. The 
Tandem SANT and SLIDE, which is unique to the ISWI family, cooperates to recognize 
nucleosomes and stimulate ATPase activity (Clapier and Cairns, 2009; Dang and 
Bartholomew, 2007; Grune et al., 2003). In addition, the HAND domain contains four alpha 
helices, three of which resemble an open hand with the fourth reposing in the palm of the hand. 
This structure confers DNA/nucleosome binding properties to these proteins (Grune et al., 
2003).  
 
 
1.4.3 Chromatin Remodeler Complex Families 
 
 
As mentioned above, chromatin remodelers fall into four families: the SWI/SNF, CHD, ISWI 
and INO80 family (Fig. 1.5). 
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Figure 1.5 Chromatin remodeler families, defined by their ATPase domains (Clapier and 
Cairns, 2009). 
 
 
1.4.3.1 The SWI/SNF Family of Chromatin Remodelers 
 
 
SWI/SNF [Switching defective (SWI) and Sucrose nonfermenting (SNF)] is the first remodeler 
that has been identified and purified from Saccharomyces cerevisiae. SWI/SNF is 
evolutionarily conserved and homologous proteins were identified in flies, plants and 
mammals (Hargreaves and Crabtree, 2011). SWI/SNF is incorporated into a 1.14 MDa 
complex of 8-11 subunits. Most eukaryotes have two SWI/SNF family remodelers that consist 
of two related catalytic subunits. The catalytic ATPase includes an HSA (helicase-SANT), a 
post-HSA and a C-terminal bromodomain. For example, BRM (homologue of Drosophila 
brahma) and BRG1 (BRM/SWI2-related gene1) contain a C-terminal bromodomain (Clapier 
and Cairns, 2009). This family has many activities in diverse processes, it can slide and eject 
nucleosomes at many loci but lacks roles in chromatin assembly (Clapier and Cairns, 2009). 
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Recently, a new role for SWI/SNF was shown in stabilizing the higher order of chromatin 
structure at centromeres by preventing ectopic CENP-A localization in S. cerevisiae 
(Gkikopoulos et al., 2011). 
 
 
1.4.3.2 The ISWI Family of Chromatin Remodelers  
 
 
ISWI (imitation switch) is a highly conserved ATPase which has been identified in many 
organisms from yeast to humans. The ISWI chromatin remodeling family includes several 
complexes which are summarized in Table 4 (Corona and Tamkun, 2004). In addition to highly 
conserved ATPase domains, ISWI contains SANT and SLIDE domains, putative DNA and 
nucleosome binding motifs which together form a nucleosome recognition module that binds 
to an unmodified histone tail and linker DNA (Boyer et al., 2004). Unlike the other families of 
chromatin remodeling complexes, ISWI lacks histone tail modification recognition motifs like 
chromodomains and bromodomains (Corona and Tamkun, 2004). Remodeling complexes 
containing ISWI (i.e. NURD, ACF, RSF) facilitate transcription from chromatin templates in 
vitro by sliding and positioning the nucleosomes at promoters in favorable order for activating 
transcription (Corona and Tamkun, 2004; Mizuguchi et al., 2004). In contrast, it was shown in 
vivo that ISWI represses transcription by sliding and spacing nucleosomes to repressive 
positions (Corona and Tamkun, 2004). ISWI can facilitate chromatin assembly in vitro by 
transforming a disordered array of nucleosomes into an evenly spaced nucleosome array, a 
process known as nucleosome spacing (Langst and Becker, 2001)  
 
 
Different ISWI-containing complexes like mammalian ISWI (Snf2h), ACF1, and WICH 
(WSTF-ISWI-containing complex) have been shown to be involved in replication of 
pericentric heterochromatin perhaps by assisting nucleosome assembly and facilitating the 
movement of the replication fork and/or by helping protein factors involved in replication to 
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interact with heterochromatin (Corona and Tamkun, 2004). ISWI remodeling complexes are 
also involved in transcriptional elongation (Wang et al., 2007). 
 
 
1.4.3.3 The CHD Family of Chromatin Remodelers 
 
 
The CHD (Chromodomain, Helicase, DNA binding) family of ATPase remodelers is 
characterized by their N-terminal tandem chromodomains in addition to conserved DEAD/H-
related ATPase domains. Members of the CHD family are divided into 3 subfamilies by the 
similarities of their domain structures: CHD1/2, with a C-terminal binding domain; CHD3/4 
with N-terminal paired PHD fingers and lack of the DNA binding domain; and CHD5-9 with 
additional functional domains in their C-terminal (Hargreaves and Crabtree, 2011). CHD 
remodelers function in promoting transcription elongation and splicing, as well as nucleosome 
ejection at promoters to stimulate gene activation (Flanagan et al., 2005; Sims et al., 2005; 
Walfridsson et al., 2007). Some of them (CHD3 and CHD4 or Mi-2α and Mi-2β) have also 
been found to be incorporated into NURD complexes. NURD is a large protein complex with 
histone deacetylase and remodeling activities. It is assumed that NURD repression of 
transcription is facilitated by its chromatin remodeling activity, although the contribution of 
these subunits (CHD/Mi) to this function is unclear (Hargreaves and Crabtree, 2011).  
 
 
1.4.3.4 The INO80 Family of Chromatin Remodelers  
 
 
The INO80 (inositol-requiring) family of remodeling complexes are characterized by “split” 
ATPase domains with a long insertion present in the middle of the ATPase domain. Helicase-
related (AAA-ATPase) RuvB 1/2 proteins and one ARP protein bind to this insertion (Clapier 
and Cairns, 2009). The INO80 family is the most evolutionarily conserved among the CRC 
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families, with a high degree of homology in the ATPase domain and surrounding sequences. 
A large number of ortholog subunits were found in many organisms and the composition of 
the complex is relatively conserved (Table 1.3).  
 
 
INO80 CRCs remodel chromatin by either sliding nucleosomes along the DNA or exchanging 
histones within nucleosomes, and thereby promote the recruitment of regulatory factors to 
DNA. This family of remodelers is involved in DNA damage repair by promoting eviction of 
nucleosomes near double strand breaks and hence increasing DNA accessibility for the repair 
machinery (Bao and Shen, 2007; Conaway and Conaway, 2009). INO80 family members are 
recruited to DNA DSB sites in yeast to mediate the homologous-recombination and non-
homologous-end joining DNA repair pathways (Wang et al., 2007). It is well established that 
the INO80 family of remodelers has crucial roles in many other essential processes such as: 
checkpoint regulation, DNA replication, telomere maintenance and chromosome segregation 
(Bao and Shen, 2007; Conaway and Conaway, 2009). Subfamilies of the INO80 family of 
chromatin remodeling complexes are: INO80 and SWR1 in S. cerevisiae; INO80, SRCAP 
(Snf2-related CBP activator protein) and p400 in mammals; and INO80 and p400 in 
Drosophila melanogaster. SWR1 has the unique ability to insert the histone variant H2A.Z 
into the nucleosome by removing the canonical histone dimers H2A-H2B and depositing 
H2A.Z-H2B dimers in a stepwise and unidirectional reaction (Luk et al., 2010). Mammals have 
two Swr1 homologues: SRCAP and p400 complexes (Table 1.3 and Fig. 1.6). The SRCAP 
complex was purified and found to catalyze the incorporation of the histone variant H2A.Z 
into chromatin in vitro (Ruhl et al., 2006). SRCAP is the only one of the 2 complexes that is 
found associated with H2A.Z-H2B dimer in solution (Wong et al., 2007). SRCAP has been 
shown to function synergistically with other co-activators such as CARM1 and GRIP1 to 
enhance AR transcriptional activity (Monroy et al., 2003). There is no known histone acetyl-
transferase (HAT) associated with the SRCAP complex, so it is possible that this complex is 
responsible for acetylation-independent H2A.Z deposition (Auger et al., 2008). 
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Table 1.3 Remodeler composition and orthologous subunits (Clapier and Cairns, 2009).  
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Specific sequences which recruit the SRCAP complex to promoters have not been established, 
however, interaction of SRCAP with CBP may allow targeting to a variety of promoters 
(Monroy et al., 2001). 
 
 
A comparison of the structure of p400 and SRCAP indicates that they share a conserved 
bipartite ATPase domain and a HSA domain. They also have distinct domains: SRCAP 
contains multiple A/T hook domains at its C-terminus, whereas p400 has a SANT domain. The 
human SRCAP complex contains ten subunits (SRCAP, DMAP1, BAF53a, ARP6, Gas41, 
Tip49a, Tip49b, ZnF-HIT1, YL1, and H2A.Z). The p400 complex shares only some of these 
subunits, namely DMAP1, BAF53a, ARP6, Gas41, Tip49a, Tip49b, and YL1. The presence 
of two complexes with H2A.Z deposition activity is intriguing and raises the possibility that 
they are targeted to different sites within the same promoter or to different promoters. In the 
following section the p400 complex is presented in more detail.  
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Figure 1.6 SWR1-related complexes in yeast and mammalian cells. Note: The full subunit 
composition of a p400 complex independent of the Tip60–p400 is partly speculative based on 
the literature and unpublished data (Billon and Cote, 2013). 
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1.5 The p400/Tip60 Chromatin Remodeling Complex 
 
 
Chromatin remodelers are key players in the regulation of chromatin 
dynamics in eukaryotic DNA, and thereby essential for all DNA-dependent biological 
processes. As it was mentioned before, in mammals H2A.Z deposition is controlled by p400 
and the SRCAP chromatin remodeling complexes that catalyze the nucleosomal exchange of 
canonical H2A with H2A.Z. In this project we were specifically interested in the role of the 
p400 complex in the regulation of H2A.Z enrichment pattern. 
 
 
p400 was first purified from HeLa nuclear extracts and its cDNA mapped to human 
chromosome 12q24.33 (Fuchs et al., 2001). The predicted protein motif structure of p400 is 
presented in Figure 1.7 It contains the distinct signature motifs that constitute the DNA 
dependent ATPase/helicase-like domain of SWI2/SNF2 family members with an unusual 
linker of ~500 residues that splits this motif into 2 segments (Fig. 1.7). This split ATPase 
domain is characteristic of INO80 family of remodeling complexes (see section 4.3.4) and 
exists in other members of this family such as SRCAP (Fuchs et al., 2001).  
  
 
 
 
 
 
 
Figure 1.7 Schematic representation of the motif structure of p400 (adapted from (Fuchs 
et al., 2001). 
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p400 is conserved from yeast to humans. The homolog of mammalian p400 in yeast is SWR1, 
in fly it is Domino (Ruhf et al., 2001) and in C. elegans it is ssl-1 (Table 1.3). p400 is essential 
for early embryonic development. Underlining the importance of p400, mice with an N-
terminally deleted p400 die at E11.5 with defects in primitive erythropoiesis and loss of bone 
marrow cells (Ueda et al., 2007).  
 
 
1.5.1 p400-Containing Complexes  
 
 
p400 is the catalytic subunit of larger complexes that have been demonstrated in vitro to deposit 
H2A.Z into nucleosomes (Gevry et al., 2007). At least two complexes containing p400 have 
been described in human cells: the Tip60 complex with HAT activity, which is homologous to 
yeast NuA4 complex and the p400 complex which lacks the HAT activity (Doyon and Cote, 
2004; Fuchs et al., 2001; Ikura et al., 2007). p400 co-purifies with a number of proteins such 
as TRRAP/PAF400, Tip49a/b, actin, actin like BAF53 and EPC1, which are all components 
of the Tip60 complex, and c-Myc (Downs et al., 2004; Doyon and Cote, 2004; Fuchs et al., 
2001; Ikura et al., 2007). In addition, the p400 complex has some common subunits with the 
other SWR1 homologous complex SRCAP (such as: DMAP1, BAF53a, ARP6, Gas41, Tip49a, 
Tip49b, YL1), but the p400 complex also contains additional subunits (such as: 
BRD8/TRC/p120, EPC1, EPC-like, Tip60, ING3, MRG15, MRGX MRGBP and FLJ11730) 
(Cai et al., 2005; Cai et al., 2003; Doyon and Cote, 2004; Fuchs et al., 2001) (See Table 1.3). 
Recently, an acidic nuclear phosphoprotein of 32 kilodalton, ANP32E, was recognized as a 
new member of the p400/Tip60 complex (Obri et al., 2014). ANP32E is a H2A.Z-specific 
chaperone which preferentially recognizes and associates with H2A.Z/H2B dimers over 
H2A/H2B dimers and catalyzes the removal of H2A.Z/H2B nucleosomes from chromatin 
(Mao et al., 2014; Obri et al., 2014). 
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1.5.2 p400 as an Adenovirus E1A Oncoprotein Interaction Partner  
 
 
p400 was first identified as an interaction partner of the adenovirus 5 E1A oncoprotein 
(Barbeau et al., 1994; Howe and Bayley, 1992). The interaction of p400 with E1A was found  
to be required to stimulate cell transformation by E1A (Fuchs et al., 2001). The oncoprotein 
transcription factor Myc is one of the targets of this interaction. E1A stabilizes the Myc protein 
via p400 and promotes the co-association of Myc and p400 at Myc target genes, leading to 
their transcriptional induction (Tworkowski et al., 2008).  
 
 
Moreover, in 2005 the Livingston laboratory showed that the interaction of p400 with E1A is 
necessary for sensitization of human (IMR90) and murine (MEF) cells to induced apoptosis. 
They showed that induction of apoptosis by Fetal Bovine Serum (FBS) withdrawal or 
adriamycin (also called doxorubicin) treatment correlates with p400 interaction with E1A 
(Samuelson et al., 2005). p400 is also required for E1A to induce p53-mediated apoptosis 
(Samuelson et al., 2005). Altogether, these studies indicate that p400 is important for E1A-
mediated cell proliferation and transformation. 
 
 
1.5.3 p400, Transcription and Chromatin Remodeling: regulating the dynamics of H2A.Z 
nucleosomes  
 
 
As mentioned, the interaction between p400 and E1A has distinct consequences, which are 
probably due to altered transcription. E1A perturbs the normal composition of the p400 
complex (Fuchs et al., 2001) and interferes with its normal function. This results in the 
deregulation of the p400 complex's remodeling activity on certain gene promoters which are 
involved in cell cycle regulation, proliferation and apoptosis. 
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Our laboratory showed that p400 colocalizes with H2A.Z and p53 at the p21 promoter at the -
2.27 kb p53 binding site and mediates the exchange of histone H2A.Z-H2B (Gevry et al., 
2007). Through its localization at the p21 promoter, H2A.Z forms a repressive barrier that 
prevents aberrant p53-dependent p21 activation (Gevry et al., 2007). p400 also colocalizes 
with c-Myc and H2A.Z at the p21 TATA initiator region, suggesting that the deposition of 
H2A.Z by p400 at this site is part of a c-Myc-dependent repression of p21 expression (Gevry 
et al., 2007). In another study, Gevry et al. demonstrated that both H2A.Z and p400 are 
essential regulators of ERα-dependent gene activation and cell proliferation. As opposed to 
p21, they showed that H2A.Z incorporation into the ERα target gene TFF1 stabilizes 
nucleosomes at its promoter, which favors the recruitment of the general transcriptional 
machinery and activates transcription upon gene induction (Gevry et al., 2009).  
 
 
While H2A.Z deposition may be a critical activity of p400 and SRCAP complexes, this does 
not constitute sufficient evidence to explain the full effect of these remodeling complexes on 
gene transcription. Indeed, the density of nucleosomes at the p21 promoter was not altered in 
the absence of p400 or SRCAP, whereas the enrichment of H2A.Z was reduced by 
approximately 50% at the distal p53 binding site upon knockdown of either remodeler in A549 
and HeLa cells (Bowman et al., 2011a). The knockdown of SRCAP showed an equivalent 
effect on H2A.Z deposition as a p400 knockdown, but did not increase the transcription of p21 
(Bowman et al., 2011a). Knockdown of p400 and SRCAP affect Sp1 transcription differently 
than p21. That is, the loss of p400 has no effect, but the loss of SRCAP decreases the 
transcription of Sp1, whereas the knockdown of p400 induces p21 and the knockdown of 
SRCAP has no effect on p21 (Bowman et al., 2011a; Gevry et al., 2007).  
 
 
In 2014, two independent genome-wide ChIP-Seq studies showed that ANP32E, a component 
of p400/Tip60 complex displays genome-wide binding profiles similar to H2A.Z. It colocalizes 
with H2A.Z at the +1 and -1 nucleosomes that surround TSSs, and upon transcription 
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induction, ANP32E dissociates from TSSs along with H2A.Z (Mao et al., 2014; Obri et al., 
2014). It is proposed that the remodeling of nucleosomes containing H2A.Z at TSSs by 
ANP32E might help the elongating RNA Pol II overcome the first nucleosome barrier (Mao et 
al., 2014). ANP32E depletion increased the accumulation of H2A.Z around the TSS as well as 
enhancers and insulators, which are otherwise normally depleted in H2A.Z (Mao et al., 2014; 
Obri et al., 2014). These data strongly suggest ANP32E is a chaperone specialized in the 
genome-wide removal of H2A.Z from chromatin and particularly from enhancer and insulator 
regions (Mao et al., 2014) 
 
 
1.5.4 p400 in Stress and DNA Damage Response (DDR)  
 
 
The repair of DNA double strand breaks requires local remodeling of chromatin structure to 
make the damaged site accessible to the DNA repair machinery. There is evidence linking 
p400 to the DNA damage response. The expression of Tip60, p400 and Tip49b is reported to 
be required for UV-induced apoptosis (Tyteca et al., 2006).  
 
 
It has been reported that Tip60 and p400 are coordinately deregulated in colorectal carcinoma 
compared to adjacent normal tissues (Mattera et al., 2009). Tip60 and p400 both are 
underexpressed, whereas the p400/Tip60 ratio is elevated, by about twofold, in colorectal 
carcinoma cells, resulting in a slight inhibition of Tip60-dependent pathways, which protect 
these cancerous cells from apoptosis. In agreement, activation of endogenous Tip60 or 
knockdown of p400 was shown to be sufficient to promote apoptosis in these cells (Mattera et 
al., 2009). It was shown that DNA damage induced by oncogenic E2F1 does not result in 
activation of DNA damage response in human colorectal cancer cells (HCT116) as indicated 
by a weak increase of γH2A.X (H2A.X phosphorylated on serine 139) and phosphorylated 
ATM, two markers of the DNA damage response. Whereas knockdown of p400 restores the 
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response to oncogene-induced DNA damage and leads to dramatic increases in γH2A.X and 
phospho-ATM-positive cells (Mattera et al., 2009). Moreover, the p400/Tip60 ratio is critical 
for the cellular resistance to 5-FU treatment, and knockdown of p400 in these cells facilitates 
5-FU induced apoptosis. The same results were reported for both wild-type and p53-deficient 
colon cancer cells, indicating that p53 activity is not required for the decreased cell survival 
observed in response to p400 inhibition (Mattera et al., 2009).  
 
 
In another study, Mattera et al. showed that p400 is required for the proper control of ROS 
metabolism. They showed that the depletion of p400 increases intracellular ROS levels and 
causes DNA damage, whereas persistent DNA double strand breaks increase the ROS level 
itself (Mattera et al., 2010). They concluded that the repressive effect of p400 on p21 
expression is partially mediated by the ATM-dependent DNA damage pathway (Mattera et al., 
2010), in addition to the direct effect of p400 on the p21 promoter, which previously was shown 
to be mediated by the deposition of H2A.Z (Gevry et al., 2007). However, ATM expression 
seems to be required for p400 knockdown to induce senescence and apoptosis as well (Mattera 
et al., 2010). 
 
 
In 2010, Xu et al. reported that p400, as a component of the Tip60 acetyltransferase complex, 
has a role in the destabilization of nucleosomes within chromatin regions that correspond to 
the γ-H2A.X domains surrounding DSBs (Xu et al., 2010). Neither the inhibition of ATM 
kinase by the specific inhibitor KU-55933 nor inactivation of the MRN complex which 
regulates ATM, blocked the reduced histone-DNA interaction after induction of DSB by 
bleomycine (Xu et al., 2010). In their low salt fractionation experiments, no histones eluted 
after knockdown of p400 by shRNA from bleomycin-treated cells. The same was shown for 
shTRRAP (Xu et al., 2010). Since the TRRAP subunit of the Tip60 complex is thought to be 
a scaffold for this complex, it is not clear if this effect is attributed exclusively to p400 or to 
the loss of other components of this complex (Xu et al., 2010). However, the HAT activity of 
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Tip60 and ATPase activity of p400 are both required for the destabilization of nucleosomes 
following DNA DSB (Xu et al., 2010). By generating DSBs at the desired endogenous locus 
using sequence-specific zinc finger nucleases, they assessed the recruitment of p400 to DSB 
by a mechanism that is independent of ATM, but requires MDC1 (Xu et al., 2010). They 
showed that the p400-mediated decrease in nucleosome stability is required for the RNF8-
dependent ubiquitination of chromatin and subsequent facilitated recruitment of BRCA1 and 
53BP1 to DSBs (Xu et al., 2010).  
 
 
In 2012, Price and his colleagues demonstrated that H2A.Z is exchanged into chromatin at 
DSBs by p400 (Xu et al., 2012). Deposition of H2A.Z in damaged sites decreases the stability 
of the histone-histone and histone-DNA interactions within nucleosomes at DSBs, creating 
open relaxed chromatin domains which are needed for DNA repair (Xu et al., 2012). Using 
zinc finger nuclease to create a unique DNA double strand break and ChIP analysis, they 
showed p400 ATPase activity is required for two important chromatin modifications during 
repair: acetylation of H4 by Tip60 and ubiquitination of chromatin by RNF8 (Xu et al., 2012). 
Depletion of H2A.Z also blocked the formation of ubiquitin foci at DSBs and consequently, 
loading of the BRCA1 repair factor was reduced (Xu et al., 2012). Consistently with these 
results, H2A.Z-depleted cells exhibited reduced levels of HR repair and surprisingly, NHEJ 
was also decreased (Xu et al., 2012). They showed that Ku70/80 complexes, which promote 
DSB repair through NHEJ, were lost from DSB-flanking chromatin in the absence of H2A.Z, 
but RPA32 binding showed an increase at the DNA break (Xu et al., 2012). Finally, co-
depletion of the DSB-resection factor CtIP and H2A.Z rescued Ku70/80 binding at DSB, 
restored normal NHEJ and reduced the increased alt-NHEJ activity observed in H2A.Z-
depleted cells. Thus, deposition of H2A.Z by p400 at DSBs could impact the choice between 
HR and NHEJ by restriction of ssDNA production by CtIP (Xu et al., 2012). 
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In parallel, in 2012, Trouche, Canitor and their colleagues showed that cells depleted in p400 
are more sensitive to DNA damage induced by bleomycin and ionizing radiation (IR) than their 
normal counterparts (Courilleau et al., 2012). They saw a delay in the clearance of γH2A.X 
foci after 6 hours post-IR in p400-depleted cells which suggests a defect in DSB repair in these 
cells. Furthermore, p400 depletion decreased the efficiency of homology-directed repair in a 
cell line with an active p53 pathway as well as in a cell line with an inactivated p53 pathway 
(Courilleau et al., 2012). In contrast to the results presented by the Price laboratory, no change 
in neither ubiquitin nor in 53BP1 foci formation was seen in p400-depleted cells after IR in 
Trouche’s study (Courilleau et al., 2012; Xu et al., 2010). 
 
 
It was shown that p400 interacts with RAD51 and this interaction is required for RAD51 foci 
formation and its recruitment to damaged sites as assessed by immunofluorescence and ChIP 
experiments (Courilleau et al., 2012). Finally, the Trouche laboratory proposed a model in 
which chromatin remodeling around RAD51-targeted DNA damage sites by p400 is required 
for DNA repair through HR (Courilleau et al., 2012). 
 
 
Later in 2014, Canitor, Trouche and colleagues presented divergent results from those obtained 
by the Price laboratory (Taty-Taty et al., 2014). They reported that H2A.Z depletion did not 
affect DNA damage repair by homology-directed repair nor NHEJ using cell lines harboring 
specific substrates allowing the measurement of DNA repair by assessing the number of GFP-
positive cells following expression of an endonuclease (Taty-Taty et al., 2014). No H2A.Z 
accumulation at sites of DNA damage was documented (Taty-Taty et al., 2014). They proposed 
that although H2A.Z is crucial for cell cycle regulation, cell proliferation and viability, its role 
in DNA damage repair might be cell type-specific and affected by p53 status. They suggested 
that the role of p400 at DSBs is not dependent on H2A.Z incorporation but is mediated by the 
Tip60-dependent acetylation of chromatin (Taty-Taty et al., 2014). 
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As it was explained in section 3.1.4 two recent studies shed light on these discrepancies (Alatwi 
and Downs, 2015; Gursoy-Yuzugullu et al., 2015a). Taken together, p400/Tip60 remodeling 
complex rapidly deposits H2A.Z into chromatin at DNA damage sites. The exchange of H2A 
for H2A.Z exposes the tail of the H4 histone to acetylation by Tip60 (Price and D'Andrea, 
2013; Xu et al., 2012; Xu et al., 2010). Afterwards, the ANP32E component of the p400/Tip60 
complex as well as the INO80 complex remove H2A.Z from DNA damage-flanking genomic 
regions (Alatwi and Downs, 2015; Gursoy-Yuzugullu et al., 2015a). Depletion of ANP32E 
causes failure to remove H2A.Z from damaged sites and results in reduced Ku70/Ku80 
recruitment that impairs NHEJ and promotes alt-NHEJ (Gursoy-Yuzugullu et al., 2015a).  
 
 
1.5.5 p400 in Development 
 
 
p400 has a critical role in the epigenetic regulation of developmentally controlled genes and 
its targeted mutation causes early embryonic lethality with defects in embryo and yolk sac 
hematopoiesis, a marked reduction in the expression of globin genes and an increased 
expression of Hox genes (Ueda et al., 2007). Moreover, phenotypic analyses revealed that 
Tip60-p400 is necessary to maintain characteristic features of embryonic stem cells (ESCs). 
Fazzio et al. showed that p400 localization to the promoters of both silent and active genes is 
dependent upon histone H3 lysine 4 trimethylation (H3K4me3) (Fazzio et al., 2008). 
Furthermore, the Tip60-p400 knockdown gene expression profile is enriched for 
developmental regulators and significantly overlaps with that of the transcription factor Nanog 
(Fazzio et al., 2008). Depletion of Nanog reduces p400 binding to target promoters without 
affecting H3K4me3 levels. Together, these data indicate that Tip60-p400 integrates signals 
from Nanog and H3K4me3 to regulate gene expression in ESCs (Fazzio et al., 2008). 
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1.5.6 p400 and The Cell Cycle 
 
The accurate regulation of the cell cycle is crutial for the control of eukaryotic cell proliferation 
and its misregulation can cause oncogenesis. Eukaryotes have evolved tightly-regulated 
networks of cyclins, cyclin-dependent kinases (CDKs), CDK inhibitors (CDKIs), checkpoints, 
ubiquitin ligases and other factors to control the orderly transition through the cell cycle and 
to ensure correct cell division. The typical eukaryotic cell cycle is divided into four phases: i. 
Gap 1 (G1) phase, in which cell typically grows; ii. Synthesis (S) phase, where the nuclear 
DNA is replicated; iii. Gap 2 (G2) where the cells get ready for mitosis; and iv. Mitosis (M) 
phase, in which sister chromatids separate and distribute to the newly forming daughter cells 
(Harashima et al., 2013). Proper transition through different phases of the cell cycle is 
monitored through checkpoints that can sense DNA defects during DNA synthesis and 
chromosome segregation. Activation of the checkpoints induces cell cycle arrest, to allow cells 
to properly repair the DNA and prevent the transmission of defective DNA to the daughter 
cells. Cell cycle progression is regulated by numerous cell cycle genes, such as Rb, p53, p21, 
p16, and cdc25. Transcriptional regulation of these genes is crucial for proper cell division and 
genome stability and their misregulation is a common feature of cancer (Malumbres and 
Barbacid, 2009). 
 
 
 
Microarray experiments and analyses showed that p400 mainly regulates genes linked to the 
cell cycle, cell division and mitosis (Mattera et al., 2010). Analysis of the cell cycle profiles of 
p400-deleted fibroblasts showed that it is essential for cell cycle progression. p400 depletion 
caused the reduced expression of cell cycle regulatory genes that are targeted by the 
transcription factors FoxM1 and Myc (Fujii et al., 2010). Depletion of p400 in human primary 
cells leads to G1 arrest, senescence-associated heterochromatin foci (SAHF) formation, 
induction of p21 transcription and premature senescence in primary human fibroblasts, but not 
in cells with deficient p53 (Chan et al., 2005; Gevry et al., 2007). ChIP experiments showed 
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that p400 complexes colocalize with p53 on the p21 promoter at a region that overlaps the 
distal p53 response elements (RE) and its knockdown favors p53 binding to its REs and 
transcription of p21 gene (Chan et al., 2005). In addition, it was shown that p400 knockdown 
prevented the phosphorylation of the retinoblastoma (Rb) protein (Tyteca et al., 2006), which 
is necessary for cell cycle progression from G1 to S.  
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GENERAL HYPOTHESIS AND OBJECTIVES  
 
 
We have reviewed the fundamentals of the molecular biology of transcription and the 
importance of the role of epigenetic mechanisms in the regulation of gene expression. Also, 
we have covered the crucial role of chromatin dynamics and chromatin remodeler complexes 
in this process in addition to DNA repair, DNA replication, and genome integrity maintenance, 
which underlies their implications in cancer initiation and/or progression. Our laboratory is 
interested in the regulation of gene expression, specifically the role of histone variant H2A.Z 
and chromatin remodelers in this process and their implications in cancer. My PhD project was 
to understand the role of H2A.Z localization in the regulation of gene transcription. H2A.Z 
localization across the genome is mostly restricted to gene regulatory regions such as gene 
transcription start sites (TSS), enhancers, and insulator sites (Gevry et al., 2007; Ku et al., 
2012; Zhang et al., 2005a). Previous studies in our laboratory showed that H2A.Z is required 
for the proper positioning of nucleosomes at promoters in both human cells and in yeast (Gevry 
et al., 2009; Guillemette et al., 2005; Marques et al., 2010; Millau and Gaudreau, 2011). It has 
been proposed that H2A.Z influences transcription by allowing key promoter nucleosomes to 
shift to positions which are either favouring the recruitment of transcription factors or the 
opposite; preventing the recruitment of such factors by masking their DNA binding sites 
(Marques et al., 2010). Beside regulatory regions, the histone variant can also be found within 
gene bodies (Coleman-Derr and Zilberman, 2012; Hardy et al., 2009; Latorre et al., 2015; 
Zilberman et al., 2008), but, the significance of the localization of H2A.Z within genes bodies 
is still not understood. There are controversial reports on the role of H2A.Z within the body of 
repressed genes (Hardy et al., 2009; Jeronimo et al., 2015; Latorre et al., 2015). We decided to 
investigate the genome-wide distribution of H2A.Z in the absence of transcription. We 
hypothesized that H2A.Z accumulation within the bodies of repressed genes is a result of the 
absence of gene transcription. We asked whether the recruitment of H2A.Z within the body of 
the repressed genes is the consequence of the lack of transcription, or it is an active mechanism 
which causes repression. The results from this study are presented in chapter 2. 
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We knew that in human cells, the SRCAP and p400 complexes deposit H2A.Z into chromatin 
(Gevry et al., 2007; Ruhl et al., 2006). However, it remained to be determined what triggers 
the association of p400 to specific chromatin regions in order to deposit H2A.Z. Hence, the 
next objective of my PhD was to investigate the mechanisms by which the p400 complex is 
targeted to chromatin. We entertained different possibilities: chromatin content, modification 
and the p400 complex subunits. The first question we addressed was whether an epigenetic 
mark(s) exists for the recruitment of the p400 complex. Based on previous studies from our 
laboratory and other groups (Gervais and Gaudreau, 2009; Horwitz et al., 2008), we 
determined that H3 acetylation at K18 by p300/CBP was a very interesting candidate mark 
among histone modifications for recruiting p400 to chromatin. I used p300/CBP double null 
MEFs as a model to investigate the role of this modification in targeting p400. Next, we asked 
which subunit(s) of the p400 complex is involved in the targeting and the subsequent 
deposition of H2A.Z into nucleosomes. The BRD8 subunit of the p400/Tip60 complex (Cai et 
al., 2005; Cai et al., 2003; Downs et al., 2004; Doyon and Cote, 2004; Doyon et al., 2004; 
Fuchs et al., 2001; Ikura et al., 2007) contains two bromodomains that can potentially 
recognize acetylated histone/protein so it was tempting to speculate that BRD8 has a role in 
this process. I used the p21 promoter as a model to investigate the steps leading to the 
positioning of H2A.Z via targeting of p400. In chapter 4, I present the preliminary results I 
obtained during the course of my PhD on the mechanisms responsible for the targeting of p400 
to chromatin, which set the stage for further investigation. 
 
Another objective of my PhD was to investigate the role of BRD8 in DNA damage response. 
Even though recent studies have highlighted the roles of bromodomains in various biological 
processes and their association with disease, the function of many human BRD proteins, 
including BRD8, is not well characterized. BRD8 protein is overexpressed in aggressive 
colorectal cancer cells. It has been proposed that overexpression of BRD8 provides a growth 
advantage and resistance to chemotherapy to the cancerous cell (Yamada and Rao, 2009). 
However, the mechanism(s) underlying the observed growth promotion and chemotherapy 
resistance is not known. This prompted me to investigate the function of BRD8 in the 
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regulation of cell cycle and DNA repair. The results I obtained for this part of my studies are 
presented in chapter 3. 
 
 
I believe that the experiments and results described in the present thesis provide answers to 
some of the questions raised above and leave us with a better understanding of the regulation 
of gene expression and DNA damage repair that may result in the discovery of new therapeutic 
strategies to combat cancer. 
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CHAPTER 2 
 
 
 
Investigation of histone variant H2A.Z localization in the human genome 
 
 
Article Description 
 
 
In this manuscript, we investigated the importance of the role of transcription in the global 
localization of histone variant H2A.Z. H2A.Z distribution across the human genome is shown 
to be mostly restricted to regulatory loci such as gene transcription start sites (TSS), enhancers, 
and insulator sites. The histone variant can also be found within gene bodies. However, the 
significance of this phenomenon and its relationship with transcription is still debatable. We 
used a genome-wide approach to investigate the distribution of H2A.Z within genes under 
normal conditions and under conditions where transcription by RNA Pol II is inhibited globaly. 
We confirm that H2A.Z localization at the body of genes is anti-correlated with transcription. 
In addition, we showed that global inhibition of transcription by α-amanitin treatment causes 
specific increase in H2A.Z incorporation within transcribed gene bodies and TSSs. We further 
showed that in the absence of transcription, H2A.Z loading chromatin remodeler p400 
incorporates H2A.Z at TSSs and also to some extent within gene bodies. Our findings 
demonstrated that the accumulation of H2A.Z within gene bodies is a consequence of the 
absence of gene transcription rather than an active mechanism required to establish a repressive 
chromatin state.  
The results of this part of my project have been submitted to the scientific journal Nucleic 
Acids Research and is currently being reviewed. 
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2.1 Abstract 
 
 
H2A.Z histone variant is an essential regulator of gene transcription, which is enriched at 
regulatory regions but is also found within gene bodies. Recent evidence suggests that active 
recruitment of H2A.Z within gene bodies is required to induce gene repression. In contrast to 
this view, we show that global inhibition of transcription results in H2A.Z accumulation at 
gene transcription start sites, as well as within gene bodies. Our results indicate that 
accumulation of H2A.Z within repressed genes can also be a consequence of the absence of 
gene transcription rather than an active mechanism required to establish the repression. 
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2.2 Introduction 
 
 
The regulation of chromatin dynamics is a key mechanism that controls essential cellular 
functions such as gene expression, DNA repair, and replication (Voss and Hager, 2014). 
Chromatin dynamics can be modulated through different mechanisms including post-
translational modification of histone tails, physical displacement of nucleosomes by ATP-
dependent nucleosome remodelers, and exchange of canonical histones by histone variants 
(Clapier and Cairns, 2009; Kouzarides, 2007). Histone variant H2A.Z has been studied in detail 
over the last decade and owing to the work of several laboratories, a detailed picture of H2A.Z 
biology has emerged. It is now clear that the distribution of H2A.Z across the human genome 
is restricted to very specific loci such as gene transcription start sites (TSS), enhancers, and 
insulator sites (Gevry et al., 2007; Ku et al., 2012; Zhang et al., 2005a). The role of H2A.Z at 
those sites seems to be important for preventing the sliding of nucleosomes along the DNA 
translational axis. Indeed, we previously showed, both in human cells and in yeast, that H2A.Z 
is required for the proper positioning of nucleosomes at promoters (Gevry et al., 2009; 
Guillemette et al., 2005; Marques et al., 2010; Millau and Gaudreau, 2011). As such, one can 
imagine that stable phasing of nucleosomes by H2A.Z may influence transcription by either 
favouring the recruitment of transcription factors or the opposite; preventing the recruitment 
of such factors by masking their DNA binding sites (Marques et al., 2010).  
 
 
Although H2A.Z is found to be located primarily at gene regulatory regions across the genome, 
the histone variant can also be found within gene bodies (Coleman-Derr and Zilberman, 2012; 
Hardy et al., 2009; Latorre et al., 2015; Zilberman et al., 2008). However, the significance of 
this phenomenon is still debatable. In recent work by Latorre and colleagues, the recruitment 
of H2A.Z within gene bodies by the DREAM (Dimerization partner, RB-like, E2F and Multi-
vulval class B) complex has been proposed to cause the repression of the targeted genes, 
suggesting that active recruitment of H2A.Z within gene bodies is required to establish 
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transcriptional repression (Latorre et al., 2015). In parallel, Hardy and colleagues previously 
showed that active gene transcription prevents H2A.Z from associating with gene bodies 
(Hardy et al., 2009). The evidence supporting this suggestion is derived from two main results 
from this group. First, they showed that upon shut down of heat shock genes in yeast, H2A.Z 
re-associates with gene bodies (Hardy et al., 2009). Secondly, they very recently found that 
yeast RNA Pol II-associated histone chaperones, FACT and Spt6, prevent accumulation of 
H2A.Z within gene bodies during transcription by evicting H2A.Z from nucleosomes and 
exchanging it with H2A (Jeronimo et al., 2015). Consequently, and in contrast to what Latorre 
and colleagues proposed, these experiments suggest that H2A.Z accumulation within gene 
bodies would be the consequence of gene repression. Based on data from both studies, it is 
thus impossible to determine whether the recruitment of H2A.Z within the body of repressed 
genes is the cause, or the consequence of the gene repression. 
 
 
To shed light on this issue, we used a genome-wide approach to investigate the distribution of 
H2A.Z within genes under normal conditions and under conditions where global transcription 
by RNA Pol II is inhibited. While we were able to confirm the anti-correlation between the 
presence of H2A.Z within genes and transcription levels, we also reveal that global inhibition 
of transcription results in a specific increase of H2A.Z incorporation within gene bodies and 
TSSs. We further demonstrate that this increase in H2A.Z incorporation within genes can be 
concomitant - at least in some genes - to the recruitment of the H2A.Z loading chromatin 
remodeler, p400, at TSSs and cohesin binding sites. Our findings provide evidence supporting 
the hypothesis that the accumulation of H2A.Z within repressed genes can also be the 
consequence of the absence of gene transcription rather than an active mechanism required to 
establish the repression.  
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2.3 Materials and Methods  
 
 
2.3.1 Cells, cell culture, and cell treatment 
 
 
HCT116 cells (a gift from Dr. Bert Vogelstein, Howard Hughes Medical Institute, Baltimore, 
MD) were cultured in a 5% CO2-containing atmosphere in DMEM (Wisent) supplemented 
with 10% fetal bovine serum (Sigma), 0.2 U/mL penicillin G, and 100 mg/mL streptomycin 
(Invitrogen). For the global inhibition of transcription, HCT116 cells were treated with 8 μM 
α-amanitin (Sigma) for 24 h. 
 
 
2.3.2 Chromatin immunoprecipitation 
 
 
ChIP assays were performed as previously described (Gevry et al., 2007). Samples were 
sonicated to generate 500-bp DNA fragments. Immunoprecipitations were carried out using 
antibodies reported in Table S1. Preimmune and no antibody controls were also performed. 
qPCR was done using the primer set reported in Table S2. ChIP experiments were performed 
as independent biological triplicates and data are presented as mean ± SD.  
 
 
2.3.3 Chromatin immunoprecipitation coupled to sequencing 
 
 
H2A.Z and Rad21 ChIP-seq were performed similarly to the ChIP experiments except for the 
following steps. For each treatment conditions, six immunoprecipitations were performed in 
parallel. For Rad21, immunoprecipitations were carried out using Dynabeads coupled to 
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protein A (Life Technologies) and no pre-clearing was done. The libraries for sequencing were 
prepared from 10 ng of ChIPed DNA using the NEBNext Ultra DNA Library Prep Kit for 
Illumina (NEB) according to manufacturer’s protocol. Samples were sequenced paired-end 
with 50 bp reads on an Illumina HiSeq-2000. As described in supplementary methods, the 
reads were aligned onto the hg19 reference genome using BWA and processed using MACS2 
and VAP (Brunelle et al., 2015; Coulombe et al., 2014; Li and Durbin, 2009; Zhang et al., 
2008). We used the ENSEMBL release 68 genome annotations (GRCh37.68). 
 
 
2.3.4 RT-qPCR 
 
 
Pre-mRNAs of p21, PCNA, DDIT4, GDF15, and mRNA of 36B4 were quantified by RT-qPCR 
and normalized to 36B4 expression level. Total RNA was extracted from cultured cells using 
EZ-10 DNAaway RNA Miniprep Kit (BioBasic). RNA was treated with DNase I, a 50 μl 
reaction containing 5 μg RNA, 1 X DNase I Buffer (Zymo), 5 u DNase I (Zymo) was 
assembled and incubated for 15 min at 37°C and then purified using the RNA Clean and 
Concentrator Kit (Zymo). Reverse transcription was carried out using the M-MLV reverse 
transcriptase enzyme (Enzymatics) and random hexamers according to manufacturer’s 
protocols. The RT-qPCR primer sets are reported in Table S3. Experiments were performed as 
independent biological triplicates and data are presented as mean ± SD 
 
 
2.3.5 RNA sequencing 
 
 
Total RNA was extracted as described in the RT-qPCR protocol section. Libraries were 
prepared from 800 ng total RNA using Illumina’s TruSeq Stranded mRNA LT Kit according 
to manufacturer’s protocol. Samples were sequenced paired-end with 50 bp reads on an 
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Illumina HiSeq-2000. As described in supplementary methods, the reads were trimmed using 
Trimmomatic, aligned onto the hg19 reference genome using TopHat2, filtered using 
SamTools, then the FPKM calculated using Cufflinks (Bolger et al., 2014; Kim et al., 2013a; 
Li et al., 2009; Trapnell et al., 2010). 
 
 
2.3.6 Immunoblotting 
 
 
Western blots of p400, H2A.Z, H3, and actin were performed on whole cell extracts. Briefly, 
cells were washed with PBS, harvested, resuspended in lysis buffer (50 mM Tris–HCl, pH 7.5, 
150 mM NaCl, 1% Triton X-100, 0.5% Na-deoxycholate, 0.2% SDS, 1 mM PMSF, 1X Roche 
Complete protease inhibitor cocktail) and passed 5 times through a 23G1 needle. Lysis was 
performed at 4°C for 1 h on a rotary wheel and the lysate was centrifuged at 14,000 rpm for 
10 min at 4°C. The supernatant was collected and dosed. 
 
 
Western blots of H2A.Z and H3 were performed on histone extracts. Cells were washed with 
PBS, collected, resuspended in Triton extraction buffer (0.5% Triton X-100, 2.5 mM PMSF, 
0.02% NaN3, 1X Roche Complete protease inhibitor cocktail), incubated on ice for 10 min, 
and centrifuged at 7,500 rpm for 8 min at 4°C. The pellet was washed with 500 μl of Triton 
extraction buffer, then centrifuged at 7,500 rpm for 8 min at 4°C. The pellet was resuspended 
in 0.2 N HCl (50 μl for 4 million cells) and incubated over-night at 4°C. The next day, histone 
extracts were cleared by a centrifugation at 7,500 rpm for 8 min at 4°C. The supernatant was 
collected and dosed.  
 
 
The list of antibodies used for the western blots are reported in Table S4. 
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2.3.7 Knock-down of p400  
 
 
For the knockdown experiment of p400, HCT116 cells were transduced immediately following 
cell passage with either lentiviruses containing the pLVTHM plasmid (Trono’s laboratory) 
directed against p400 (TRCN0000312676 + TRCN0000312686) or a control shRNA in the 
presence of polybrene (8 μg/ml) for 24 h. On the fourth day following infections, the cells were 
collected for subsequent experiments. 
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2.4 Results and Discussion 
 
 
2.4.1 H2A.Z level is low within gene bodies and anti-correlates with transcription at 
nucleosome +1. 
 
 
We first aimed at investigating the effect of transcription on the distribution of H2A.Z within 
genes bodies in human cells. To achieve this, we made use of chromatin immuno-precipitation 
assays coupled to high-throughput sequencing (ChIP-seq) to measure the genome-wide 
distribution of H2A.Z in HCT116 colon cancer cells. In parallel to ChIP-seq, RNA from 
HCT116 cells was extracted and sequenced (RNA-seq) in order to measure gene expression 
levels. As such, we were able to sort genes according to their relative expression level using 
their respective “Fragments Per Kilobase of transcript per Million mapped reads” (FPKM), as 
well as generate H2A.Z aggregate profiles. We observed that H2A.Z accumulates only at the 
-1 and +1 nucleosomes of transcribed genes’ TSS, and was absent from the TSSs of non-
transcribed genes (Fig. 2.1). We also noted that, as transcription increases, H2A.Z is evicted 
from the +1 nucleosome (Fig. 2.1). Finally, we observed that the level of H2A.Z within gene 
bodies of transcribed decreases as genes transcription level increases, suggesting that 
transcription maintains low levels of H2A.Z within gene bodies (Fig. 2.1 and Fig. 2.S1). 
 
 
Taken together, these results, in agreement with the data from Hardy et al. and Jeronimo et al., 
suggest that active transcription may lead to the eviction of H2A.Z from genes (Hardy et al., 
2009; Jeronimo et al., 2015). These experiments however do not directly test whether active 
transcription per se is directly responsible for remodeling histone H2A.Z within gene bodies. 
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Figure 2.1 The presence of H2A.Z at genes anti-correlates with transcription. Average 
H2A.Z ChIP-seq signal at TSS of non-overlapping genes grouped by FPKM values. 
 
 
 
2.4.2 Inhibition of transcription specifically increases the incorporation of H2A.Z within 
genes 
 
 
In order to measure H2A.Z incorporation under conditions where RNA pol II transcription is 
globally inhibited, we treated HCT116 cells with α-amanitin. This molecule is a very strong 
inhibitor of transcription that stops the translocation of RNA pol II and causes its release from 
DNA (Bushnell et al., 2002). To first verify that α-amanitin treatment efficiently inhibits 
transcription, we used our RNA-seq data to select a set of control genes that are transcribed in 
non-treated HCT116 cells, and used ChIP to monitor RNA pol II levels at their TSS following 
α-amanitin treatment (Fig. 2.S2). This experiment validated that α-amanitin treatment results 
in a severe decrease in RNA pol II binding at their genes’ respective TSSs (Fig. 2.S2A). Next, 
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to verify that the eviction of RNA pol II decreases the transcription of these genes, we 
measured the level of their pre-mRNAs by RT-qPCR following α-amanitin treatment (Fig. 
2.S2B). We monitored pre-mRNAs because their half-life is shorter than those of mature 
mRNAs, and, as such, the quantification of pre-mRNA is more likely to reflect the 
transcriptional activity that occurs at a given gene. As expected, the α-amanitin treatment 
significantly decreased transcription levels measured at control genes (Fig. 2.S2B).  
 
 
We then performed ChIP-seq to measure H2A.Z levels in HCT116 cells following α-amanitin 
treatment. We observed that at genes that were not transcribed, H2A.Z remained absent from 
their TSSs, whether or not transcription was inhibited (Fig. 2.2A). On the other hand, at genes 
that were transcribed, the α-amanitin treatment triggered a strong accumulation of H2A.Z at 
TSSs and within gene bodies (Fig. 2.2A). The accumulation of H2A.Z was very specific and 
restricted to TSSs and gene bodies as the inhibition of transcription had virtually no effect on 
the level of H2A.Z in non-transcribed regions located outside genes (Fig. 2.2B). 
 
 
We then investigated whether the inhibition of transcription also affects the level of H2A.Z at 
functional elements located within gene bodies. To this aim, because H2A.Z is known to 
colocalize with Rad21, we analyzed H2A.Z signals at the binding sites of this cohesin subunit 
identified through peak calling using Rad21 ChIP-seq data generated in HCT116 cells (Millau 
and Gaudreau, 2011). Figure 2.2C shows that only Rad21 sites located within genes that were 
transcribed prior to transcription inhibition present an accumulation of H2A.Z. The 
accumulation is global and not restricted to the Rad21 sites, as the signal increases equally in 
the surrounding region (Fig. 2.2C). This accumulation was also specific to gene bodies as no 
increase in H2A.Z level was observed at Rad21 sites located outside genes (Fig. 2.2D). These 
data support that the inhibition of transcription globally increases the level of H2A.Z within 
gene bodies, regardless of whether the region is a functional element or not. 
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In order to verify that the accumulation of H2A.Z that we observed was due to an increase in 
H2A.Z incorporation within nucleosomes, rather than to an increase of nucleosome density, 
we performed a ChIP of histones H3 and H2A.Z at control sites (Fig. 2.S3A). We observed 
that, while H3 levels remained mostly stable following α-amanitin treatment, the level of 
H2A.Z increased, supporting the view that the increase in H2A.Z levels following inhibition 
of transcription is due to an increase in the incorporation of H2A.Z. Finally, to ensure that the 
incorporation of H2A.Z within gene bodies following α-amanitin treatment was restricted to 
specific loci and was not occurring globally across the entire genome, we measured global 
levels of H2A.Z present in chromatin by performing an immunoblot of H2A.Z using acid-
extracted histones (Fig. 2.S3B). This experiment revealed that there is no global increase in 
H2A.Z incorporation within chromatin, but rather α-amanitin treatment prompts the 
incorporation of H2A.Z at a limited set of genomic loci. 
 
 
Based on these data, we conclude that gene levels of H2A.Z increase globally within gene 
bodies and TSSs when transcribed genes become transcriptionally inactive (see example Fig. 
2.2E). We propose that when transcription is prevented, and RNA pol II is evicted from TSSs 
and gene bodies, H2A.Z is incorporated throughout these loci. However, it remains to be 
determined which chaperone could be involved for actively loading H2A.Z throughout gene 
bodies.  
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Figure 2.2 Inhibition of transcription specifically increases the incorporation of H2A.Z 
within genes. (A) Average H2A.Z ChIP-seq signal at TSS of non-transcribed (FPKM=0 
n=14,676) or transcribed (FPKM>0.5 n=5,046) non-overlapping genes following treatment of 
cells with 8 μM α-amanitin for 24h. (B) Average H2A.Z ChIP-seq signal at regions located 
outside genes (n=4,238) following treatment of cells with 8 μM α-amanitin for 24h. The 
average distance of these sites to the closest gene is >30 kb. (C) Average H2A.Z ChIP-seq 
signal at Rad21 sites located within non-transcribed (FPKM=0 n=3,193) or transcribed 
(FPKM>0.5 n=9,550) non-overlapping genes following treatment of cells with 8 μM α-
amanitin for 24 h. (D) Average H2A.Z ChIP-seq signal at Rad21 sites located outside genes 
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(n=8,825) following treatment of cells with 8 μM α-amanitin for 24h. (E) Example of genes 
where H2A.Z accumulates within gene bodies following transcription inhibition. RNA-seq 
(blue) and H2A.Z ChIP-seq (black) tracks are shown. 
 
 
2.4.3 p400 ATPase is recruited to genes following transcription inhibition 
 
 
In human cells, the p400 chromatin-remodeling ATPase is known to play a critical role in the 
incorporation of H2A.Z within chromatin (Bowman et al., 2011b; Gevry et al., 2007). We 
speculated that this remodelling complex might be responsible for the incorporation of H2A.Z 
within TSSs and gene bodies following α-amanitin treatment. We thus performed a ChIP of 
p400 in HCT116 cells treated or not with α-amanitin. Remarkably, p400 recruitment was 
increased at the TSSs of all tested genes, and we also observed an increase in H2A.Z 
incorporation following α-amanitin treatment (Fig. 2.3A, 2.S3A). We also measured p400 
levels at Rad21 sites located within genes and outside of genes. Following α-amanitin 
treatment, we observed that p400 can be recruited to the Rad21 sites located within CDKN1A 
and GDF15 genes, but is totally absent at FDXR site (Fig. 2.3A). We also found that, under 
those conditions, p400 is not recruited to Rad21 sites that lie outside of genes, even though 
H2A.Z is incorporated (Fig. 2.3A, 2.S32A). We thus conclude that the incorporation of H2A.Z 
at TSSs and within gene bodies is correlated in most part with the recruitment of p400. It 
remains to  
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Figure 2.3 The p400 chromatin-remodeling ATPase is specifically recruited at gene 
TSSs following transcription inhibition. (A) p400 ChIP following treatment of cells with 8 
μM α-amanitin for 24h. (B) Immunoblot analysis of p400, H2A.Z, H3, and actin in p400 
depleted HCT116 cells. (C) RT-qPCR of p400 and H2A.Z in p400 depleted HCT1166 cells.  
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be determined whether other chaperones, such as SRCAP, also participate in reloading H2A.Z 
after transcription ceases. Finally, to further substantiate that p400 is important for the 
incorporation of H2A.Z within chromatin, we made use of shRNA to deplete its expression 
and subsequently measured total H2A.Z using immunoblotting with an anti-H2A.Z antibody 
either from total extracts or from acid extracted histones. We found no significant drop in 
H2A.Z levels with total cellular H2A.Z, while a significant decrease is observed with 
chromatin-associated H2A.Z (Fig. 2.3B). Finally, using ChIP, we observed that the depletion 
of p400 resulted in a decrease of H2A.Z levels at TSSs and Rad21 sites (Fig. 2.S4). These 
experiments confirm that when p400 protein levels are decreased, the incorporation of H2A.Z 
within chromatin is also decreased. As a control, we confirmed that cellular depletion of p400 
did not significantly affect the level of H2A.Z mRNA (Fig. 2.3C).  
 
 
Taken together, our results demonstrate that after transcription is terminated, p400 incorporates 
H2A.Z at TSSs and also, to some extent, within gene bodies including at Rad21 sites. It remains 
to be determined however what triggers p400 to associate with those gene regions in the 
absence of transcription. Part of the answer may lie in an observation made by Fazzio et al.. 
They showed that the H3K4me3 mark is responsible for the recruitment of p400 at both silent 
and active genes (Fazzio et al., 2008). This may account for its association to TSSs following 
cessation of transcription. Nonetheless, we surmise that chaperones such as p400 can use TSSs 
and Rad21 sites to initiate deposition of H2A.Z “unidirectionally” from TSSs and 
“bidirectionally” from cohesin sites, which may then facilitate H2A.Z spreading within gene 
bodies. We propose a model where transcriptionally active RNA pol II machinery and 
associated histone chaperones force H2A.Z eviction at the TSS of genes (+1 nucleosome), as 
well as within gene bodies (Jeronimo et al., 2015). Upon transcription cessation, H2A.Z is 
reincorporated within gene bodies at least to some extent by p400 and possibly other 
chaperones (Fig. 2.4). 
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Figure 2.4 A schematic model illustrating H2A.Z accumulation at gene following 
inhibition of transcription. (A) In the presence of weak transcription H2A.Z is incorporated 
at nucleosome -1 and +1 of TSSs and intragenic cohesin sites by p400 or another remodelling 
complex (indicated by a question mark). (B) When transcription level is high, the sustained 
passage of elongating RNA pol II accompanied by its histone chaperone (e.g. FACT and 
Spt6H) results in the eviction of H2A.Z from gene bodies. (C) When transcription is inhibited 
by α-amanitin, RNA pol II is evicted from DNA and H2A.Z accumulates specifically within 
gene bodies through the action of chromatin remodelers such as p400. 
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In conclusion, while Latorre et al. propose that accumulation of H2A.Z within gene bodies is 
an active mechanism required to establish repression, our data indicates that accumulation of 
H2A.Z within the body of repressed genes can also be the consequence of a decrease in 
transcription and, as such, should be taken into consideration when interpreting results related 
to H2A.Z genome wide distribution (Latorre et al., 2015).  
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2.8 Supplementary Figures 
 
 
 
 
Figure 2.S1 Average H2A.Z ChIP-seq signal at TSS. Average H2A.Z ChIP-seq signal at 
TSS of non-overlapping genes grouped by FPKM values (FPKM 0-0.5 n=19,113, FPKM 0.5-
5 n=1,637, FPKM 5-250 n=3,290). 
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Figure 2.S2 Inhibition of transcription using α- amanitin. (A) RNA pol II ChIP at the TSSs 
of control genes following treatment of cells with 8 μM α-amanitin for 24 h. (B) RT-qPCR of 
pre-mRNA of control genes following treatment of cells with 8 μM α-amanitin for 24h. 
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Figure 2.S3 Inhibition of transcription specifically increases the incorporation ofH2A.Z 
within genes. (A) H3 ChIP following treatment of cells with 8 μM α-amanitin for 24h. (B) 
H2A.Z ChIP following treatment of cells with 8 μM α-amanitin for 24h. (C) Immunoblot of 
H2A.Z and H3 in HCT116 cells treated or not with 8 μM α-amanitin for 24h. 
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Figure 2.S4 Knockdown of p400 decreases the incorporation of H2A.Z within chromatin. 
H2A.Z ChIP following p400 depletion using shRNA. 
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2.9 Supplementary Material and Methods 
 
 
2.9.1 RNA-seq data analysis 
 
 
We used the RNA-seq pipeline version 1.4 developed by MUGQIC 
(https://bitbucket.org/mugqic/mugqic_pipelines) to analyze our data. Briefly, the raw reads 
were trimmed using Trimmomatic 0.32 (Bolger et al., 2014) to remove from the 3’-end the 
bases with a Phred quality score below 30, and remove the trimmed reads shorter than 32 bp. 
The trimmed reads were then aligned onto the human reference genome hg19 using TopHat 
2.0.11 (Kim et al., 2013a) and Bowtie 2.2.2 (Li and Durbin, 2009) with default parameters 
except --library-type fr-firststrand -G transcripts_ensembl.gtf (GRCh37.68), then 
MarkDuplicates from Picard 1.118 was applied. Finally FPKM values were calculated for each 
gene using Cufflinks 2.1.1 (Trapnell et al., 2010) with default parameters except -G 
transcripts_ensembl.gtf (GRCh37.68).  
 
 
2.9.2 ChIP-seq data analysis 
 
 
We based the analyses of our H2A.Z and Rad21 ChIP-Seq data on the ChIP-seq pipeline 
version 1.4 developed by MUGQIC. Briefly the raw reads were trimmed as for RNA-Seq 
reads, then aligned onto hg19 using BWA 0.7.5a with default parameters, then filtered on 
alignment quality using Samtools 0.1.19  with the settings view -F4 -q 20 (Li et al., 2009). The 
two biological replicates per condition were then combined using makeTagDirectory from 
Homer 4.1 (Heinz et al., 2010). The signal density files in BedGraph format of the H2A.Z 
datasets were generated using makeUCSCfile from Homer. Rad21 narrow peak summits were 
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determined using MACS2 version 2.0.10 (Zhang et al., 2008) with default parameters except 
--fix-bimodal -f BAMPE.  
 
 
2.9.3 ChIP-seq aggregate profiles 
 
  
To generate the aggregates profiles of H2A.Z at TSS (Fig. 2.1 and 2.2A), we used the the 
Versatile Aggregate Profiler (VAP) version 1.1.0 (Coulombe et al., 2014) with the following 
parameters: Annotation mode, Absolute analysis method, 1 reference point, txStart/txEnd at 
5’, 50 bp windows, 80 windows in the upstream and the downstream blocks, mean aggregate 
value, smoothing 6, and missing data were considered as “0”. For the genome annotations file, 
we took the gene coordinates from the transcripts GTF used in the RNA-Seq pipeline 
(GRCh37.68) but excluded the overlapping genes to avoid any signal contamination. The 
groups of genes were based on the gene’s FPKM generated by Cufflinks (Fig. 2.1: 19,113 
genes with FPKM between 0-0.5, 4,927 with FPKM between 0.5-250, 69 between 250-500, 
25 between 500-1,000, and 25 genes with FPKM >1,000). In Figure 2.2A, the non-transcribed 
genes are those with a FPKM=0 (n=14,676) and the transcribed ones are the union of the 4 
other groups (FPKM>0.5 n= 5,046).  
 
 
The profiles over Rad21 binding sites (Fig. 2.2C-D) were generated using the summits of the 
narrow peaks identified by MACS2 and similar VAP parameters than over TSS, except that 
we used the Coordinates mode and 334 windows per block. In Figure 2.2C we used the Rad21 
sites (with a signal >25) located in non-transcribed genes (FPKM=0 for a total of 3,193 sites) 
and transcribed genes (FPKM>0.5, 9,550 sites), while in Figure 2.2D we used the 8,825 peaks 
located outside genes (at +5 kbp from a TSS or the end of a gene). 
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To generate the profiles in regions located outside genes (Fig. 2.2B), rather than selecting 
random intergenic sites, we subtracted 5 kb from the coordinates of the Rad21 peaks, then 
applied a filter to remove those at less than 5 kb of genes. The resulting intergenic sites are 
located at an average of >30 kb of the closest genes (minimum 5kb, maximum 650kb, median 
17kb) and >95% of those sites are located at >6kb from a gene.  
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Table 2.S1 ChIP antibodies 
 Company Reference 
H2A.Z - Raised against CSLIGKKGQQKT 
H3 Abcam ab1791 
RNA pol II (8WG16) Covance MMS 126R 
Rad21 Abcam ab992 
p400 Abcam ab5201 
 
 
Table 2.S2 ChIP primers 
 Forward Reverse 
CDKN1A TSS nuc+1 GGGGCGGTTGTATATCAGGG CGCTCTCTCACCTCCTCTGA 
PCNA TSS nuc+1 CAGGCGGGAAGGAGGAAAG CGTAGCAGAGTGGTCGTTGT 
DDIT4 TSS nuc+1 GGTTCGCACACCCATTCAAG AGCTCTAGGACCCACACACA 
GDF15 TSS nuc+1 GCAAGAACTCAGGACGGTGA CGCAACTCTCGGAATCTGGA 
GDF15 Cohesin CATCAGACACTGACCGAGGA GTTGGAGCCATTTGCAGAGT 
FDXR Cohesin CTCCTGCCTGGGAAGTCCT CTCTTCGGCGTTGTCCTG 
TP53I3 Cohesin GCAACGGGGACCACTGTC CCAGCCCAGGTCTTCCAG 
Cohesin outside gene CCGCCTGGCTACTGGAAC ATCCTGCCCCCTTGTGAC 
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Table 2.S3 RT-qPCR primers 
 Forward Reverse 
p21 ACCAGGGCCTTCCTTGTATC GCATGGGTTCTGACGGAC 
PCNA TTAAACGGTTGCAGGCGTAG TCTAGCTGGTTTCGGCTTCA 
DDIT4 GGTTCGCACACCCATTCAAG GCTCTAGGACCCACACACAG 
GDF15 GTTCCTGGAAAACGGTAGGC CCCGAGAGATACGCAGGTG 
36B4 CGACCTGGAAGTCCAACTAC ATCTGCTGCATCTGCTTG 
 
 
Table 2.S4 Western blot antibodies 
 Company Reference 
Actin Sigma A2066 
H2A.Z Abcam ab4174 
H3 Abcam ab1791 
p400 Abcam ab5201 
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CHAPTER 3 
 
 
 
Investigating the role of the Bromodomain protein 8 (BRD8) in cell cycle 
regulation and DNA damage response 
 
 
Article Description 
 
In this manuscript, we investigated the molecular mechanisms underlying growth defects and 
cell death in BRD8-depleted human colorectal cancer cells (HCT116). We report that cellular 
depletion of BRD8 results in an increased expression of p21, which leads to cell cycle arrest 
in G1/S and to p53-dependent apoptosis. We also provide evidence that the DNA damage 
response pathway is activated following the knockdown of BRD8. The growth deficiency 
induced by BRD8 knockdown was also observed in p53-null and p21-null HCT116 cells.  In 
the p53-null cells, BRD8-KD cells accumulated in the G2 phase of the cell cycle, suggesting 
the existence of un-repaired DNA damage or persistent replication stress. In addition, reduced 
H4K16 acetylation in BRD8-depleted cells suggested that BRD8 may have a role in the 
recruitment and/or stabilization of the p400/Tip60 complex within chromatin, and thus 
facilitates DNA repair. Furthermore, in BRD8 depleted cells CHK2 is activated which is 
consistent with an activation of the DNA damage response pathway. However, surprisingly, 
we observed that CHK1 protein levels were severely reduced. Our results suggest that BRD8 
is required for preventing DNA damage in non-stressed cells. 
The manuscript containing the results of this part of my project is currently under revision to 
submit to the journal Cell Cycle. 
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3.1 Abstract 
 
 
In an attempt to investigate a potential role of the BRD8 bromodomain protein – a member of 
the p400/Tip60 complex - in p53-mediated signaling, we sought to test if acute cellular 
depletion of the factor would affect p21 gene expression.  We find that knockdown of BRD8 
leads to p21 induction, and concomitant cell cycle arrest in G1/S. We further demonstrate that 
the p53 transcriptional pathway is activated in BRD8-depleted cells, and this accounts for 
upregulation of not only p21 but also proapoptotic genes, an event that leads to consequent 
apoptosis. Importantly, the DNA damage response is induced upon depletion of BRD8 and 
DNA damage foci, as indicated by immunostaining for γ-H2AX are detectable in BRD8-
depleted cells under normal growth conditions. Notably, H4K16 acetylation is reduced in 
BRD8-depleted cells suggesting that BRD8 may have a role in recruitment and/or stabilizing 
the p400/Tip60 complex within chromatin, and thus facilitate DNA repair. Consistent with the 
activated DNA damage response, we find that in BRD8-depleted cells, CHK2 is activated but 
surprisingly, CHK1 protein levels are severely reduced.  Taken together, our results suggest 
that BRD8 is involved not only in mediating p53-dependant gene suppression, but also in 
mediating the DNA damage response.  
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3.2 Introduction 
 
 
Dynamic changes in chromatin structure are an inevitable necessity in many cellular processes 
such as gene transcription, DNA replication, DNA repair and recombination (Clapier and 
Cairns, 2009; Voss and Hager, 2014). Chromatin dynamics can be modulated through different 
mechanisms including post-translational modification of histone tails, physical displacement 
of nucleosomes by ATP-dependent chromatin remodelers, and exchange of canonical histones 
by histone variants (Clapier and Cairns, 2009; Kouzarides, 2007). Histone post-transcriptional 
modifications alter the structure of chromatin and also act as docking sites for regulatory 
proteins that specifically recognize these modifications to recruit or stabilize factors involved 
in chromatin-associated processes such as nucleosome remodeling. Among the various histone 
modifications, lysine acetylation is the most dynamic as this modification directs structural 
changes in chromatin as well as modulates gene transcription (Tessarz and Kouzarides, 2014; 
Venkatesh and Workman, 2015). Emerging evidence suggests that histone acetylation plays 
an important role in DNA repair and replication, but the precise mechanism remains to be 
elucidated (Gong et al., 2015; Gong et al., 2016; Gursoy-Yuzugullu et al., 2015b; Miller et al., 
2010; Price and D'Andrea, 2013). Lysine acetylation on histone tails creates docking sites for 
bromodomain (BRD) -containing proteins (Filippakopoulos and Knapp, 2014). BRDs are an 
important family readers of lysine acetylation and can recognize acetylated-lysine residues on 
proteins including histone tails (Filippakopoulos and Knapp, 2014; Sanchez and Zhou, 2009). 
Dysfunction of BRD-containing proteins has been linked to pathological conditions, including 
cancer, inflammation and viral replication (Sanchez and Zhou, 2009). Even though recent 
studies have highlighted the roles of BRDs in various biological processes and their association 
with disease, the function of many human BRD proteins, such as BRD8, is not well 
characterized. The BRD8 protein contains two tandem BRDs and is highly expressed in 
skeletal muscle cells (Nielsen et al., 1996). BRD8 also binds to the thyroid hormone receptor 
ligand-binding domain (Monden et al., 1997). The human BRD8 gene is located on 
chromosome 5q31.2. BRD8 is present in human cells in several different isoforms, 
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predominantly isoforms 1 and 2. Isoform 2 is larger (135.4 kDa) than isoform 1 (102.8 kDa). 
Both isoforms are subunits of the p400/Tip60 chromatin remodeler/Histone Acetyl Transferase 
(HAT) complex (Cai et al., 2005; Cai et al., 2003; Downs et al., 2004; Doyon and Cote, 2004; 
Doyon et al., 2004; Fuchs et al., 2001; Ikura et al., 2007) which is implicated in the regulation 
of gene expression, cell cycle regulation, and DNA repair. In mammals, the p400/Tip60 
remodeling complex deposits the histone variant H2A.Z into specific regions of chromatin 
(Gevry et al., 2007).  
 
 
Repair of damaged DNA requires the remodeling of local chromatin structure to allow access 
of the repair machinery to the site of DNA damage (Gursoy-Yuzugullu et al., 2015b; Lukas et 
al., 2011). It is well known that chromatin remodeling complexes, histone modifications and 
dynamic changes in nucleosome organization are active players in the process of efficient DNA 
damage repair (Gursoy-Yuzugullu et al., 2015b). The role of the p400/Tip60 remodeling 
complex has been well established in this process. Loss of functional p400/Tip60 leads to 
defective double-strand breaks (DSBs) repair and increased sensitivity to DNA damaging 
agents (Mattera et al., 2009; Murr et al., 2006; Sun et al., 2009). It has been shown that many 
of the subunits of mammalian p400/Tip60 are recruited to DNA DSBs, suggesting that the 
intact complex is recruited to DNA lesions (Courilleau et al., 2012; Kusch et al., 2004; Murr 
et al., 2006; Xu et al., 2010). At DNA damage sites, p400/Tip60 promotes the relaxation of 
chromatin by first catalyzing the exchange of H2A.Z for the p400 SWI/SNF ATPase and then 
by promoting the rapid acetylation of histones H2A/H2AX and H4 by the Tip60 
acetyltransferase (Ikura et al., 2007; Murr et al., 2006; Xu et al., 2012; Xu et al., 2010). 
However, little is known about the function of the BRD8 subunit in the context of damaged 
DNA. 
 
 
Previously, a cDNA fragment from the BRD8 gene was isolated from HeLa cells based on a 
cDNA-expression screen for factors that increase the sensitivity to microtubule inhibitor 
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chemotherapeutic drugs (Yamada and Gorbsky, 2006). BRD8’s protein expression level was 
shown to be elevated several-fold in metastatic colorectal cancer cell lines compared to slow 
proliferating colorectal tumor cell lines and is barely detectable in normal colonic mucosa 
(Yamada and Rao, 2009). It has been shown that BRD8 protein levels are significantly higher 
in aggressively growing tumors induced by simultaneous treatment with azoxymethane 
(AOM) and dextran sodium sulfate (DSS) compared to tumors normally appearing in rat 
colonic mucosa and AOM-induced colorectal adenocarcinoma tissue (Yamada and Rao, 2009). 
Treatment with AOM and DSS is known to produce aggressive adenocarcinomas (Tanaka et 
al., 2006). BRD8 knockdown induced cell death or growth delay in colorectal cancer cell lines, 
and surviving BRD8 knockdown (KD) cells were sensitive to spindle poisons (nocodazole and 
taxol) and the proteasome inhibitor MG132 (Yamada and Rao, 2009). Yamada and Rao’s 
(2009) experiments proposed BRD8 as the factor over-expressed in aggressive colorectal 
cancers that provides growth advantage and resistance to spindle poison chemotherapy 
(Yamada and Rao, 2009). They suggested that BRD8 expression is associated with tumor 
progression toward advanced stages of colorectal cancers (Yamada and Rao, 2009). However, 
the mechanism(s) for growth promotion and chemotherapy resistance is (are) not known. 
 
 
In the present study, we have investigated the molecular mechanisms underlying growth defect 
and cell death in BRD8-depleted human colorectal cancer cells (HCT116). Here we report that 
cellular depletion of BRD8 by siRNA increases the expression of p21, which leads to cell cycle 
arrest in G1/S and subsequent p53-dependent apoptosis. We also provide evidence that the 
DNA damage response pathway is activated following BRD8 knockdown. Our results show 
that BRD8 knockdown activates CHK2, but decreases CHK1 expression in HCT116 cells. The 
growth deficiency induced by BRD8 knockdown was also observed in p53-null and p21-null 
HCT116 cells. In the p53-null cells, BRD8-KD cells accumulated in the G2 phase of the cell 
cycle suggesting the existence of un-repaired DNA damage or persistent replication stress. 
Taken together, our results suggest that BRD8 is required to prevent DNA damage 
accumulation. 
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3.3 Results 
 
 
3.3.1 BRD8 knockdown induces cell cycle arrest and cell death through induction of p53-
dependent apoptosis in HCT116 cells 
 
 
BRD8 was previously shown to be over-expressed in metastatic and highly proliferating 
colorectal cancer cell lines. It has also been proposed that BRD8 expression is associated with 
tumor progression towards advanced stages by providing a growth advantage (Yamada and 
Rao, 2009). To investigate the possible function of elevated BRD8 expression in the 
proliferation of cancer cells, we depleted BRD8 in HCT116 cells. Two siRNAs targeting 
different regions of the BRD8 mRNA were used. Transfection of HCT116 cells with both 
siRNA constructs significantly reduced BRD8 mRNA transcription after 48 hours of 
transfection as measured by RT-qPCR (to levels equivalent to 4%-10% of control cells) (Fig. 
3.1A). The protein levels of both BRD8 isoforms 1 and 2 also decreased strongly to %15 of 
control cells after transfection with both siRNA constructs (Fig. 3.1B). 
 
 
We first monitored cell viability by crystal violet staining at 24, 48, 72, 96 hours after 
transfection. Consistent with previous results (Yamada and Rao, 2009), depletion of BRD8 in 
HCT116 p53+/+ cells significantly reduced the number of viable cells compared to the control 
siRNA (Fig. 3.2A). To investigate the mechanism(s) underlying the decrease in viability 
following BRD8 KD, we analyzed the cell cycle distribution of transfected cells. Cell cycle 
analysis showed that transfection of HCT116 cells with BRD8 siRNA significantly reduced 
cell population in S-phase (S-phase: 27.25 ± 3.07% in control transfection to 8.50 ± 0.57% and 
5.89 ± 0.77% in BRD8 siRNA transfection) (Fig. 3.2B and C). In agreement with a previous 
study (Yamada and Rao, 2009), knock down of BRD8 also induced an increase of the cell 
population in sub-G1 (sub-G1: 1.28 ± 0.56% in control transfection to 5.88 ± 0.23% and 12.01 
± 1.31%), indicating an increase in DNA fragmentation and cell death compared to control 
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(Fig. 3.2B and C). Thus, we reasoned that the observed decrease in viability might be caused 
by G1/S arrest as well as induction of cell death in HCT116 p53+/+ cells.  
 
 
 
 
 
Figure 3.1 Knockdown of BRD8 using two siRNA in HCT116 p53+/+ cells.  BRD8 depleted 
in HCT116 cells with two siRNAs targeting BRD8 (siBRD8-35 and siBRD8-36) or non-
targeting siRNA (Ctrl) for 48h. (A) Expression levels of BRD8 in HCT116 p53+/+ cells before 
and after knockdown using siRNA. mRNA expression levels of the 36B4 gene (also called 
ribosomal phosphoprotein P0 (RPLP0)) were used to normalize the qPCR. (B) Immunoblot 
showing BRD8 expression in BRD8 knockdown cells. The arrows present the two isoforms of 
BRD8. 
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Figure 3.2 BRD8 knockdown induces cell cycle arrest and cell death. (A) Crystal violet 
staining viability assay of HCT116 p53+/+ cells at 24, 48, 72 and 96Ԝ h post transfection 
with siRNAs targeting BRD8 (siBRD8-35 and siBRD8-36) or non-targeting siRNA (Ctrl), 
0
0.1
0.2
0.3
0.4
0.5
0.6
0.7
24h 48h 72h 96h
O
D
59
0 
va
lu
e
siCtrl
siBRD8-35
siBRD8-36
0 250 500 750 100
0
50
100
150
200
0 250 500 750 100
0
50
100
150
200
0 250 500 750 100
0
50
100
150
200
0
5
10
15
20
25
30
35
40
45
50
siCtrl siBRD8-35 siBRD8-36
%
nu
m
be
r o
f c
el
ls
subG1
G1
S
G2
*
***
**
A 
B 
C
ou
nt
 
siCtrl siBRD8-35 siBRD8-36 
C 
 94 
 
the cells were fixed and stained with crystal violet. Crystal violet stain was dissolved and 
optical absorbance was measured at 590 nm (OD590). Two independent experiments were 
performed in triplicate; the mean ± SD is shown. (B) Cell cycle distributions of HCT116 
p53+/+ following BRD8 knockdown for 72h and analyzed by PI staining FACS; (C) the 
mean of 3 independent experiment ± SD is shown. * P≤0.05; ** P ≤0.02 compared to 
control. 
 
Given that the knock down of BRD8 leads to decreased cell survival and increased sub-G1 
population, we wanted to see if this correlated with the induction of apoptosis. For this 
purpose, Annexin V-FITC/propidium iodide (PI) staining of BRD8-depleted HCT116 cells 
was performed. The results indicate that BRD8 knockdown reproducibly caused a 
significant increase in the population of Annexin V-positive PI-negative cells (early 
apoptotic cells) in HCT116 p53+/+ cells (Fig. 3.3A). The same results were obtained with 
both BRD8 siRNAs and shRNA (Fig. 3.3A). We also assayed PARP cleavage which is an 
indicator of caspase activation and apoptosis. Western blot analysis showed that, in BRD8 
depleted HCT116 p53+/+ cells, PARP protein cleavage was enhanced (Fig. 3.3C).  
 
 
Apoptosis may occur in either a p53-dependent or -independent manner (Haupt et al., 2003; 
Liebermann et al., 1995). We thus tested whether the induced apoptosis was p53-
dependent. For this purpose we knocked down BRD8 in isogenic HCT116 cells which were 
p53 -/-. Knockdown of BRD8 in HCT116 p53-/- cells did not significantly induce apoptosis 
(Fig. 3.3B), nor was any increase in PARP cleavage detected in p53-/- cells following 
BRD8 knockdown (Fig. 3.3D), indicating that BRD8 depletion induced p53-dependent 
apoptosis in HCT116 cells. 
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Figure 3.3 BRD8 Knock down induces apoptosis in HCT116 p53+/+ cells. Apoptosis 
in HCT116 p53+/+ (A) and HCT116 p53-/- (B) cells were quantified by FACS analysis of 
Annexin V and PI double staining 72h post transfection with siRNA targeting BRD8 
(siBRD8-35 and siBRD8-36) (upper panels) and shRNA targeting BRD8 (lower panels) or 
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non-targeting siRNA/shRNA (Ctrl). Immunoblot showing the cleaved PARP in HCT116 
p53+/+ (C) and HCT116 p53-/- (D) cells in BRD8 depleted cells. Data are the mean± SD 
from three independent experiments* P≤ 0.05; ns = non significant 
 
 
In order to identify the molecular mechanism of apoptosis following BRD8 knockdown, 
we investigated the effect of BRD8 depletion on transcription of p53 proapoptotic target 
genes. Among the p53 target genes, p21 and Puma (p53 upregulated mediator of apoptosis) 
are the major mediators of p53 tumor suppressor effects such as growth arrest and 
apoptosis. Puma, a proapoptotic BCL-2 family protein, was previously shown to be 
required for the induction of p53-dependent apoptosis (Jeffers et al., 2003). Puma is directly 
induced by p53 in response to stress stimuli such as DNA damage. (Erlacher et al., 2006; 
Jeffers et al., 2003; Michalak et al., 2008; Villunger et al., 2003). As shown in Figure 3.4A, 
knockdown of BRD8 significantly induced the transcription of Puma. Next we assayed the 
expression of p53DINP1 (p53-dependent damage-inducible nuclear protein 1), which is 
responsible for the induction of apoptosis in response to DSBs (Okamura et al., 2001). As 
shown in Figure 3.4B, knockdown of BRD8 significantly induced the transcription of 
p53DINP1. In addition, p53 activates the extrinsic apoptotic pathway through the 
transcriptional induction of the trans-membrane proteins, such as cell surface receptors Fas, 
which is a member of the TNF-R family of receptors (Muller et al., 1998). Knock down of 
BRD8 significantly induced Fas transcription (Fig. 3.4C). In addition, TIGAR (TP53-
induced glycolysis and apoptosis regulator) mRNA was also slightly increased following 
depletion of BRD8 (Fig. 3.4D). We also measured the transcription of another p53-
inducible proapoptotic gene, Bax. Whereas transcription of Puma, Fas and p53DINP1 are 
significantly induced and TIGAR mRNA is slightly increased, Bax was unaffected 
following depletion of BRD8 (Fig. 3.4E). The requirement for Bax in p53-mediated 
apoptosis is cell type dependent (Attardi et al., 2000; Chong et al., 2000; McCurrach et al., 
1997). It has been shown that in colonic epithelia cells, Bax is not essential for apoptosis in 
response to irradiation (Pritchard et al., 1999). Taken together, these results suggest that 
the induction of apoptosis by cellular depletion of BRD8 is the result of the transcriptional 
activation of proapoptotic p53 target genes.  
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Figure 3.4 BRD8 knockdown induces pro-apoptotic p53 target genes in HCT116 cells.  
(A-E) RT-qPCR assay showing mRNA expression levels of Puma, 53DINP1, Fas, TIGAR, 
Bax. Data are the mean± SD from three independent experiments * P≤ 0.05; ** P≤ 0.005; 
ns = non significant  
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3.3.2 Cellular depletion of BRD8 induces p53-dependent p21 transcription in HCT116 
cells 
 
 
In order to provide insights into the molecular mechanisms involved in G1/S cell cycle 
arrest, we assayed whether the transcription of cell cycle regulating genes is affected by 
depletion of BRD8. The progress of the cell cycle is regulated by three protein families: 
Cyclins, cyclin-dependent kinases (CDKs) and CDK inhibitors (CDKIs). G1/S transition 
is triggered by the formation of cyclin D1-CDK4/6 complexes which regulate the synthesis 
of DNA to be prepared for cell division (Casimiro et al., 2014), while the CKIs CDKN1A 
(p21) and CDKN1B (p27) have a negative regulatory role in this process (Dutto et al., 2015; 
Ray et al., 2009). It is well known that cyclin-dependent kinase inhibitor p21 is essential 
for G1/S cell cycle arrest (Deng et al., 1995; Dutto et al., 2015). Depletion of BRD8 
significantly increased p21 mRNA (Fig.3.5A). We also determined p21 protein levels in 
BRD8-depleted cells by Western blot. In agreement with our RT-qPCR data, p21 protein 
level increased in BRD8 KD compared to control cells (Fig.3.5E). Another key component 
in the regulation of cell cycle progression is p53, which is activated in response to a wide 
spectrum of stresses (Horn and Vousden, 2007). When activated by genotoxic stresses, p53 
directly up-regulates the p21 gene to inhibit cell cycle progression (Dutto et al., 2015). As 
expected from our apoptosis data, analysis of p53 expression indicated that both mRNA 
(Fig.3.5B) and protein levels (Fig. 3.5E) of p53 are elevated in BRD8-depleted cells. To 
evaluate whether BRD8 depletion activates the p53 transcriptional pathway, we also 
examined the expression of MDM2, which is a canonical transcriptional target of p53 that 
provides negative feedback regulation of p53 activity (Vousden and Lu, 2002). As shown 
in Figure 3.5C, knockdown of BRD8 induced the transcription of Mdm2 in response to 
elevated p53 expression.  
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Figure 3.5 Knockdown of BRD8 activate p53 in HCT116 p53+/+ cells.  (A-D) BRD8 
depleted in HCT116 cells with two siRNAs targeting BRD8 (siBRD8-35 and siBRD8-36) 
or non-targeting siRNA (Ctrl) for 48h. total RNA extraction and RT-qPCR assay. mRNA 
expression levels of  p21, p53, MDM2 and p27. The mean ± SD from three independent 
experiments are shown. Total cell extract of HCT116 p53+/+ (E) and HCT116 p53-/- (F) 
were subjected to immunoblot assays using indicated antibodies. Of note GAPDH is the 
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same as in Figure 3.12 C as they are from the same cell extract. * P≤ 0.05; ** P≤ 0.005; ns 
= non significant 
 
 
The regulation of p21 gene transcription occurs through p53-dependent and p53-
independent pathways (Abbas and Dutta, 2009). We asked whether BRD8 siRNA-
mediated p21 expression is exclusively p53-dependent. For this purpose, isogenic p53-null 
HCT116 cells (HCT116 p53-/-) were infected with siRNA BRD8. In contrast to p53-
positive cells, knockdown of BRD8 did not increase the basal levels of p21 protein in 
HCT116 p53-/- cells, indicating that the induction of p21 was p53-dependent (Fig. 3.5F).  
  
 
We also assayed the transcription level of the other member of the Cip/Kip family of cyclin-
dependent kinase inhibitors, protein p27 (CDKN1B), which controls cell cycle progression 
at G1, by RT-qPCR. As shown in Figure 3.5D, p27 mRNA levels were unchanged in BRD8 
knockdown cells compared to control cells. Hence, it can be assumed that the G1/S arrest 
seen in the BRD8 depleted cells is due to increased p21 expression level.  
 
 
To determine whether p21 is the gene responsible for growth deficiency in BRD8-depleted 
cells, we knocked down BRD8 in isogenic p21-null HCT116 cells (HCT116 p21-/-) and 
assayed cell viability. The absence of p21 did not counter the growth deficiency by 
knockdown of BRD8 in HCT116 p21-/- cells. Viability of HCT116 p21-/- cells decreased 
significantly following the knockdown of BRD8 by BRD8-targeting siRNA compared to 
control siRNA (Fig. 3.6A). We further examined the effect of BRD8 knockdown on the 
induction of apoptosis in HCT116 p21-/- using Annexin V-FITC/propidium iodide (PI) 
staining followed by FACS analysis. As shown in Figure 3.6B, knockdown of BRD8 
caused an increase in the population of both Annexin V positive/PI negative early apoptotic 
and Annexin V positive/PI positive late apoptotic and dead cells. We also analyzed the cell 
cycle distribution of p21 null cells. Cell cycle analysis showed that BRD8 KD increased 
cell population in G2-phase about 2 fold (G2-phase: 24.06% in control cells to 35.49% in 
BRD8 depleted cells), induced a modest increase in the cell populations with G1-phase 
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DNA content (G1: 6.74% in control to 9.89% in BRD8 depleted cells) and also induced a 
significant decreasein the cell population withS-phase DNA content (S-phase: 51.58% in 
control to 36.35% in BRD8 depleted cells) in p21 null cells (Fig. 3.S2). The effect of BRD8 
knockdown on p21-null background indicates that besides the up-regulation of p21, other 
molecular mechanisms exist to explain the proliferation defects and cell death observed in 
BRD8 depleted cells. 
 
 
As mentioned before, BRD8 is a subunit of the p400/Tip60 complex (Doyon and Cote, 
2004). Previous studies in our laboratory have demonstrated that p400-dependent 
deposition of H2A.Z at the distal p53-binding site of the p21 promoter inhibits p53-
dependent p21 transcription and thereby inhibits replicative senescence (Gevry et al., 
2007). Our laboratory has demonstrated that knockdown of H2A.Z results in an increase in 
p21 expression and cellular senescence (Gevry et al., 2007). Moreover, the decrease in the 
expression of p400 was shown to induce p21 expression and cellular senescence through 
the p53/p21 pathway (Chan et al., 2005; Gevry et al., 2007). In addition, loss of MRG15 
was shown to limit neural stem/progenitor cell proliferation via increased expression of p21 
(Chen et al., 2011). Thus, we investigated this possibility in BRD8-depleted HCT116 cells. 
Despite the fact that H2A.Z transcription was decreased by BRD8 depletion, the protein 
levels of H2A.Z were not affected by the knock down of BRD8, at least not during the 
course of our experiments (Fig. 3S1 B and E). As shown in Figure S1A, transcription levels 
of p400, MRG15 and Tip60 were not affected by KD of BRD8 (Fig. S1 A,C and D). This 
suggests that the increase in p21 expression in BRD8-depleted cells is specific and it not 
due to change in expression and/or protein levels of these subunits of the p400/Tip60 
complex.  
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Figure 3.6 Lack of p21 did not rescues proliferation arrest and apoptosis in BRD8 
depleted cells (A) Crystal violet staining assay of HCT116 p21-/- cells at 24, 48, 72 and 
96h post transfection with siRNAs targeting BRD8 (siBRD8-35 and siBRD8-36) or non-
targeting siRNA (CT). Three independent experiments were performed in triplicate; the 
mean ± SD is shown. (B) Apoptosis in HCT116 p21-/- cells were quantified by FACS 
analysis of Annexin V and PI double staining 72h post transfection.  
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3.3.3 BRD8 is required to prevent DNA damage in non-stressed cells 
 
 
The above experiments indicate that the knock down of BRD8 induces p53-dependent 
apoptosis in non-stressed cells. This begs the question as to what triggers programmed cell 
death in these cells. It has been shown that apoptosis can be triggered in response to DNA 
damage (Roos and Kaina, 2006). In order to investigate this possibility, we first assayed 
whether BRD8 knockdown affects p53 accumulation. As mentioned above, analysis of p53 
expression indicated that both mRNA and protein levels of p53 was elevated in BRD8 
depleted cells (Fig. 3.5B and E). P53-Ser15 phosphorylation is one of the well-known 
modifications in response to DNA damage that can be mediated through ATM (Lavin and 
Kozlov, 2007). In response to DNA damage, activation of ATM itself occurs through 
phosphorylation of its Ser1981 (Lavin and Kozlov, 2007). As shown in Figure 3.5E, BRD8 
knockdown resulted in an increase in p53-Ser15 phosphorylation, ATM protein levels and 
ATM-Ser1981 phosphorylation (p-ATM) in p53+/+ cells. Immunoblot analysis also 
confirms that DNA repair pathway is activated in BRD8 depleted p53-/- cells and ATM is 
phosphorylated at Ser 1981 (Fig. 3.5F). 
 
 
Moreover, DNA damage, particularly DSBs, induces the phosphorylation of histone H2AX 
on Ser139 (γ-H2A.X) (Rogakou et al., 1998; Sedelnikova et al., 2002) that can be mediated 
by activated ATM (Lavin, 2007; Lavin and Kozlov, 2007). Hence, we analyzed γ-H2A.X 
by immunofluorescence staining and immunoblotting. Similar to previously published data 
(Gong et al., 2015), BRD8 antibody stained the chromatin in nuclei and excluded from the 
nucleoli (Fig. 3.7A upper panel). In BRD8 depleted cells, the fluorescence intensity of 
BRD8 antibody was declined markedly indicating the efficiency of our knockdown (Fig. 
3.7A). When we monitored γ-H2A.X foci formation, the fluorescence intensity of γ-H2A.X 
was clearly higher in siBRD8 than in control cells (Fig.3.7A lower panel). We further 
analyzed γ-H2A.X foci formation by manual counting of the foci in acquired images and 
cells containing more than 10 foci were scored as positive. The percentage of cells with 
more than 10 foci is shown Figure 3.7 C. The percentage of cells with more than 10 γ-
H2A.X foci was higher following knockdown of BRD8 (Fig. 3.7 B). In addition, 
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immunoblot analysis of γ-H2A.X also confirms that the levels of γ-H2A.X increased (about 
3-5 fold) in both p53+/+ (Fig. 3.7C) and p53-/- cells (Fig.3.7 D). These data suggest that 
BRD8 is required to prevent DNA damage in non-stressed cells.  
 
 
 
 
 
                                                                                                         
  
 
       
 
 
 
 
 
 
 
 
 
Figure 3.7 BRD8 knock down activates DNA damage pathway (A) Detection of DNA 
damage foci in BRD8 knockdown cells. HCT116 p53+/+ cells were transfected with 
siRNAs targeting BRD8 (siBRD8-35) or non-targeting siRNA (Ctrl). Cells were fixed and 
foci of γH2A.X (red) and BRD8 (green) detected by immunostaining. Nuclei were 
counterstained with DAPI. Scale bar is 20μm. (B) The percentage of cells with more than 
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10 γH2A.X foci. Total cell extract of HCT116 p53+/+ (C) and p53-/- (D) were subjected 
to immunoblot assays using indicated antibodies 48h following KD with siRNAs targeting 
BRD8 (siBRD8-35 and siBRD8-36) or shBRD8 non-targeting siRNA/shRNA (Ctrl). 
 
 
We then asked whether BRD8 is recruited to DNA damage sites on chromatin. To examine 
this possibility, HCT116 cells were treated with 1 μM camptothecin (CPT), an inhibitor of 
topoisomerase I which induces DNA replication-associated DSBs. Despite the strong 
induction of γ-H2A.X foci, no BRD8 foci formation at DNA damage sites marked with γ-
H2A.X were detected (Fig. 3.8A enlarged insets). To further validate these results, we used 
UV laser microirradiation (laser striping) to create localized tracks of DNA damage in 
HCT116 and U2OS cells to better study BRD8 localization in response to DNA damage 
(Suzuki et al., 2011). BRD8 was not recruited to DNA damage sites and no change in the 
pattern of BRD8 localization was detected at the indicated time points (Fig. 3.8B). This is 
in agreement with previously published data that categorized BRD8 among the BRD 
proteins that are not recruited to DNA damage (Gong et al., 2015). 
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Figure 3.8 Co-staining of BRD8 with DNA damage foci (A) HCT116 p53+/+ cells were 
treated with camptothecin (1μM) for 1 hour, pre-extracted, fixed and γH2A.X (red) and 
BRD8 (green) detected by immunofluorescent staining. Enlarged insets are in the right 
column. Scale bar is 20μm. (B) Laser striping was used to create DNA damage in HCT116 
and U2OS cells. Cells were pre-extracted at indicated time. γH2A.X (red) and BRD8 
(green) detected by immunofluorescent staining. Nuclei were counterstained with DAPI. 
Scale bar is 5μm. 
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3.3.4 BRD8 knockdown causes a severe decrease in CHK1 protein levels 
 
 
In response to DNA damage, ATM and ATR (ATM and Rad3-related), which belong to 
the PI3K family of proximal transducer kinases, activate checkpoints to arrest cell cycle 
progression until DNA integrity is restored (Ahn et al., 2004; Dai and Grant, 2010; 
Marechal and Zou, 2013; Matsuoka et al., 1998). Since both ATM and p53 were activated 
through phosphorylation following the knockdown of BRD8, we sought to investigate the 
status of CHK1 and CHK2 in BRD8-depleted cells. Cells were transfected with siBRD8 
and Western blots for CHK1/2 proteins were performed. Unexpectedly, the levels of CHK1 
protein drastically decreased in BRD8-depleted cells (Fig. 3.9A). We then examined the 
levels of phosphorylated CHK1 at Ser317 in BRD8 depleted cells and found that the 
phosphorylated CHK1 follows the same pattern as CHK1 protein (Fig. 3.9). Unlike CHK1, 
the total protein levels of CHK2 remained unchanged upon the knockdown of BRD8 
whereas CHK2 was activated through phosphorylation of Thr68 in BRD8 depleted cells 
(Fig. 3.9A) suggesting that DNA damage repair pathway is activated in these cells. We also 
examined the levels of CHK1 protein in HCT116 p53-/- cells and found CHK1 levels 
decreased in BRD8 depleted cells like p53+/+ cells (Fig. 3.9B).  
 
 
Next, we monitored cell viability at 24, 48, 72, 96 hours after the transfection. Similarly to 
what we observed in HCT116 p53+/+ cells, BRD8 knockdown significantly reduced the 
number of viable cells compared with control siRNA in HCT116 p53-/- cells (Fig.3.10A). 
Then we analyzed the effect of BRD8 knockdown on cell cycle distribution in HCT116 
p53-/- cells. The G2 population significantly increased in both siBRD8 transfected cells 
when compared with that of control cells (Fig. 3.10B) indicating G2 arrest. When we 
knocked down BRD8 in p53 null cells, p21 was not up-regulated and these cells did not 
arrest in G1/S, though cell cycle arrest occurred later in G2. Taken together our data 
suggests that in p53-/- cells like in p53 +/+ cells, BRD8 is required for proper cell cycle 
progression most probably to prevent DNA damage and/or repair the damaged DNA. 
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Figure 3.9 BRD8 knockdown activates CHK2 but abrogates CHK1 Total cell extract 
of HCT116 p53+/+ (A) and p53-/- (B) were subjected to immunoblot assays using indicated 
antibodies 48h post transfection with siRNAs targeting BRD8 (siBRD8-35 and siBRD8-
36) or non-targeting siRNA (Ctrl).  
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Figure 3.10 Effect of BRD8 knock down on cell cycle distribution and proliferation of 
HCT116 p53 null cells. (A) Crystal violet staining assay of HCT116 cells at 24, 48, 72 and 
96Ԝ h post transfection with siRNAs targeting BRD8 (siBRD8-35 and siBRD8-36) or non-
targeting siRNA (CT), the cells were fixed and stained with crystal violet. Crystal violet 
stain was dissolved and optical absorbance was measured at 590 nm (OD590). Two 
independent experiments were performed in triplicate; the mean ± standard is shown. (B) 
Cell cycle distributions of HCT116 p53-/- following BRD8 knockdown for 72h and 
analyzed using flow cytometery. * p≤0.05; ** p≤0.005 
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3.3.5 Acetylation of histone H4K16 is partially suppressed in BRD8 depleted cells 
 
 
To further explore the potential role of BRD8 in the recruitment of p400/Tip60 complex 
on chromatin, we assayed the total acetylation of H4 on the p21 promoter. Tip6o is one of 
the major histone acetyltransferases which acetylates histone H4. Knockdown of BRD8 
reduced the basal levels of the acetylated H4 but did not prevent its acetylation after 
daunorubicin treatment (data not shown). We examined the acetylation of lysine 16 at the 
N-terminal tail of histone H4 (H4K16). Tip60 is responsible for this modification at DNA 
damage sites (Kusch et al., 2004). We observed that the knockdown of BRD8 led to a 
decrease of chromatin-bound H4K16 acetylation (Fig. 3.11) whereas there was no 
difference in Tip60 transcription (Fig. 3.S1). These results suggest that BRD8 has a role in 
recruitment or stabilization of p400/Tip60 complex on the chromatin and facilitates the 
acetylation of H4K16.  
 
 
                                                                                  
 
 
Figure 3.11 BRD8 knockdown decrease H4K16 acetylation Histone extract of HCT116 
p53+/+ were subjected to immunoblot assays using indicated antibodies 48h post 
transfection with siRNAs targeting BRD8 (siBRD8-35 and siBRD8-36) or non-targeting 
siRNA (Ctrl).  
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3.4 Discussion 
 
 
In this study, we describe a mechanism that underlies a previously reported cell 
proliferation deficiency observed in BRD8-depleted cells (Yamada and Rao, 2009). 
Importantly, we have shown for the first time that cellular BRD8 depletion induces a DNA 
damage response and activates CHK2 under normal growth conditions. We demonstrate 
that p53 is activated with concomitant target gene transcription in BRD8-depleted cells and 
this accounts for upregulation of p21 as well as the proapoptotic genes Puma, p53DINP1, 
and Fas. These events lead to G1/S cell cycle arrest and apoptosis in p53-dependent 
manner. Accordingly, in the absence of either p53 or p21, cells that were depleted for BRD8 
showed G2/M-phase arrest and growth deficiency. Our results strongly suggest that loss of 
BRD8 somehow impairs the cell's ability to repair DNA, thereby activating the G1/S check 
point in p53+/+ cells, and the G2/M checkpoint in p53 and p21 null cells. 
 
 
Even though there is a clear involvement of BRD8 in the DNA damage response, we were 
not able to detect BRD8 at DNA damage foci induced by camptothecin or laser striping. 
Although this is in agreement with previously published data (Gong et al., 2015), several 
subunits of the p400/Tip60 complex - of which BRD8 is a subunit - including Trrap (Murr 
et al., 2006; Robert et al., 2006), p400 (Courilleau et al., 2012; Mattera et al., 2009; Xu et 
al., 2010), Tip60 (Jha et al., 2008; Murr et al., 2006; Sun et al., 2005; Sun et al., 2009), 
DMAP1 (Negishi et al., 2009; Penicud and Behrens, 2014), Ruvbl1/2 (Jha et al., 2013; Jha 
et al., 2008), MRG15 (Sy et al., 2009), and ANP32E (Gursoy-Yuzugullu et al., 2015a; Sy 
et al., 2009) were shown to be recruited to DSBs. These studies suggest that the intact 
p400/Tip60 is recruited to the DSB. However, different factors including the dynamic 
behavior of the p400/Tip60 complex’s subunits, the presence of some the subunits in other 
protein complexes, as well as different experimental conditions complicate the conclusion. 
The p400/Tip60 chromatin remodeler/HAT complex and histone H2A.Z have both been 
implicated in the regulation of the transcription of p53 target genes and in DNA damage-
induced apoptosis (Gevry et al., 2007; Lee et al., 2012; Tang et al., 2006; Tyteca et al., 
2006). It is important to note that our data eliminate the possibility that BRD8 negatively 
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controls p53-target genes’ expression via the expression of H2A.Z or p400, Tip60 and 
MRG15 subunits of the Tip60/p400 complex. 
 
 
Repair of damaged DNA requires remodeling of the local chromatin structure to facilitate 
the access of repair machinery to the sites of DNA damage. p400/Tip60 complex decreases 
nucleosome stability and provides more open and flexible chromatin at DNA damage sites 
by the exchange of H2A.Z which then promotes rapid acetylation of histones H2A/H2AX 
and H4 by Tip60 acetyltransferase (Gursoy-Yuzugullu et al., 2015b; Ikura et al., 2007; 
Murr et al., 2006; Tang et al., 2013; Xu et al., 2012; Xu et al., 2010). Interestingly, we 
observed a significant reduction of H4K16 acetylation in BRD8 depleted cells. Our results 
suggest that BRD8 modulates chromatin structures through recruitment of Tip60 to 
efficiently acetylate H4 for proper DNA damage repair. 
 
 
It is also important to note that H2A.Z plays an important role in DSB repair  (Alatwi and 
Downs, 2015; Gursoy-Yuzugullu et al., 2015a; Keogh et al., 2006; Kobor et al., 2004; 
Mizuguchi et al., 2004; Taty-Taty et al., 2014). Therefore it is possible that BRD8 depleted 
cells may have defects in H2A.Z deposition, leading to defects in DNA repair and hence 
accumulation of DNA damage. Although previous studies have reported the role of BRD8 
in H2A.Z deposition to chromatin (Couture et al., 2012), the effect of the absence of BRD8 
on the recruitment and/or stabilization of the complex and also on the deposition of H2A.Z 
to chromatin at DNA damage sites remain to be determined. 
 
 
Notably, in BRD8 depleted cells, CHK1 protein level is severely decreased. CHK1 
functions as a major effector in the G2/M-phase DNA damage checkpoint and S-phase 
replication checkpoint (Petermann and Caldecott, 2006; Syljuasen et al., 2005). One of the 
CHK1 regulatory mechanisms in response to genotoxic and replicative stress is 
proteosomal degradation (Zhang et al., 2005b). Moreover, CHK1 protein decrease or 
deactivation could lead to replicative stress which would then cause DSBs and activate 
DNA damage response (Forment et al., 2011). Whether BRD8 regulates CHK1 
 113 
 
transcription or whether CHK1 is degraded in response to genotoxic and replication stress 
in BRD8 depleted cells, both scenarios could result in DNA damage and explain the 
activated DNA damage response in absence of BRD8. 
 
 
Finally, consistent with our observations in human cells, it has been reported that yeast cells 
mutated for the BRD8 homologous genes, bdf1and bdf2, display DNA damage 
accumulation, significant reduction of H4 acetylation, and deficiency in recovery of 
replication fork breakage during S-phase (Garabedian et al., 2012). These results suggest 
that the Bdf1/2 proteins modulate chromatin structure to coordinate DNA replication and 
S-phase stress response through proper acetylation of H4 and deposition of H2A.Z. It is 
possible that BRD8 has the same role in human cells to prevent replicative stress-induced 
DNA damage.  
 
 
Taken together our observations indicate that BRD8 may be required for DNA repair and/or 
for preventing DNA damage. This most probably occurs through the recruitment and the 
stabilization of the p400/Tip60 complex within chromatin. The complex would then 
facilitate the acetylation of H4 in order to maintain the acetylation state of chromatin, which 
is required for proper DNA damage repair. However, the cause of the DNA damage, the 
mechanism(s) by which BRD8 prevents the activation of the DNA damage response, and 
whether BRD8 is involved in preventing DNA replication stress responses remain to be 
elucidated.  
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3.6 Materials and Methods 
 
 
3.6.1 Cell Culture 
 
 
HCT116 40.16 (p53+/+), HCT116 397.2 (p53-/-) and HCT116 (p21-/-) cell lines were 
generously gifted by Dr. Bert Vogelstein (Howard Hughes Medical Institute at the 
Hopkins-Kimmel Comprehensive Cancer Center, Baltimore 21287, USA). U2OS were 
obtained from the American Type Culture Collection (ATCC). All the cell lines were 
maintained in Dulbecco’s modified Eagle’s medium (Wisent) supplemented with 10% fetal 
bovine serum (Sigma), 0.2 u/ml penicillin G and 100 mg/ml streptomycin (Invitrogen). All 
cell cultures were incubated at 37Ԝ °C in a humidified incubator containing 5% CO2. 
 
 
3.6.2 BRD8 knockdown  
 
 
siRNA: siRNA for BRD8 was purchased from Sigma (SASI_Hs01_00131635 and 
SASI_Hs01_00131636; target sequences start 2223 and 1473, respectively). Non targeting 
control siRNA (Qiagen) was kindly gifted form Dr. Alexandre Maréchal. Transfection was 
performed with lipofectamine RNAiMAX transfection reagent (Life Technologies) 
following manufacturer's instructions. Briefly, for transfection of one well in a 6-well plate, 
1.25 μl of 20 μM siRNA and 5 μl of lipofectamine RNAiMAX were mixed in 500 μl Opti-
MEM reduced serum medium (Gibco by Life Technologies ) and added to the wells. Then 
200,000 cells in 2 ml antibiotic-free DMEM medium were added to siRNA and transfection 
reagent. 
 
 
shRNA: To knockdown BRD8, a mix of two shRNAs directed against BRD8 
(TRCN0000229929 + TRCN0000229926, Sigma) and a control shRNA in Plko.1-based 
lentiviral vector were used. Cells were infected immediately following cell passage with 
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either the mix of two lentiviruses containing BRD8 shRNAs or control shRNA in the 
presence of polybrene (8 μg/ml) for 24 h. After 48 hours, cells were treated or not with 250 
μM daunorubicin (Sigma). 56 hours following infections, the cells were collected for 
subsequent experiments. 
 
 
3.6.3 Immunoblotting 
 
 
Briefly, cells were washed once with PBS, harvested and re-suspended in lysis buffer 
containing 50 mM Tris-HCl pH 7.5, 150 mM NaCl, 1% triton X-100, 0.5% Na-
deoxycholate, 0.2% SDS, supplemented with 1 mM PMSF, 1X Roche Complete protease 
inhibitor cocktail, and phosphatase inhibitor cocktail (ThermoFisher Scientific) and passed 
5 times through a 23G1 needle. Then lysis was performed by incubation at 4°C for 1 hour 
on rotator. Then cell lysates were centrifuged at 14,000 rpm for 10 minutes at 4°C and the 
supernatants were dosed using the Bradford method and then boiled at 95°C with SDS 
loading buffer for 10 minutes.  
 
 
Western blots of H2A.Z and H3 were performed on histone extracts. Cells were washed 
with PBS, collected, resuspended in Triton extraction buffer (0.5% Triton X-100, 2.5 mM 
PMSF, 0.02% NaN3, 1X Roche Complete protease inhibitor cocktail), incubated on ice for 
10 min, and centrifuged at 7,500 rpm for 8 min at 4°C. The pellet was washed with 500 μl 
of Triton extraction buffer and then centrifuged at 7,500 rpm for 8 min at 4°C. The pellet 
was resuspended in 0.2 N HCl (50 μl for 4 million cells) and incubated over-night at 4°C. 
The next day, histone extracts were cleared by centrifugation at 7,500 rpm for 8 min at 4°C. 
The supernatant was collected and dosed. 
All the antibodies used are listed in Table 3.S1. 
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3.6.4 Isolation of RNA and quantitative PCR  
 
 
Total RNA was extracted using Quick-RNA™ MicroPrep (Zymo Research) according to 
the manufacturer’s protocols. One microgram of RNA was reverse transcribed using M-
MuLV reverse transcriptase (Enzymatics) and random hexamers (Sigma) according to the 
manufacturers’ protocols. Samples were then subjected to quantitative PCR (qPCR) using 
CFX Connect Real Time System (Bio-Rad Laboratories). The relative abundance of target 
mRNA was calculated according to the ∆∆ cycle threshold method. Housekeeping gene 
36B4 was used as an internal control to normalize each reaction. The relative expression 
levels were calculated as fold enrichment of treated cells over the control cells. Experiments 
were performed as independent biological triplicates and data are presented as mean ± SD. 
The complete list of primers used in RT-qPCR experiments is provided in Table 3S2.  
 
 
3.6.5 Cell viability assay 
 
 
Crystal violet staining was performed to assess cell viability. Cells were incubated in 48-
well plates at 2.0×104 cells per well and cell viability was measured at the indicated time 
points. For crystal violet staining, the culture medium was removed; the cells were washed 
with PBS and fixed with 4% formaldehyde in PBS at room temperature for 10 min, washed 
with PBS and stained with 0.1% crystal violet for 30 min at room temperature. The cells 
were then washed with water, after which the water was removed and the cells were dried 
out. Crystal violet dye was dissolved in 200 μl of 10% acid acetic and transferred to 96-
well plate. Optical densities were measured at a wavelength of 590 nm using a Bio-tek 
μQuant Monochromatic Microplate Spectrophotometer. Experiments were performed as 
independent biological triplicates and data are presented as mean ± SD. 
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3.6.6 Cell cycle analysis 
 
 
Fluorescence-activated cell sorting (FACS) analysis was used for cell cycle profiling. 
FACS samples were harvested with trypsinization, washed twice with PBS, fixed with -
20˚C 70% ethanol and stored at 4°C until use. The cells were rehydrated with PBS, treated 
with ribonuclease A (10 μg/ml) and propidium iodide (50 μg/ml) in PBS and subjected to 
FACS analysis. FACS analysis was performed using FACS-calibur flowcytometer (BD 
Biosciences, Mississauga, Ontario, Canada). Analysis of data was performed with FCS 
Express 5 software.  
 
 
3.6.7 Apoptosis detection 
 
 
Apoptosis analyses were performed using the Annexin V-FITC Apoptosis Detection Kit 
(Sigma) according to manufacturer’s instructions. Briefly, cells were harvested by 
trypsinization, washed twice with PBS, re-suspended at a concentration of 1X106 per 
milliliter in 1 ml 1X binding buffer, then 10 μl propidium iodide and 5 μl FITC conjugated 
AnnexinV were added, incubated for 10 minutes at room temperature in the dark and 
subjected to FACS analysis. FACS analysis was performed using FACS-calibur 
flowcytometer (BD Biosciences, Mississauga, Ontario, Canada). Analysis of data was 
performed with BD CellQuest software.  
 
 
3.6.8 Laser microirradiation  
 
 
For laser microirradiation, cells were grown directly on culture slides (Millipore). Cells 
were pre-sensitized with 10 μM BrdU for 24 hours at 37°C. Before microirradiation, media 
was replaced with DMEM without phenol red. Laser microirradiation was performed using 
MMI Cellcut Plus 335 nm Laser Capture microscope (Molecular Machines & Industries). 
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Laser power was 50-55% of maximum to generate DNA damage restricted to the laser 
paths. Following damage, cells were incubated for indicated time for recovery and 
processed for immunofluorescence staining and analysis. 
 
 
3.6.9 Immunofluorescence 
 
 
For immunostaining, cells were grown on coverslips or directly on culture slides (for Laser 
microirradiation). Cells were pre-extracted with 0.25%-0.125% Triton X-100 in PBS on 
ice, and then fixed with 3% paraformaldehyde in 2% sucrose solution for 15 minutes at 
room temperature. Then cells were permeabilized with ice cold 0.5% Triton X-100 in PBS 
on ice for 5 minutes, blocked in 3% BSA and 0.05% Tween-20 in PBS prior to incubation 
with primary antibodies. After 3 washes with 0.05% Tween-20 in PBS, cells were 
incubated with secondary antibodies. For nuclei staining, 1 μg/mL DAPI solution was used. 
Coverslips were mounted onto microscope slides using ProLong® Diamond Antifade 
Mountant (Life Technologies). All the antibodies used are listed in Table 3S1. 
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3.7 Supplementary Tables 
 
 
Table 3.S1 Antibodies 
 Company Reference  
Actin Sigma A2066 WB 
ATM Bethyl-rabbit A300-299A WB 
ATM-Ser 1981 Epitomic 2052-1 WB 
BRD8  Abcam ab17969 WB/IF 
Chk1 Cell Signaling 2345 WB 
Chk1-Ser317 Cell Signaling 2344 WB 
Chk2 Millipore 05-649 WB 
Chk2-Thr68 Cell Signaling 2661 WB 
GAPDH Ambion AM4300 WB 
H2A.X-Ser139 Santa Cruz sc-9718 WB 
H2A.X-Ser139 Millipore 05-636 IF 
H2A.Z Abcam ab4174 WB 
H3 Abcam ab1791 WB/ChIP 
H4 Abcam ab177840 WB 
H4ac (pan acetyl) Active motif 39243 ChIP 
H4 acetyl K16 Abcam ab109463 WB 
p400 Abcam ab5201 WB 
p53 Santa Cruz sc-6243 WB 
P53-ser15 Cell Signaling 9284S WB 
PARP Santa Cruz sc-74470 WB 
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Table 3.S2 RT-qPCR Primers 
 Forward Reverse 
36B4 CGACCTGGAAGTCCAACTAC ATCTGCTGCATCTGCTTG 
BAX GTTGTCGCCCTTTTCTACTTT GGAGGAAGTCCAATGTCCAG 
BRD8 ATGGTGGGGAGATACAGCAA AGTATGTGGATCCCCCACAG 
CDKN1A (p21) GGAGACTCTCAGGGTCGAAA GGATTAGGGCTTCCTCTTGG 
CDKN1B (p27) ACCAGAGGCAGTAACCATGC CCTGTAGGACCTTCGGTGAC 
Fas GGTTGGTGGACCCGCTCAGTACGGAG CTGGTTCATCCCCATTGACTGTGCAGTCC 
H2A.Z TGGGAAGAAAGGACAACAGAA TGGAATCACCAACACTGGAC 
GAPDH GGCCTCCAAGGAGTAAGACC AGGGGAGATTCAGTGTGGTG 
MDM2 CAAGTTACTGTGTATCAGGCAGGG TCTGTTGCAATGTGATGGAAGG 
MRG15 CACCCATGTCCCAGGTGTAT GCAAGGCTCTTCTCATCCAG 
MRGBP GGAGGAGACAGTGGTGTGGA GAGGTGGAGGTGTGCCTCT 
p400 AACTTTTGCCAAACCCACAG GTGAGGTTCAAAGGCAGCTC 
p53 TCATTCAGCTCTCGGAACATC CTCACCATCATCACACTGGAA 
p53DINP1 TTCCTGTTTACCGGCATCTC AGCTCTTGGGTTGTTCCAGA 
PUMA GACCTCAACGCACAGTACGAG AGGAGTCCCATGATGAGATTG 
TIGAR CAAAGCGCTAAGTGAGCTGAG AAAAAGTCTATTCCACGCATTTTC 
Tip60 CATCCTCCAGGCAATGAGAT ACTTGGCCAAAAGACACAGG 
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3.9 Supplementary Figures 
             
            
 
 
 
Figure 3.S1 The protein levels of H2A.Z and transcription levels of p400, Tip60 and 
MRG15 is not significantly affected in BRD8 depleted cells.  HCT116 cells were 
transfected with two siRNAs targeting BRD8 (siBRD8-35 and siBRD8-36) or non-
targeting siRNA (CT) for 48h. mRNA expression levels of p400 (A), H2A.Z (B), Tip60 
(C) and MRG15(D) measured by RT-qPCR . The mean ± SD from three independent 
experiments are shown. (E) Histone extract of HCT116 p53+/+ were subjected to 
immunoblot assays using indicated antibodies. * P≤ 0.05; ** P≤ 0.005; ns = non significant  
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Figure 3.S2 Effect of BRD8 knock down on cell cycle distribution and proliferation of 
HCT116 p21 null cells. (A-B) Cell cycle distributions of HCT116 p21-/- following BRD8 
knockdown for 72h and analyzed using flow cytometry.   
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Figure 3.S3 BRD8 depletion using shRNA. BRD8 depleted in HCT116 cells with 
shRNAs targeting BRD8 or non-targeting shRNA (Ctrl) for 48h. (A) mRNA expression 
levels of BRD8 in HCT116 p53+/+ cells before and after knockdown (B) Immunoblot 
showing BRD8 protein in BRD8 knockdown HCT116 p53+/+ cells. 
 
  
0
0.2
0.4
0.6
0.8
1
1.2
shCT shBRD8R
el
at
iv
e 
fo
ld
 c
ha
ng
e
Brd8
A B 
BRD8 
actin 
  shRNA: 
 136 
 
CHAPTER 4 
 
 
 
Investigating the mechanisms by which the p400 complex is targeted to 
chromatin 
 
 
4.1 Introduction 
 
 
It has been shown in our laboratory and others that incorporation of H2A.Z into promoters 
is required to prepare genes for proper expression in response to physiological signals 
(Gevry et al., 2007; Gevry et al., 2009; Guillemette et al., 2005; Raisner et al., 2005). 
Genome-wide studies showed that H2A.Z preferentially localizes within promoter regions 
of both yeast and human cells (Barski et al., 2007; Guillemette et al., 2005; Li et al., 2005; 
Li and Reinberg, 2011; Raisner et al., 2005). In yeast Saccharomyces cerevisiae, Swr1 
deposits H2A.Z into chromatin (Kobor et al., 2004; Krogan et al., 2003; Mizuguchi et al., 
2004). In mammals, two orthologs of Swr1, the SRCAP and p400 complexes, deposit 
H2A.Z within chromatin (Gevry et al., 2007; Ruhl et al., 2006), while the histone chaperone 
ANP32E (a newly recognized subunit of the p400/Tip60 complex) facilitates H2A.Z 
removal (Obri et al., 2014). 
 
 
In chapter 2, when we investigated the role of transcription in the positioning of histone 
H2A.Z, we demonstrated that the accumulation of H2A.Z within gene bodies is a 
consequence of the absence of gene transcription rather than an active mechanism required 
to establish a repressive chromatin state. We further showed that in the absence of 
transcription p400 incorporates H2A.Z at TSS’s and also to some extent within gene bodies. 
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However, it remains to be determined what triggers p400 to associate to those gene regions. 
The question that we would like to address here is how the p400/Tip60 remodeling complex 
is targeted to chromatin.  
 
 
We considered different possible mechanisms that might be responsible for targeting 
p400/Tip60 complex to chromatin: i. interaction with DNA-binding regulatory elements 
such as transcription factors, activators or co-activators; ii. post-translational modifications 
by p300/CBP, and iii. bromodomain containing subunit of p400/Tip60 BRD8. 
  
 
It is known that the histone content of the nucleosome can affect transcription factor-DNA 
interaction. Despite the general assumption that transcription factor-DNA binding occurs 
at low nucleosome occupancy or naked DNA, there are factors that preferentially bind 
within a chromatin context of high nucleosome occupancy or nucleosomal DNA (Espinosa 
and Emerson, 2001; Lidor Nili et al., 2010; Tillo et al., 2010). Our laboratory has previously 
demonstrated that the localization and positioning of H2A.Z within promoter regions can 
be dictated by the presence of sequence specific transcription factors such as Myc, p53 and 
ERα (Gevry et al., 2007; Gevry et al., 2009). Moreover, the carboxyl-terminal region of 
p400 directly interacts with AF-1 and the DNA binding domain region of ERα, and ChIP 
results demonstrate that ERα recruits the p400/Tip60 complex to deposit H2A.Z at the 
TFF1 promoter (Gevry et al., 2009). These studies suggest that DNA binding regulatory 
factors may have a role in targeting p400/Tip60 to chromatin to deposit H2A.Z within 
specific loci. 
 
 
In addition, in an effort to identify an epigenetic pattern possibly facilitating the deposition 
of the H2A.Z in chromatin using the available genome-wide histone modification data, it 
was shown in our laboratory that H3K18ac, H4K5ac and H4K8ac are positively and 
uniquely associated with H2A.Z-containing nucleosomes as opposed to H2A-containing 
nucleosomes (Gervais and Gaudreau, 2009). H4K5ac histone mark is catalyzed by several 
acetyltransferases, including Tip60 and CBP/p300 proteins in mammals (Kimura and 
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Horikoshi, 1998; Schiltz et al., 1999). Similarly, H4K8ac is also catalyzed by several 
acetyltransferases including GCN5 and Tip60 (Farria et al., 2015; Kuo et al., 1996). Finally, 
H3 acetylation at lysine 18 (H3K18ac) is specifically and redundantly catalyzed by CBP 
and p300 acetyltransferases (Jin et al., 2011). 
 
 
p300 (Ep300) and CBP (Crebbp) are important transcriptional coactivators, which can also 
acetylate histones and form a complex with the basal transcriptional machinery. They have 
roles in many transcriptional programs and biological processes. They possess intrinsic 
histone/protein lysine acetyltransferase activity (Dekker and Haisma, 2009; Kalkhoven, 
2004; Vo and Goodman, 2001). p300 was first reported to be a binding partner of the 
adenovirus early region 1A (E1A) protein (Bannister and Kouzarides, 1996; Eckner et al., 
1994; Yee and Branton, 1985). In addition, the E1A oncoprotein infection model showed 
a threefold reduction in total cellular H3K18ac in infected cells (Horwitz et al., 2008). 
Depletion of H3K18Ac has been associated with aggressive cancer phenotypes and poor 
patient prognostic outcome (Manuyakorn et al., 2010; Seligson et al., 2009). Because 
aberrant expression of H2A.Z has been also detected in different cancers with poor 
prognostic outcomes (Hua et al., 2008; Kim et al., 2013b), the acetylation of H3K18 by 
p300/CBP appears as a very interesting candidate histone mark for the targeting of p400 to 
chromatin. 
 
 
In addition, the p400/Tip60 complex also contains a bromodomain factor BRD8 (Doyon et 
al., 2004). Bromodomains are the only known domains to bind acetylated protein. In yeast, 
the Swr1 complex (p400 ortholog) is responsible for the deposition of H2A.Z in vivo 
(Kobor et al., 2004; Krogan et al., 2004; Mizuguchi et al., 2004) and has two bromodomain 
protein subunits, Bdf1 and Bdf2, which both bind to acetylated histone tails. Bdf1 was 
shown to be required for efficient deposition of H2A.Z (Raisner et al., 2005). It is plausible 
that BRD8 has the same role and binds directly to acetylated histones to target p400 to 
acetylated chromatin in vivo. Finally, we investigated the role of BRD8 in the targeting of 
p400 to chromatin. 
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4.2 Materials and Methods 
 
 
4.2.1 Cell culture and lentiviral infections 
 
 
HCT116 p53+/+ were generously gifted by Dr. Bert Vogelstein (Howard Hughes Medical 
Institute at the Hopkins-Kimmel Comprehensive Cancer Center, Baltimore 21287, USA). 
U2OS and BJ cells were obtained from the American Type Culture Collection (ATCC). 
All the cell lines were maintained in Dulbecco’s modified Eagle’s medium (Wisent) 
supplemented with 10% fetal bovine serum (Sigma), 0.2 u/ml penicillin G and 100 mg/ml 
streptomycin (Invitrogen). All cell cultures were incubated at 37Ԝ °C in a humidified 
incubator containing 5% CO2. 
 
 
For the knockdown experiment, shRNAs directed against H2A.Z 
(ATACTCTAACAGCTGTCCA) and control shRNA were cloned in pLVTHM-based 
lentiviral vector (Trono’s laboratory). Cells were infected immediately following cell 
passage with either lentiviruses containing H2A.Z shRNAs or control shRNA in the 
presence of polybrene (8 μg/ml) for 24 h. On day 4 following infections, the cells were 
harvested for subsequent experiments. 
 
 
Immortalized CBP flox/flox p300 flox/flox MEFs were generously gifted by Dr. Kai Ge 
(National Institutes of Health, Bethesda, MD 20814, USA). MEFs were maintained in 
Dulbecco’s modified Eagle’s medium (Wisent) supplemented with 10% fetal bovine serum 
(Sigma), 0.2 u/ml penicillin G and 100 mg/ml streptomycin (Invitrogen). All cell cultures 
were incubated at 37Ԝ °C in a humidified incubator containing 5% CO2. To generate 
CBP/p300 DKO cells, MEFs were infected immediately following cell passage with Cre 
expression lentivirus in the presence of polybrene (4 μg/ml) for 4 h followed by re-infection 
overnight and selection with puromycin (3 μg/ml) for 3 days. Cells were then collected for 
subsequent experiments. 
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Lentiviruses expressing Cre were produced in HEK293T cells by co-transfection of 
Puro.Cre expression lentiviral vector and lentiviral envelope and packaging vectors 
pMD2G and psPAX2 (Trono’s laboratory) for 4 days. Culture media were filtered using 
0.45 μm filters and used for infection. 
 
 
4.2.2 Immunoblot assay 
 
 
Briefly, cells were washed once with PBS, harvested and re-suspended in lysis buffer 
containing 50 mM Tris-HCl pH 7.5, 150 mM NaCl, 1% triton X-100, 0.5% Na-
deoxycholate, 0.2% SDS, supplemented with 1 mM PMSF, 1X Roche Complete protease 
inhibitor cocktail, and phosphatase inhibitor cocktail (ThermoFisher Scientific) and passed 
5 times through a 23 G1 needle. Then lysis was performed by incubating the samples on a 
rotator at 4°C for 1 hour. Cell lysates were then centrifuged at 14,000 rpm for 10 minutes 
at 4°C and the supernatants were dosed using the Bradford method and then boiled at 95°C 
with SDS loading buffer for 10 minutes. Immunoblotting was performed using the 
antibodies listed in Table 4.1. 
 
 
Western blots of histones were performed on histone extracts. Cells were washed with PBS, 
collected, resuspended in Triton extraction buffer (0.5% Triton X-100, 2.5 mM PMSF, 
0.02% NaN3, 1X Roche Complete protease inhibitor cocktail), incubated on ice for 10 min, 
and centrifuged at 7,500 rpm for 8 min at 4°C. The pellet was washed with 500 μl of Triton 
extraction buffer, then centrifuged at 7,500 rpm for 8 min at 4°C. The pellet was 
resuspended in 0.2 N HCl (50 μl for 4 million cells) and incubated over-night at 4°C. The 
next day, histone extracts were cleared by centrifugation at 7,500 rpm for 8 min at 4°C. 
The supernatant was collected and dosed. All the antibodies used are listed in Table 4.1. 
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Table 4.1 Antibodies used for Western blot experiments 
 Company Reference 
Actin Sigma A2066 
CBP Santa Cruz sc-369 
H2A.Z Abcam ab4174 
H3 Abcam ab1791 
H3K18ac Santa Cruz sc-6243 
p300 Santa Cruz sc-585 
p53 Abcam sc-6243 
 
 
4.2.3 RT-qPCR 
 
 
Total RNA was extracted using Quick-RNA™ MiniPrep kit (Zymo Research) according 
to the manufacturer’s protocols. One microgram of RNA was reverse transcribed using M-
MuLV reverse transcriptase (Enzymatics) and random hexamers (Sigma) according to the 
manufacturers’ protocols. Samples were then subjected to quantitative PCR (qPCR) using 
CFX Connect Real Time System (Bio-Rad Laboratories). The relative abundance of target 
mRNA was calculated according to the ∆∆ cycle threshold method. The housekeeping gene 
36B4 (Rplp0) was used as an internal control to normalize each reaction. The relative 
expression levels were calculated as fold enrichment of treated cells over the control cells. 
Experiments were performed as independent biological triplicates and data are presented 
as mean ± SD. The complete list of primers used in RT-qPCR experiments is provided in 
Table 4.2.  
 
 
Table 4.2 Primers used for RT-qPCR analysis 
 Species Forward Reverse 
36B4 (Rplp0) human CGACCTGGAAGTCCAACTAC ATCTGCTGCATCTGCTTG 
CBP mouse GGGGAAATTTTGGCTGGCAAG CTGCTCTACCTAAATTCCCAG 
CDKN1A (p21) human GGAGACTCTCAGGGTCGAAA GGATTAGGGCTTCCTCTTGG 
Pgk1 mouse GGTGGACTTCAACGTTCCTA TTCAGCAGCAACTGGCTCTA 
H2A.Z human TGGGAAGAAAGGACAACAGAA TGGAATCACCAACACTGGAC 
P300 mouse GGCAATGCTGGCAGTTTATT ACTGCCTTTTTGTCCATTGC 
p400 human AACTTTTGCCAAACCCACAG GTGAGGTTCAAAGGCAGCTC 
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4.2.4 Chromatin Immunoprecipitation assay 
 
 
ChIP assays were performed as previously described (Gevry et al., 2007). Samples were 
sonicated to generate ~500-bp DNA fragments. Immunoprecipitation was carried out using 
the antibodies listed in Table 4.3. Pre-immune and no antibody controls were also 
performed. H2A.Z results were normalized to H3 to account for nucleosome density. The 
recovered DNA was analyzed by qPCR using primers relevant to the promoter regions of 
the p21 gene. All the primers used are listed in Table 4.4. Results are shown as percent of 
input. ChIP experiments were performed as independent biological triplicates and data are 
presented as mean ± SD.  
 
 
Table 4.3 Antibodies used for ChIP experiments 
 Company Reference 
p400 Abcam ab5201 
H2A.Z − Raised against CSLIGKKGQQKT 
p53 Santa Cruz sc-6243X 
H3 Abcam ab1791 
 
 
 
Table 4.4 Primers used for ChIP-qPCR analysis 
 Species Forward Reverse 
CDKN1A- distal p53 
binding site Human CTGTGGCTCTGATTGGCTTT CTCCTACCATCCCCTTCCTC 
CDKN1A- distal p53 
binding site Mouse CTCGGAGACCAGCAGCAAA CACCTCTTCAATTCCAGGGCT 
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4.3 Results 
 
 
4.3.1 H2A.Z depletion decreases the recruitment of p400 at distal p53 response 
element at the p21 promoter  
 
 
Our laboratory has previously demonstrated that the localization of H2A.Z regulates the 
transcription of the p21 gene (Gevry et al., 2007). H2A.Z colocalizes with p53 and p400 at 
the p21 promoter (Gevry et al., 2007). p400-dependent deposition of H2A.Z at the distal 
p53-binding site of p21 promoter inhibits p53-dependent p21 transcription (Gevry et al., 
2007). Upon the p53-dependent induction of the p21 gene with daunorubicin, H2A.Z is 
evicted from the distal p53-binding site of the p21 promoter (Gevry et al., 2007). In another 
study, Gevry et al. demonstrate that H2A.Z is essential for efficient recruitment of RNA 
pol II, p300, TBP and Brg1 to the TFF1 promoter upon the induction of gene transcription 
(Gevry et al., 2009). These studies suggest that the presence of H2A.Z may influence the 
recruitment of p53 and p400 to p53 binding elements at the p21 promoter. In order to 
investigate this possibility, I performed ChIP experiments in a carcinoma cell line that 
contains functional p53 (HCT116 p53+/+), in which H2A.Z was knocked down using a 
lentiviral shRNA (Gevry et al., 2009). Following infection with the shH2A.Z lentivirus, we 
observed that H2A.Z mRNA was efficiently depleted by 90% compared to control cells 
(Fig. 4.1A). In parallel, I showed that protein levels of H2A.Z also decreased proportionally 
(Fig.4.1B). Our ChIP results show a significant decrease in the enrichment of H2A.Z at the 
distal p53-binding site of the p21 promoter after the knockdown (Fig. 4.1D). Figure 4.1D-
F depicts the results of ChIP assays carried out with the aforementioned antibodies. The 
p21 promoter and the position of the primer pairs used in ChIP experiments are illustrated 
in Figure 4.1C. As expected, there was an enrichment of H2A.Z at the distal p53-binding 
site, which greatly diminished upon the induction of the p21 gene following daunorubicin 
treatment (Fig. 4.1D). Daunorubicin is a DNA damaging agent known to strongly induce 
p21 via the p53 pathway (Gewirtz, 1999; Seoane et al., 2002). H3 binding was monitored 
as a nucleosome density control, and there was no significant reduction at the p53-distal 
binding site (data not shown). As previously observed (Gevry et al., 2007), p400 
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colocalized with H2A.Z at the distal p53-binding site. Upon induction of the p21 gene with 
daunorubicin, p400 binding to the p53-distal site increased markedly. Interestingly, 
knockdown of H2A.Z led to a significant reduction in the recruitment of p400 to the distal 
p53-binding site in non-stressed cells. Notably, in daunorubicin-induced conditions, p400 
recruitment did not increase and the level of p400 at the relevant p53 binding site was 
comparable to non-stressed control cells (Fig.4.1E). Of note, in H2A.Z knockdown cells 
the mRNA levels of p400 were not statistically different from controls (p-value = 0.09) 
(Fig. 4.1A). In the same set of experiments, a p53 ChIP assay was performed before and 
after daunorubicin induction, and as expected, the level of p53 binding to its distal binding 
site on the p21 promoter increased fivefold following daunorubicin induction (Fig. 4.1F). 
Knockdown of H2A.Z diminished the binding of p53 after daunorubicin induction, but not 
before, as compared to relevant controls (Fig. 4.1F). Taken together, these data show that 
histone variant H2A.Z positively influences the recruitment of p400 and p53 binding to the 
p21 promoter, at least, at the distal p53 binding element. 
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Figure 4.1 H2A.Z depletion decreases the recruitment of p400 and p53 to the distal 
p53 response element within the p21 promoter. (A) Expression levels of H2A.Z and p400 
in HCT116 p53+/+ cells before and after H2A.Z knockdown using shH2A.Z. mRNA 
expression levels of the 36B4 gene (also called ribosomal phosphoprotein P0 (RPLP0)) 
were used to normalized the qPCR. (B) Immunoblot showing the knockdown of H2A.Z 
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expression by shH2A.Z. (C) Schematic depiction of the p21 promoter illustrating p53 
binding elements and the position of qPCR amplicons (blue bar) used in ChIP experiments. 
The arrow represents the transcription start site. (D) ChIP-qPCR analysis of H2A.Z 
enrichment (percent input H2A.Z/H3), (E) recruitment of p400 and (F) binding of p53 at 
distal p53 binding element of the p21 promoter performed in HCT116 p53+/+ cells infected 
with shCtrl or shH2A.Z for 5 days and then treated or not with 250 μM daunorubicin 
(Dauno) for 8 hours. 
 
 
4.3.2 Deletion of p300/CBP abrogates the presence of p400 at the distal p53 response 
element on p21 promoter. 
 
 
In order to investigate the impact of H3K18ac on the recruitment of the p400/Tip60 
complex and subsequent deposition of H2A.Z at p21 promoter, I used immortalized mouse 
embryonic fibroblasts (MEFs) that can be made deficient for both CBP and p300 through 
the use of Cre/Loxp conditional knockout alleles (MEFs p300 flox/foxl/CBP flox/flox) (Jin et 
al., 2011). In order to knock out both p300 and CBP, a lentiviral delivery vector containing 
CRE (Puro.Cre) construct was used. Double knocked out (DKO) cells for p300/CBP were 
selected using puromycin for 4 days. Deletion of p300/CBP was confirmed at both the 
mRNA (Fig. 4.2 A and B) and protein levels (Fig. 4.2 D). As mentioned before, p300 and 
CBP are specifically and redundantly responsible for H3K18ac. The efficiency of the knock 
out was also monitored by immunobloting of H3K18ac using histone extracts. The 
knockout was efficient, because H3K18ac was markedly reduced (Fig. 4.2E). However, no 
increase in the basal level of p21 transcription was observed in DKO MEFs (Fig. 4.2C).  
 
When ChIP was carried out in MEFs p300 flox/foxl/CBP flox/flox cells before and after 
knockout, we observed a significant reduction in the recruitment of p400 at the distal p53-
binding site following the knockout of p300/CBP in non-stressed cells. Notably, in 
daunorubicin-induced conditions, p400 recruitment did not increase and the level of p400 
at the relevant p53 binding site was comparable to non-stressed p300/CBP depleted cells 
(Fig. 4.2F). Despite the marked reduction in H3K18ac mark upon p300/CBP knockout in 
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our immunoblot experiment (Fig. 4.1B), we observed that the level of H3K18ac in 
p300/CBP depleted cells was comparable to the one in non-treated control cell when 
measured by ChIP. It is plausible that other HATs such as GCN5 and PCAF could 
compensate to maintain the basal level of H3K18 acetylated in the absence of p300/CBP 
(Kim et al., 2009). When daunorubicin was added, H3K18ac increased in control cells but 
not in p300/CBP depleted cells (Fig. 4.2H). We next monitored H2A.Z enrichment at this 
site; we expected to see a decrease in H2A.Z enrichment in p300/CBP-depleted cells 
because p400 recruitment was diminished. Indeed, depletion of p300/CBP resulted in 
increased enrichment of H2A.Z at the distal p53-binding site within the p21 promoter (Fig. 
4.2G). 
 
 
Thus far, our results suggest that p300 and/or CBP are involved in the targeting of p400 to 
the distal p53 binding site on the p21 promoter partly through H3K18ac. In addition, our 
H2A.Z ChIP analysis suggests that p300/CBP may be involved in the removal of H2A.Z 
form this site. The mechanisms underlying these phenomena remain to be investigated. 
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Figure 4.2 Deletion of p300/CBP abrogates association of p400 at the distal p53 
response element within the p21 promoter. (A and B) Expression levels of p300 and CBP 
in MEFs p300 flox/flox/CBP flox/flox cells with/without Puro-CRE expression. (C) Basal 
expression level of p21 in MEFs p300 flox/flox/CBP flox/flox cells. mRNA expression levels of 
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Pgk1 gene were used to normalize the qPCR. (D) Western blot showing the depletion of 
p300 and CBP and (E) reduction of H3K18ac in p300 flox/flox/CBP flox/flox cells with/without 
Puro-CRE expression. (F-H) ChIP- qPCR analysis of p400, H2A.Z, H3 and H3K18ac of 
p53 distal response element on p21 promoter in non-treated or p300/CBP DKO MEFs p300 
flox/flox/CBP flox/flox cells (CRE). Dauno = 250 μM daunorubicin for 8 hours. 
 
 
4.3.3 p400/Tip60 recruitment at the p21 promoter is modestly affected by BRD8 
knockdown 
 
  
In S. cerevisiae, specific acetylation patterns of histone H3 and H4 tails as well as the 
bromodomain protein Bdf1, a component of the Swr1 remodeling complex that deposits 
H2A.Z, were shown to be required for efficient deposition of H2A.Z (Raisner et al., 2005). 
This suggests that recognition of histone acetylation is a mechanism potentially involved 
in the targeting of H2A.Z deposition into chromatin. Like BRD8, Bdf1 contains two tandem 
bromodomains known to localize at acetylated chromatin and to bind to acetylated histone 
tails (Kurdistani et al., 2004; Ladurner et al., 2003; Matangkasombut et al., 2000). We asked 
whether BRD8 is important for targeting p400/tip60 to chromatin to deposit H2A.Z. Thus, 
we used the p21 promoter as a model promoter and performed ChIP assays in HCT116 
p53+/+. Figure 4.3C-E depicts the results of ChIP assays carried out with the 
aforementioned antibodies. In accordance to our immunoblot analyses shown in chapter 3 
that showed that p53 protein levels are increased in BRD8 depleted cells (Fig. 3.13A), our 
ChIP assay also showed significant increase of p53 binding at the distal p53 response within 
the p21 promoter in non-stressed BRD8-depleted cells (Fig. 4.3 C). Further treatment of 
cells with daunorubicin resulted in more binding of p53 to its response element on p21 
promoter. As previously observed (Gevry et al., 2007), p400 colocalized with H2A.Z at the 
distal p53-binding site, and knockdown of BRD8 led to a slight increase in the recruitment 
of p400 to the distal site in non-stressed cells. Upon induction of the p21 gene with 
daunorubicin, p400 binding to the distal element was markedly increased in control cells. 
Notably, in BRD8 depleted cells following daunorubicin treatment, p400 recruitment is 
increased but not at the same level as p400 at the relevant p53 binding site in daunorubicin-
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treated control cells (Fig. 4.3D). We next monitored H2A.Z enrichment at this site, and 
observed that depletion of BRD8 resulted in decreased enrichment of H2A.Z at the distal 
p53-binding site within the p21 promoter in both daunorubicin-treated- or -untreated cells 
compare to a relevant control (Fig. 4.3 E). It is difficult to conclude from these data whether 
the decreased-enrichment of H2A.Z is the direct effect of BRD8 on deposition of H2A.Z 
by targeting the p400/Tip60 complex to the p21 promoter, or more probably p53-dependent 
activation of the gene. However, slightly reduced p400 levels in daunorubicin-treated 
BRD8 depleted cells suggest that BRD8 promotes the recruitment of the remodeler at this 
site. These results suggest that BRD8 depletion does not prevent the recruitment of the 
p400/Tip60 complex to the distal p53 response element at the p21 promoter, but restricts 
its recruitment after daunorubicin induction of p21.  
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Figure 4.3 BRD8 depletion does not affect the recruitment of p400 at distal p53 RE on 
the p21 promoter. BRD8 depleted in HCT116 cells using lentivirus containing BRD8 
shRNA or non-targeting shRNA (Ctrl) for 48h. Cells treated or not with 250 nM 
daunorubicin (Dauno) for 8 hours as a positive control to induce p21 transcription in p53-
dependent manner before harvesting (A) Expression levels of BRD8 by RTqPCR. mRNA 
expression levels of the 36b4 (RPLP0) were used to normalized the qPCR (B) Immunoblot 
showing BRD8 protein expression. (C-F) ChIP-qPCR analysis of distal p53 binding 
element of p21 gene promoter. The mean ± standard deviation from three independent 
experiments is shown. 
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4.4 Discussion 
 
 
p400/Tip60-dependent incorporation of H2A.Z has been shown to regulate gene 
transcription in response to different physiological signals, but the mechanisms by which 
p400 is targeted to specific chromatin regions remain to be determined. Here, we show that 
pre-deposition of histone variant H2A.Z is required for the optimal recruitment of p53 and 
p400 to the distal p53 binding element of the p21 promoter upon p53-dependent gene 
induction. To investigate the possible role of H2A.Z in p53 binding to its response element, 
we analyzed the association of the protein to its binding site at the p21 promoter in H2A.Z 
depleted cells. Our ChIP results in H2A.Z depleted cells revealed that H2A.Z positively 
influences p53 binding to its distal site within the p21 promoter under DNA damaging 
conditions, but not in unstressed conditions. In other words, pre-deposition of H2A.Z is 
required for optimal p53 binding upon DNA damage and p53-dependent induction of the 
p21 gene. 
 
 
It has been shown in our laboratory that H2A.Z is localized at p53 response elements within 
the promoter of p53-target genes (Gevry et al., 2007). Our laboratory later showed that 
H2A.Z located at ERα target gene promoters allows nucleosomes to adopt preferential 
positions along the DNA translational axis, which either favors or inhibits the binding of 
the transcriptional machinery and regulatory factors (Gevry et al., 2009). Intriguingly, 
chromatin organization around the p53 response elements is one of the key factors 
controlling p53 binding to DNA (Cui and Zhurkin, 2014; Laptenko et al., 2011; Sahu et al., 
2010). p53 is reported to bind nucleosomal DNA (Espinosa and Emerson, 2001; Lidor Nili 
et al., 2010), and nucleosome occupancy and positioning affect the binding of p53 to its 
response elements on the p21 promoter (Laptenko et al., 2011). Taken together, these 
studies, in addition to our results, suggest an important role for H2A.Z in chromatin 
organization at p53 response elements. However, it remains to be determined whether the 
presence of H2A.Z in nucleosomes at p53 response elements can actually affect the 
nucleosome positioning and whether these observations also hold true at other p53-binding 
elements. Experiments carried out in vitro to measure the binding of p53 to its response 
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element in reconstituted mononucleosomes, as well as mononucleosomal ChIP-seq 
experiments performed in H2A.Z depleted cells, may provide insight on the role of H2A.Z 
in the positioning of nucleosomes and its effects on the binding of p53 to chromatin. 
 
 
We also showed that knockdown of H2A.Z expression led to severe reduction in p400 
binding to the distal p53-binding site. Further treatment with daunorubicin did not rescue 
the reduced recruitment of p400 in H2A.Z depleted cells. A plausible scenario is that p400 
targeting and H2A.Z positioning in chromatin are dictated by transcription factors, p53 in 
this case. Gevry et al. demonstrated that p53, c-Myc and ERα can dictate histone variant 
H2A.Z positioning at certain promoters (Gevry et al., 2007; Gevry et al., 2009). In addition, 
Gevry et al. demonstrated that p400 could physically interact with ERα in a ligand 
independent manner (Gevry et al., 2009). Together, these data raise the question as to 
whether the physical interaction of p400 with transcription factors, such as p53, plays a role 
in targeting p400 to specific chromatin regions, which in turn would direct H2A.Z to these 
regions. One can also wonder whether this is a general mechanism by which transcription 
factors regulate chromatin dynamics and gene expression. Protein-protein interaction 
experiments in combination with immunoprecipitation assays may provide some insights 
to this question.  
 
 
Of note, in our experiments, p400 binding to the p53-distal site was markedly increased 
upon induction of the p21 gene with daunorubicin. The same result was obtained in human 
osteosarcoma U2OS cells, which also express wild type p53, and in human primary 
fibroblast BJ cells (data not shown). This is in contrast to the previous results showing that 
p400 is cleared from this site when p21 is induced using daunorubicin (Gevry et al., 2007). 
This discrepancy can be explained because antibodies directed against different residues of 
the p400 protein were used in those experiments. In the present study we used an antibody 
directed against the N-terminal residue 200-300, while in the previous study, the p400 
antibody was against the C-terminal residue 3107-3124 (Chan et al., 2005). The SANT 
domain of p400 which directly interacts with Tip60 (Park et al., 2010) is close to the C-
terminal, there is thus a possibility that this interaction masks the epitope recognized by the 
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p400 antibody. Note that following daunorubicin treatment, p21 is induced and Tip60 is 
recruited to the distal p53-binding site (Gevry et al., 2007), a situation that possibly prevents 
the binding of the p400 antibody to its epitope. In addition, we tested the specificity of the 
p400 antibody using the peptide used to generate the antibody (p400 peptide cat. #ab13753) 
in a ChIP assay (Fig. 4S2). Pre-incubation of p400 antibody with its peptide results in the 
loss of p400 signal at distal p53-binding site on p21 promoter (Fig. 4S2). 
 
 
Next, we investigated a possible role for p300/CBP HAT in targeting the p400/Tip60 
complex to chromatin at the p21 promoter. Based on previous studies we found H3K18ac 
an attractive candidate for the recruitment of p400 to chromatin. Since we were still able to 
detect H3K18ac, our H3K18ac ChIP results indicate that other HATs can acetylate H3 at 
lysine 18 in the absence of p300/CBP, at least at the site investigated in this study.  
However, in DKO MEFs, the level of H3K18ac was reduced by 50% compared to what we 
observed in control cells. The level of H3K18 acetylation following daunorubicin treatment 
was no greater than what was observed in non-treated DKO MEFs. Interestingly, our ChIP 
assay in DKO MEFs revealed that the depletion of p300/CBP reduced the recruitment of 
p400 by 25% following daunorubicin treatment compared to control cells. The decrease in 
H3K18ac level was not proportional to the one of p400 (50% compared to 25%) indicating 
that other mechanisms, such as interaction with transcription factors and/or a co-activator 
or acetylating other substrates (i.e. H2A.Z and/or p53), might be involved in the optimal 
recruitment of p400 to chromatin. Unexpectedly, in the same set of ChIP assays, H2A.Z 
was enriched in p300/CBP depleted cells. Previously we showed that knockdown of p400 
in cells with intact p300/CBP results in a decrease in H2A.Z enrichment at the promoter 
regions of several genes (chapter 2 Fig. 2S3 KDp400 ChIP H2A.Z). Our data suggest that 
p300 and/or CBP are somehow involved in targeting p400 to remove H2A.Z from 
regulatory elements. It is not unlikely that p300/CBP could be involved in the p400/TIP60-
specific targeting of ANP32E to remove H2A.Z from nucleosomes. ANP32E is the histone 
chaperone that evicts the H2A.Z from nucleosomes (Obri et al., 2014). 
Another possible explanation for the observed effect of p300/CBP DKO on p400 
recruitment and H2A.Z deposition in chromatin is the involvement of p300/CBP in the 
acetylation of H2A.Z, directly and/or indirectly. A recent study by Pradhan et al. showed 
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that p400 and BRD8 are enriched on acetylated H3.3/H2A.Z double variant nucleosomes 
compared to non-acetylated double variant nucleosomes (Pradhan et al., 2016). 
In Saccharomyces cerevisiae, the histone acetyltransferases ESA1 and GCN5 mediate the 
acetylation of Htz1 (yeast ortholog of H2AZ) (Keogh et al., 2006; Mehta et al., 2010; Millar 
et al., 2006). In mammals, the ortholog of ESA1 is TIP60. It is tempting to speculate that 
recruitment and/or expression of Tip60 protein is affected by the depletion of p300/CBP. 
The reasons for this speculation are: 1. Tip60 is required for p53 to activate the endogenous 
p21 promoter and 2. Activation of p21 by HDAC inhibitors requires acetylation of H2A.Z. 
Whether knockout of p300/CBP affects H2A.Z acetylation, directly or indirectly through 
recruitment of Tip60, and whether acetylation of H2A.Z is necessary for its removal 
remains to be determined. Some direct evidence, such as in vitro HAT assays, would be 
required to establish whether p300/CBP is able to acetylate H2AZ. In addition, the p53 
protein itself is a substrate for acetyltransferases and deacetylases. Importantly acetylation 
of p53 is required for the recruitment of transcription co-activators such as TRRAP and 
GCN5 (Barlev et al., 2001). CBP/p300 acetylates p53 at several Lysine residues including 
K382, K381, K373, K372 and K370 (Gu and Roeder, 1997; Liu et al., 1999; Sakaguchi et 
al., 1998). Whether the lack of these p53 acetylations also affects the recruitment of the 
p400/Tip60 complex in p300/CBP DKO MEFs is a very interesting subject to investigate. 
 
 
Finally, I investigated the role of the BRD8 subunit of the p400/Tip60 complex in the 
targeting of the complex to chromatin. I found that BRD8 depletion has a minor effect on 
the recruitment of p400 to the p21 promoter as the knockdown of BRD8 led to a slight 
increase in the recruitment of p400 to the distal p53-binding site in non-stressed cells. 
Following the induction of p21 in BRD8 depleted cells, p400 recruitment is increased but 
not to the same level as p400 at the relevant p53 binding site in daunorubicin-treated control 
cells. In addition, BRD8 knockdown resulted in decreased enrichment of H2A.Z at the 
distal p53-binding site within the p21 promoter compared to the control. However, it is 
difficult to conclude from these data whether the decreased enrichment of H2A.Z is the 
direct effect of BRD8 on deposition of H2A.Z by targeting p400/Tip60 complex to the p21 
promoter or most probably through p53-dependent activation of the gene, as we have 
described earlier in chapter 3.  
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Overall, our preliminary data open the door to a series of new questions ripe for 
investigation. Our experiments suggest a possible mechanism by which p400 and p53 are 
recruited to chromatin and set the stage for more experiments to reveal the details of the 
mechanism involved in this process. 
 
 
  
 157 
 
4.5 Supplementary Figures  
 
 
 
 
Figure 4.S1 Recruitment of p300 and CBP at p53 distal element on p21 promoter is 
increased upon induction of p21. ChIP-qPCR analysis of recruitment of (A) p300 and (B) 
CBP at distal p53 binding element of the p21 promoter performed in HCT116 p53+/+ cells 
treated or not with 250 nM daunorubicin (Dauno) for 8 hours. 
 
 
 
 
 
  
A B 
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Figure 4.S2 Recruitment of p400 at p53 distal element on p21 promoter is increased 
upon induction of p21. ChIP-qPCR analysis of recruitment of p400 at distal p53 binding 
element of the p21 promoter performed in (A) BJ cells and (B) U2OS cells. (C) Specificity 
assay of p400 antibody (ab5201). ChIP-qPCR analysis of recruitment of p400 at distal p53 
binding element of the p21 promoter performed in HCT116 p53+/+ cells treated or not with 
250 nM daunorubicin (Dauno) for 8 hours. p400 antibody pre-incubated or not with the 
peptide used to generate the antibody (p400 peptide cat. #ab13753).
p400 peptide: 
A B 
C 
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CHAPTER 5 
 
 
 
5.1 GENERAL DISCUSSION 
 
 
One of the major challenges in biology is to understand how the chromatin state influences 
the pattern of gene expression. In eukaryotic cells, DNA is packaged through its association 
with histones in the nucleus, forming nucleosomes (Kornberg, 1974; Luger et al., 1997). 
For the proper execution of gene transcription, DNA replication, and DNA damage repair, 
three major mechanisms are involved: histone post-translational modification, exchange of 
canonical histones with histone variants, and ATP-dependent chromatin-remodeling 
activities (Kouzarides, 2007; Narlikar et al., 2013).  
 
 
One of the most intriguing mechanisms to modulate chromatin structure is exchanging 
canonical histones with histone variants (Clapier and Cairns, 2009; Kouzarides, 2007). 
Histone H2A.Z is one of these variants and has received much attention from many 
laboratories over the last decade. Due to the efforts of several laboratories, we have learned 
a great deal on H2A.Z biology, but the role of H2A.Z in transcription has remained elusive. 
The variant has been linked to both gene activation and repression (Barski et al., 2007; 
Gevry et al., 2007; Gevry et al., 2009; Guillemette et al., 2005; Li et al., 2005; Marques et 
al., 2010; Raisner et al., 2005). Although genome-wide localization of H2A.Z shows strong 
enrichment within gene regulatory regions such as TSSs and enhancers, highlighting an 
important feature of H2A.Z as an essential regulator of gene transcription, significant levels 
of the histone variant can also be found within gene bodies (Coleman-Derr and Zilberman, 
2012; Hardy et al., 2009; Latorre et al., 2015; Zilberman et al., 2008). However, the role of 
H2A.Z within gene bodies is still not well understood.  
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During my Ph.D., I focused my interest on histone variant H2A.Z and the chromatin 
remodeler complex that deposits the variant into chromatin, p400/Tip60. I was interested 
in clarifying the role of H2A.Z localization within gene bodies in transcriptional gene 
regulation. There are controversial reports from two different laboratories. A recent study 
from Dr. Ahringer’s laboratory suggests that the recruitment of H2A.Z within gene bodies 
is an active mechanism responsible for transcriptional repression of DREAM repressor 
complex target genes (Latorre et al., 2015). In stark contrast, Dr. Robert’s laboratory 
showed that active transcription prevents H2A.Z from incorporating within gene bodies 
suggesting that H2A.Z accumulation within gene bodies is a consequence of gene 
repression (Hardy et al., 2009; Jeronimo et al., 2015). To clarify whether the recruitment 
of H2A.Z within the gene bodies of repressed genes is the cause of repression or the 
consequence of the lack of transcription, we investigated how active transcription by RNA 
polymerase II itself can affect the H2A.Z landscape within the genome. 
 
 
In chapter 2, I presented the results of our study on the localization of histone variant H2A.Z 
in the human genome in the absence of transcription. In this study, we showed, on a 
genome-wide scale, that the presence of H2A.Z at the +1 nucleosome decreases as gene 
transcription increases (Fig. 1A from FPKM 0.5-250 to >1000), suggesting that active 
transcription counteracts H2A.Z incorporation downstream of gene TSSs. We further 
analyzed the potential effects of transcription on H2A.Z levels within gene bodies at the 
binding sites of the cohesin subunit Rad21 identified through peak calling using Rad21 
ChIP-seq data obtained in HCT116 cells. Our ChIP-seq data showed that H2A.Z levels are 
reduced at cohesin sites within the body of transcribed genes as compared to non-
transcribed genes, confirming the observations made at the genes’ TSSs. Although these 
data, together with the data from Hardy et al. (2009) and Jeronimo et al. (2015), indicate 
that active transcription results in the eviction of H2A.Z within gene bodies, it does not 
answer the question as to whether active gene transcription per se is directly responsible 
for remodelling histone H2A.Z within gene bodies. To answer this question, we used α-
amanitin to inhibit transcription. While inhibition of transcription had very little effect on 
the levels of H2A.Z at TSSs and cohesin sites within gene bodies of non-transcribed genes, 
it caused a strong accumulation of the histone variant at TSSs and cohesin sites located 
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within gene bodies of transcribed genes. This effect is specific to genes bodies and it does 
not occur globally across the entire genome since no increase in H2A.Z incorporation was 
detected outside of genes in the absence of transcription. We further showed that when 
transcription is inhibited, p400 incorporates H2A.Z at TSSs and to some extent within gene 
bodies. 
 
 
We thus confirmed at a genome wide scale that the presence of H2A.Z within gene bodies 
anti-correlates with transcription and that global inhibition of transcription results in a 
strong increase of H2A.Z incorporation at TSSs as well as at gene bodies. We can speculate 
that H2A.Z replaces non-processive RNApol II in the absence of transcription. This is in 
accordance with Dr. Robert’s data which shows that the passage of elongating pol II, along 
with its chaperones Spt6 and FACT, prevents the incorporation of H2A.Z in gene bodies 
of transcribed genes (Hardy et al., 2009; Jeronimo et al., 2015). Lattore and colleagues 
(2015), on the other hand, suggest that active recruitment of H2A.Z facilitated by the 
DREAM complex causes repression of target genes. Their conclusion is based on two 
observations. First, the level of gene body H2A.Z is enriched in repressed DREAM target 
genes in which DREAM is bound to the promoter, and the mutation in Lin35 subunit of the 
DREAM complex upregulates transcription and reduces gene body H2A.Z (Latorre et al., 
2015). Second, DREAM indirect target genes, in which DREAM is not bound to the 
promoter, but are up-regulated upon mutation in Lin-35, do not exhibit H2A.Z enrichment 
on either the promoter or gene body (Latorre et al., 2015). For direct targets we know that 
these genes are repressed and their ChIP-seq profiles are in accordance with weakly 
transcribed genes. However, we do not know if the indirect target genes were repressed or 
transcribed before the knock down of DREAM; the H2A.Z profiles of these genes are 
similar to transcribing genes (Lattore et al., 2015 Fig 4.A). Our data indicate that inhibition 
of transcription causes the accumulation of H2A.Z within genes bodies of transcribing 
genes, which theoretically includes DREAM target genes because they are not completely 
silenced but weakly transcribing. We think that the observed increased gene body H2A.Z 
in DREAM direct target genes may not be an active mechanism by which the DREAM 
complex represses the genes but the consequence of repressed transcription.  
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Taken together, our data suggest that accumulation of H2A.Z within gene bodies of 
repressed genes is the consequence of reduced transcription However, whether the 
recruitment of H2A.Z into chromatin has a role in establishing transcription repression  is 
still conceivable. Furthermore, we still have to identify the mechanisms by which H2A.Z 
and p400 are targeted to chromatin in the absence of transcription. 
 
 
In chapter 3, I presented the results of the second part of my Ph.D. research project which 
was investigating the role of the BRD8 subunit of the p400/Tip60 remodeler complex. 
Recent studies have pointed out the importance of BRD/acetyl-lysine binding in 
coordinating molecular interactions in various biological processes such as chromatin 
biology, regulating gene transcription, and their association with disease. Despite immense 
attention and progress in BRD protein biology our knowledge about BRD8 is restricted to 
very few studies (Couture et al., 2012; Jiang et al., 2016; Yamada and Rao, 2009; 
Yamaguchi et al., 2010). In chapter 3, we describe a mechanism that underlies a previously 
reported cell proliferation deficiency observed in BRD8-depleted cells (Yamada and Rao, 
2009). Importantly, we have shown for the first time that cellular BRD8 depletion induces 
a DNA damage response and activates CHK2 under normal growth conditions. We detect 
an increase in DNA damage foci as indicated by immunofluorescence assay for formation 
of γ-H2A.X foci upon the knock down of BRD8. We demonstrate that p53 is activated with 
concomitant target gene transcription in BRD8-depleted cells, and this accounts for the 
upregulation of p21 as well as the proapoptotic genes Puma, p53DINP1, and Fas. These 
events lead to consequent G1/S cell cycle arrest and apoptosis in a p53-dependent manner. 
Accordingly, in the absence of either p53 or p21, cells that were depleted for BRD8 showed 
G2/M-phase arrest and growth deficiency. Our results strongly suggest that loss of BRD8 
somehow impairs the cell's ability to repair DNA, thereby activating the G1/S check point 
in p53+/+ cells and the G2/M checkpoint in p53 and p21 null cells. 
 
 
Even though there is a clear involvement of BRD8 in the DNA damage response, we were 
not able to detect BRD8 at DNA damage foci induced by camptothecin or laser striping. 
Although this is in agreement with previously published data (Gong et al., 2015), it has 
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been shown that many of the subunits of mammalian p400/Tip60, of which BRD8 is a 
subunit, are recruited to DNA double-strand breaks (DSBs), implying that the intact 
complex may recruit to the DSB (Courilleau et al., 2012; Kusch et al., 2004; Murr et al., 
2006; Xu et al., 2010). Furthermore, we observed that the knock down of BRD8 results in 
reduction of H4K16 acetylation. Acetylation of H4K16 by Tip60 on DNA damage sites 
provides more open chromatin domains and promotes homologous recombination repair 
(Gursoy-Yuzugullu et al., 2015b; Tang et al., 2013). This suggests that BRD8 may be 
involved in regulating the chromatin state through recruitment of Tip60 to promote DNA 
damage repair. 
 
 
Importantly, in BRD8 depleted cells, CHK1 protein levels are severely decreased. CHK1 
is a major effector of the G2/M-phase DNA damage checkpoint and S-phase replication 
checkpoint (Petermann and Caldecott, 2006; Syljuasen et al., 2005). One of the CHK1 
regulatory mechanisms in response to genotoxic and replicative stress is proteosomal 
degradation (Zhang et al., 2005b). Moreover, CHK1 decrease or deactivation could lead to 
replicative stress, which would then cause DSBs and activate DNA damage response 
(Forment et al., 2011). Whether BRD8 regulates CHK1 transcription or whether CHK1 is 
degraded in response to genotoxic and replication stress in BRD8 depleted cells, both 
scenarios could result in DNA damage and explain the activated DNA damage response in 
absence of BRD8. Consistently, it has been reported that yeast mutated for bdf1and bdf2, 
yeast homologs of BRD8, display DNA damage accumulation, reduced H4Kac and 
replicative stress (Garabedian et al., 2012), this strongly suggests that BRD8 might have a 
similar role in mammalian cells and is involved in the recruitment of Tip60 histone 
acetyltransferase to chromatin. 
In chapter 2, when we investigated the role of transcription in the positioning of histone 
H2A.Z, one question remained to be addressed: How is the p400/Tip60 remodeling 
complex targeted to chromatin? In chapter 4, the last part of my Ph.D. project, I investigated 
different possible mechanisms that might be responsible for targeting p400/Tip60 complex 
to chromatin. p400-dependent incorporation of H2A.Z has been shown to regulate gene 
transcription in response to different physiological signals, but the mechanisms by which 
p400 is targeted to specific chromatin regions remains to be determined. I investigated the 
 164 
 
following mechanisms that might be responsible for targeting the p400/Tip60 complex to 
chromatin: i. the role of the H2A.Z histone variant itself; ii. post-translational modification 
by p300/CBP and iii. bromodomain containing subunit of p400/Tip60 BRD8. First, I 
investigated the possible role of H2A.Z in recruitment of p53 and p400 to the p21 promoter. 
Here, we show for the first time that histone variant H2A.Z is essential for efficient 
recruitment of p53 and p400 to the distal p53 binding element of the p21 promoter. 
Interestingly, our ChIP results in H2A.Z depleted cells revealed that the histone variant 
positively influences the recruitment of p400 and p53 binding to the p21 promoter, at least, 
at the distal p53 binding element. We showed that knockdown of H2A.Z expression led to 
severe reduction in p400 binding to the distal p53-binding site. Further treatment with 
daunorubicin did not rescue the reduced recruitment of p400 in H2A.Z depleted cells. In 
addition, our p53 ChIP data indicate that pre-deposition of H2A.Z is required for optimal 
p53 binding upon DNA damage and p53-dependent induction of the p21 gene. Secondly, I 
investigated a possible role for p300/CBP HAT in targeting the p400/Tip60 complex to 
chromatin at the p21 promoter. Our ChIP assay in DKO MEFs revealed that the depletion 
of p300/CBP leads to a severe decrease in the recruitment of p400 at the p21 promoter 
compared to control cells. In the same set of ChIP assays, H2A.Z was enriched in 
p300/CBP depleted cells suggesting that p300/CBP-dependent p400 recruitment is 
somehow involved in the removal of H2A.Z from the chromatin. This might occur through 
the newly recognized subunit of the p400/Tip60 complex ANP32E which is the chaperone 
that evicts the H2A.Z from nucleosomes (Obri et al., 2014). Finally, as the third part of this 
research question, I investigated the role of the BRD8 subunit of the p400/Tip60 complex 
in targeting the complex to chromatin. I found that BRD8 depletion has a minor effect on 
the recruitment of p400 to the p21 promoter as the knockdown of BRD8 led to a slight 
increase in the recruitment of p400 to the distal p53-binding site in non-stressed cells. 
Following the induction of p21 in BRD8 depleted cells, p400 recruitment is increased but 
not at the same level as p400 at the relevant p53 binding site in daunorubicin-treated control 
cells. In addition, BRD8 knockdown resulted in decreased enrichment of H2A.Z at the 
distal p53-binding site within the p21 promoter compared to control that most probably is 
the consequence of p53-dependent activation of the gene as we have described earlier in 
chapter 3.  
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Our results open up new avenues to help increase our understanding of the role of histone 
variant H2A.Z in the regulation of transcription, as well as of the mechanisms of 
recruitment of p400/Tip60 complex to chromatin to deposit the variant. Our studies on the 
BRD8 component of p400/Tip60 revealed important insights about the role of this 
bromodomain protein as a new player during the response to DNA damage. 
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5.2 PERSPECTIVE 
 
 
Mechanism of specific-gene bodies’ accumulation of H2A.Z in the absence of 
transcription 
 
 
Our analysis showed that when transcription is ceased, H2A.Z specifically accumulates 
within genes bodies. We have shown that for a set of genes H2A.Z accumulation is 
accompanied to some extent by the recruitment of the remodeling complex p400. It would 
be informative to investigate the genome wide recruitment of p400 and the mammalian 
H2A.Z remodeling complex SRCAP to chromatin when transcription is inhibited. One of 
the barriers to doing this is the lack of good antibodies to perform p400 ChIP-seq 
experiments. Recent advances in genome editing techniques could help to overcome this 
limitation. CrispR/cas9 genome-editing technique could be used to introduce suitable labels 
for ChIP to the chromatin remodelers. 
 
 
It also remains to be determined what triggers p400 recruitment to chromatin in the absence 
of transcription. One of the potential mechanisms for the recruitment of p400 to chromatin 
is histone post-transcriptional modifications. One of the histone marks shown to be 
responsible for p400 recruitment is H3K4me3 (Fazzio et al., 2008). This hypothesis could 
be tested by mutating different lysine residues in the tail of H3 using the CrispR/cas9 
genome-editing technique to identify the modifications responsible for targeting p400 and 
SRCAP to chromatin when transcription is inhibited.  
  
 
It is known that H2A.Z localizes at cohesin binding sites within chromatin (Millau and 
Gaudreau, 2011). Given that we have shown that p400 is responsible for the incorporation 
of the variant at Rad21 sites, it raises the possibility that cohesin may have a role in the 
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recruitment of p400 to deposit H2A.Z, thus making it interesting to investigate the 
mechanisms by which cohesin is involved in H2A.Z localization. 
 
 
Furthermore, it is established that over-expression of H2A.Z contributes to cancer initiation 
and progression (Dryhurst and Ausio, 2014; Monteiro et al., 2014). In addition, increased 
gene body H2A.Z has shown to promote cryptic transcription in yeast (Jeronimo et al., 
2015). Hence, it would be very interesting to investigate the role of gene body H2A.Z in 
gene transcription misregulation in carcinogenesis.  
 
 
Role of BRD8 in DNA damage response 
 
 
Our results clearly indicate that BRD8 is involved in DNA damage repair and/or in 
preventing DNA damage. In order to test the involvement of BRD8 in DNA repair, we 
could induce DNA damage in cells using radiation and then determine the recovery time 
after the damage. Despite the obvious involvement of BRD8 in DNA damage response, we 
were not able to detect BRD8 at DNA damage sites by immunofluorescence. Knowing that 
other subunits of the p400/Tip60 complex are known to be recruited to DNA damage sites, 
it would be interesting to further investigate whether BRD8 localizes to DNA damage sites 
using ChIP experiments at an artificially induced DNA break site.  
 
 
We also showed that in BRD8 depleted cells CHK1 protein is almost absent. This result 
raises several interesting questions: Is BRD8 involved in the transcriptional regulation of 
CHK1? Does BRD8 act as a transcription factor for CHK1 and/or for ChK1 master 
transcription regulator E4F1? Is CHK1 degradation a result of replicative stress in BRD8 
KD cells? We could easily address the question about transcriptional regulation of CHK1 
by BRD8 by RT-qPCR. Another alternative explanation relates to the decreased CHK1 
protein levels. This decrease could be proteosomal degradation in response to replicative 
stress. The induction of replication stress in BRD8 depleted cells could be tested by 
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monitoring the status of upstream kinase involved in the replication stress pathway such as 
ATR or its substrates (e.g. RPA). Phosphorylation of CHK1 at Ser345 by ATR is also 
known to activate CHK1 and marks it for proteosomal degradation (Zhang et al., 2005b). 
We could also use a proteasome inhibitor like MG132 and then check the levels of CHK1 
protein in BRD8 depleted cells. If our hypothesis is true and BRD8 depletion causes 
replication stress-dependent proteosomal degradation of CHK1, treatment with MG132 
should result in prolonged arrest in S-phase and cell death. In agreement with this 
hypothesis, it has been shown that MG132 increases cell deaths in BRD8 depleted cells 
(Yamada and Rao, 2009). 
 
 
Recently it has been shown that Tip60–p400 recruitment to many target genes is enhanced 
by promoter-proximal R-loops, RNA-DNA hybrid structures formed when G-rich 
sequences on RNA hybridize with their DNA template (Chen et al., 2015). R-loops are a 
major threat to genome stability. Unresolved R loops induce DNA damage and genomic 
instability. For this reason, cells have evolved various factors and processes to limit or 
prevent R-loop formation and accumulation. Dysfunction of these factors causes R-loop 
accumulation, which leads to replication stress, genome instability, chromatin alterations 
or gene silencing, phenomena that are frequently associated with cancer and a number of 
genetic diseases (Santos-Pereira and Aguilera, 2015). It would be interesting to verify the 
number of stalled DNA replication fork/R-loops in the absence of BRD8 by 
immunofluorescence using S9.6 monoclonal antibody and also by DNA–RNA 
immunoprecipitation followed by sequencing (DRIP–seq) to map R loops on a genome-
wide scale. 
 
 
Mechanisms for targeting p400 to chromatin 
 
 
In chapter 4 we showed that pre-deposition of histone variant H2A.Z is important for the 
recruitment of p53 and p400 to the distal p53 binding element of the p21 promoter. Our 
results raise a series of very interesting questions that remain to be investigated. For 
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example, how can H2A.Z containing nucleosomes affect p53 binding to its response 
element? What is the mechanism underlying the observed decrease in recruitment of p400 
in the absence of H2A.Z? Does the interaction of p400 with transcription factors, such as 
p53, play a role in targeting p400 to specific chromatin regions, which in turn direct H2A.Z 
to these regions? Do these observations also hold true at other p53-binding elements as 
general mechanisms for regulating p53’s binding to chromatin? And, more interestingly, is 
this is a general mechanism by which transcription factors regulate chromatin dynamics 
and gene expression? 
 
 
We also showed that p300/CBP is involved in targeting p400 to remove H2A.Z from 
regulatory elements. But the mechanisms yielding our results remain to be elucidated: How 
is HAT activity of p300/CBP involved in the signaling to recruit p400? Does p300/CBP 
acetylate H2A.Z? Is the presence of p300 and/or CBP themselves, apart from their HAT 
activities and through protein-protein interactions, required for targeting p400? It should 
be noted that p300 and CBP are large proteins that contain several protein domains, 
including one bromodomain (BRD). Contradictory reports exist on the effect of specific 
p300/CBP HAT inhibitors and BRD inhibitors on p53-dependent induction of p21. CBP’s 
BRD small molecule inhibitor ischemin prevented p53-dependent induction of p21 
following doxorubicin treatment (Borah et al., 2011). Another specific BRD inhibitor for 
p300/CBP also effectively inhibits p53 transcriptional activity in a reporter assay carried 
out in RKO cells (colon carcinoma with wild type p53) (Hay et al., 2014). These studies 
demonstrated that the p300/CBP-Kac interaction is crucial for p53-dependent induction of 
p21. On the contrary, a specific inhibitor of p300/CBP HAT (C646 compound) induces p21 
expression and cell cycle arrest and promotes cellular senescence in human melanoma cells 
(Yan et al., 2013).  
 
 
Answering the above questions could lead us to better understand the mechanisms 
underlying tightly regulated chromatin states and the mechanisms utilized by each factor 
to orchestrate DNA metabolism in response to different stimuli.  
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